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ABSTRACT
GENETIC, METABOLIC, AND HISTOPATHOLOGICAL STUDIES OF
PARTICLE-ASSOCIATED RESPIRATORY ALTERATIONS
Mohamed Mohamedy Ghanem
Cytochrome P450s (CYPs) form a superfamily of enzymes crucial for the
oxidative metabolism of a wide variety of endogenous and exogenous (xenobiotic)
compounds. Cytochrome P4501A1 (CYP1A1) is a member of the CYP1A subfamily that
is involved in pulmonary carcinogenesis. CYP1A1 metabolizes polycyclic aromatic
hydrocarbons (PAH), such as benzo[a]pyrene in cigarette smoke into DNA-binding
reactive metabolites resulting in gene mutation and carcinogenesis. Silicosis and coal
workers’ pneumoconiosis (CWP) are two pulmonary diseases associated with
occupational exposure to silica and coal dust (CD), respectively. Most coal miners are
smokers or ex-smokers and epidemiologic studies of coal dust carcinogenesis are
confounded by the presence of both cigarette smoke and respirable particles. To clarify
the nature of this interaction, we investigated the hypotheses that (1) CYP1A1 induction
and activity (EROD) are inhibited by CD and silica. (2) CYP1A1 inhibition by particle
exposure is associated with changes in the cellular populations in the exposed lung.
Western blot analysis, immunofluorescent-labeling, bronchoalveolar lavage fluid
analysis, biochemical assays, and histopathology were used to evaluate our hypotheses.
Because of a current debate about using the rat to extrapolate particle-induced pulmonary
alterations to humans, the rabbit silicosis and sheep CWP model, were also used. The
results indicate that (1) CYP1A1 induction and its metabolic activity (EROD) were
suppressed by CD exposure in rats and sheep; and by silica in rabbits (2) CYP1A1
expression was reduced in alveolar epithelial cells by CD or silica exposure (3) silica and
CD increased the size (hypertrophy) and number (hyperplasia) of alveolar type II cell
with reduction of CYP1A1 expression in these cells (4) CD particles induced dosedependent pulmonary inflammation, manifested by recruitment of alveolar macrophages
and polymorphonuclear leucocytes (5) CD particles induced the preapoptotic Bax protein
expression in alveolar epithelial cells and triggered apoptosis (6) inhibition of apoptosis
and Bax by the caspase inhibitor, Q-VD-OPH, did not alter CYP1A1 induction (7)
suppression of CYP1A1 induction was associated with pulmonary inflammation. These
findings are consistent with the hypothesis that CYP1A1 induction and its metabolic
activity are inhibited by particle exposure and associated with pulmonary inflammation.
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CHAPTER 1
GENETIC, METABOLIC, AND HISTOPATHOLOGICAL STUDIES OF
PARTICLE-ASSOCIATED RESPIRATORY ALTERATIONS
INTRODUCTION
One of the most biologically important enzymatic systems involved in the
metabolism of xenobiotics in the lung is cytochrome P450. Cytochrome P450s (CYPs)
are monooxygenases that activate molecular oxygen necessary for oxidative metabolism
of different internal or external lipophilic xenobiotics (Barker et al, 1992; Hasler et al,
1999) producing less lipophilic substances, thus facilitating their excretion (Mucci et al,
2001). Some CYP members, such as CYP1A1 are induced by substrates, such as
polycyclic aromatic hydrocarbons (PAHs). Unfortunately the induced CYP1A1 may
metabolize the PAH into highly reactive intermediates. For example, a CYP1A1dependent enzymatic process can metabolize the PAH benzo(a)pyrene in cigarette smoke
into the highly carcinogenic metabolite, benzo(a)pyrene diol epoxide (BPDE) (Bjelogrlic
et al, 1993). This reactive intermediate covalently interacts with DNA nucleotide bases,
particularly guanine and adenine, producing DNA adducts with potential ensuing
mutations of important genes. Cells with damaged DNA may be removed by apoptosis
(programmed cell death) (Venkatachalam et al, 1993). Alternatively, if a permanent
mutation occurs in a critical region, an oncogene may be activated, or a tumor suppressor
gene, such as p53 may be inactivated (Wang et al, 1995). The excessive presence of such
mutational events leads to aberrant cells with loss of normal growth control and,
ultimately, to cancer (Liang et al, 2003).
Pulmonary xenobiotic metabolism is currently a subject of extensive research
from the standpoints of genetic and metabolic aspects because of our increasing
exposures to foreign respirable compounds that may alter and modify the metabolic
activity and expression of pulmonary enzymatic systems. The lung, being exposed to air
is a target organ frequently exposed to xenobiotics via inhalation (Pairon et al, 1994).
Examples of lung diseases associated with respirable foreign particulate inhalation are
coal workers’ pneumoconiosis (CWP), bronchitis, emphysema, and silicosis (Green and
Vallyathan, 1998; Kleinerman et al, 1979). CWP is an occupational lung disease
associated with inhalation of poorly soluble respirable dust (Schins and Borm, 1999). It
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may occur as a simple form or a complicated form known as progressive massive fibrosis
(PMF) (Yeoh and Yang, 2002). In the simple form, only macules (<0.5 cm in diameter)
appear in the lung and these consist mainly of dust-laden macrophages (Castranova,
2000). In the complicated form, PMF, the lesion is irregular coal dust-laden, fibrotic
masses with haphazardly arranged collagen fibers associated with compromised lung
functions (Castranova and Vallyathan, 2000).
At least one epidemiological study stated that lung cancer risk in smoking miners
is not statistically different from, or even less than, other smoking populations (Costello
et al, 1974). Although silica has been classified as carcinogenic by the International
Agency for Research in Cancer (IARC, 1997), lung cancer was almost absent in lungs
concomitantly exposed to silica and chemical carcinogens, such as PAH (Cocco et al,
2001). Attempts to determine the carcinogenic effect of coal dust and silica exposure in
miners may be invalid because smoking miners are exposed to a mixture of the
carcinogenic PAHs in cigarette smoke and the respirable insoluble particles that may
modify chemical carcinogenesis. If respirable particles modify chemical carcinogen
metabolism in the lung, epidemiologic studies of respirable particles in smoking miners
may need to control respirable particles and smoking as modifiers rather than covariables.
Extrapolating from a rat model to determine the human response to inhaled
particles is controversial (Mauderly, 1997), particularly when Nikula et al (1997) showed
a difference in particle retention and pulmonary response to inhaled respirable
particulates between rats and primates.
In this study, we investigated the hypothesis that pulmonary CYP1A1 induction
by the model PAH, beta-naphthoflavone, is inhibited by respirable coal dust and silica.
To overcome limitations of any specific animal model, we have investigated this
hypothesis in rats, rabbits, and lambs. In addition, we have investigated changes in lung
cell populations and their changing CYP1A1 expression after particle exposure. Finally,
we investigated the association between altered CYP1A1 expression and particle
associated apoptosis, caspase inhibition, Bax expression and inflammation.

3
OBJECTIVES
The objectives of this study were to:
1- Establish a relationship between coal dust or silica inhalation and deposition in
the lung and CYP1A1 induction.
2- Establish a relationship between particle exposure and histopathological changes
associated with deposition of these particles in lung alveoli, such as alveolar type
II cell hyperplasia and hypertrophy and pulmonary inflammation.
3- Establish a relationship between particle-associated pulmonary changes and the
pattern of CYP1A1 expression in lung alveolar cells.
4- Investigate these relationships in different animal models including rats, rabbits,
and lambs.
5- Investigate the association of apoptosis, caspase inhibition, Bax expression, and
inflammation with regulation of CYP1A1 expression by pulmonary exposure to
respirable particles.
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CHAPTER 2
REVIEW OF LITERATURE
1-Cytochrome P450s (CYPs)
1.A. Introduction
CYPs are membrane-bound heme-containing proteins (hemeproteins) resulting
from expression of a gene superfamily containing about 1000 members that is found in
all species ranging from prokaryotes to plants and animals (Hasler et al, 1999, Mckinnon,
2000). The letter P means a pigment that produces a broad absorption band with a peak
of 450 nm (Omura and Sato, 1964; Remmer and Merker, 1965). Although the name
cytochrome is a misnomer, because these are enzymes and not pigments, it has been
established as a nomenclature for these proteins (Mckinnon, 2000). These proteins
comprise a class of monooxygenases or mixed function oxidases, which activate
molecular oxygen necessary for oxidative metabolism of a diversity of lipophilic organic
materials (Barker et al, 1992; Hasler et al, 1999).
CYPs play vital roles in catalyzing biological reactions involved in drug and
xenobiotic metabolism, steroid hormone biosynthesis, oxidation and metabolism of
unsaturated fatty acids (Kawajiri and Fujii-Kriyama, 1991; Hasler et al, 1999, Petersen et
al, 1991). The human CYP1A subfamily, which is the most extensively studied of these
enzyme systems, consists of 2 functional genes: CYP1A1, which is involved in the
metabolism of PAHs, and CYP1A2, which is involved in the metabolism of arylamine
(Peterson et al, 1991).
1.B. History and Background
The first experimental evidence relating to CYP was documented in 1955 by
Axelrod and Brodie et al, who identified an enzyme system in the endoplasmic reticulum
of the liver that was able to oxidize xenobiotic compounds. In 1958, Garfinkel detected a
carbon monoxide binding pigment in liver microsomes which had an absorption
maximum at 450nm (Figure 1) during their spectrophotometric studies. This
characteristic absorbance peak has been used since then as the signature of P450 proteins;
i.e. the name P450 was derived from this property of the pigment. Because this
absorbance was unique to CYPs among all hemeproteins (except nitric oxide synthase), it
was used for specrtophotometric identification and quantification of CYPs activity. CYPs
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remained a spectrophotometric puzzle until they were unveiled by Omura and Sato
(1962, 1964) who identified the pigment as a hemeprotein. Soon after that, Estabrook et
al (1963) demonstrated the role of adrenal cortex P450 hydroxylation of progesterone
using the classic photochemical action spectrum technique developed by Otto Warburg
(1949). By using the same methods, Cooper et al (1965) confirmed that P450s occurring
in liver microsomes metabolize drugs and other xenobiotics.

Figure 1. Absorbance spectrum of reduced form of CYP showing the maximum peak at
450 nm (Adapted from Thomas and Gillham, 1989).
CYPs enzymes have a wide tissue distribution as they have been isolated from
many different mammalian tissues, including liver, kidney, lung, intestine, and adrenal
cortex (Hasler et al, 1999). The amount of microsomal CYP in a human liver is
comparatively high (e.g., ~7500 nmoles in a 1.5-kg liver). CYPs have also been isolated
from insects, plants, yeast, and bacteria (Mckinnon, 2000). While CYPs are distributed in
almost every organ, the types of CYPs in a tissue appear to be specific (Hasler et al,
1999). Ten families and 16 subfamilies of human CYPs have been identified, and their
structure, function and regulation have been investigated. The contribution of each
individual isoform of human CYPs to the metabolism and bioactivation of different
carcinogens has been extensively studied by using gene- or cDNA-directed expression of
CYPs and human liver microsomes in conjunction with specific antibodies (Kawajiri and
Fujii-Kriyama, 1991).
1.C. Structure of CYPs
CYPs are hemeproteins that consist of a protein (the apoprotein or apoenzyme)
and a heme moiety, called iron-protoporphyrin IX (Testa, 1995). This porphyrin is not
only present in all CYP enzymes, but also in other hemeproteins -and enzymes such as
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hemoglobin, myoglobin, catalase and most peroxidases. The protein component of the
enzyme varies greatly from one enzyme/isozyme to the other. Therefore, differences in
isozyme properties, such as molecular weight (approximate range 45 to 60 kDa),
substrate and product specificities, and sensitivity to inhibitors could be attributable to
this variation in protein.
The structure of the prosthetic heme of CYP is portrayed in Figure 2 (Testa et al,
1995). An iron cation is bound to the four pyrrole nitrogens. Two additional nonporphyrin ligands in axial positions, the fifth ligand X and the sixth ligand Y, are also
shown. The X is the thiolate ligand, the chiral orientation of the heme shown in the
Figure 1 is that found in CYP. The detailed structure of protoporphyrin IX has been
revealed by X-ray crystallographic studies (Caughey and Ibers, 1977). Cytochrome
P450cam, a soluble bacterial enzyme, showed comparable results by crystallographic
examination (Poulos, 1988 and 1991; Poulos and Raag, 1992, Poulus et al 1986).

Figure 2. The structure of iron-protoporphyrin IX, the prosthetic heme of CYPs (Adapted
from Pasta, 1995).
The fifth ligand to the iron cation (X) is a thiolate group that occurs near the
carboxyl end of the protein from an essential cysteine. This ligand binds to the central
heme by an extraordinary strong iron-sulfur bond, which is indispensible for the catalytic
activity of CYPs (Black and Coon, 1985; Collman et al, 1976; Poulos and Raag, 1992;
Silver and Lukas, 1982; Ruf et al, 1979.
The composition of the sixth ligand (Y) is controversial. Some years ago, a
number of investigators demonstrated that this ligand was not a strong nitrogencontaining ligand, but a weaker, oxygen-containing one (Dawson et al, 1982; White and
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Coon, 1982). This decision was based on the observation of a hydroxyl group, either
from an adjacent amino acid residue or a water molecule (Kumaki and Nebert, 1978).
Recently, the sixth ligand has been described as a hydroxyl group related to a tyrosinyl
residue located near the heme, while in cytochrome P450cam (bacterial enzyme) it
appears to be a water molecule (Janig et al, 1984; Poulos and Raag, 1992; Poulos et al,
1986).
The significance of the liganded heme in CYPs structure is extremely important.
It can exist in different electronic states (either ferric or ferrous oxidation state) which are
responsible for many of the properties of CYP, most significantly for the binding of
ligands and the activation of molecular oxygen (Testa, 1995).
1.D. Nomenclature of CYP Genes and Proteins
It has been recommended that CYP genes be named according to the following
rules (McKinnon, 2000; Nelson et al, 1996):
-The root symbol CYP for cytochrome P450
-An Arabic number for the cytochrome P450 family
-A capital letter for the subfamily; and
-An Arabic number for the individual gene
-When describing a CYP gene, all letters and numbers should be written in italics
-When describing a CYP protein, all letters and numbers should be in non-italicized
form.
For example, CYP1A1 is the gene encoding CYP1A1 where:
CYP: is the cytochrome P450
1: is the CYP family,
A: is the subfamily (expression of this particular subfamily is induced by aromatic
hydrocarbons)
1: is the individual gene.
It is estimated that the various CYP families diverged from one another more
than 1.2 billion years ago (McKinnon, 2000); consequently, any enzyme in a particular
CYP family is less than 40% similar to any enzyme from another CYP family at the
amino acid level (Nebert et al, 1987). In addition, the subfamilies diverged from one
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another about 400 million years ago. Any 2 enzymes within the same subfamily generally
share more than 55% amino acid similarity (Nebert et al, 1987). It is noteworthy that the
nomenclature system was based upon the evolutionary relationships among CYP
enzymes and not on substrate profiles because some CYPs from the same family have
different substrate profiles or physiological functions (McKinnon, 2000).
1.E. Functions and Mechanism of Actions of CYPs
CYPs are known to catalyze reactions such as epoxidations, hydroxylations, N-,
S-, and O- dealkylation, sulfoxidations, dehalogenations, N-oxidations, and many other
reactions (Groves, 1985). The iron protoporphyrin IX center is the primary reactive site
for these reactions. Seven sequential catalytic steps have been associated with CYPscatalyzed reactions, which can be summarized as follows: (1) Substrate binding, (2)
Reduction of the CYP from resting (ferric) to the ferrous state, (3) Formation of a ferrous
CYP-dioxygen complex by binding of molecular oxygen, (4) Transfer of a second
electron to the complex producing a peroxoiron (III) complex, (5) Protonation and
cleavage of the O-O bond with the formation of reactive iron-oxo species, (6) Oxygen
atom transfer from this oxo complex to the bound substrate, (7) Dissociation of the
product. Therefore, CYPs function as monooxygenases

(Hayaishi, 1962) or mixed

function oxidases (Mason, 1957) by incorporating one of the two oxygen atoms of an O2
molecule into a wide variety of lipophilic substrates with concomitant reduction of the
other oxygen atom by two electrons to H2O (Hasler et al 1999) as shown in the following
CYP-dependent oxygenation reaction:
NADPH + O2 + AH2 + H+

NADP+ + AHOH + H2O

Ortiz de Montellano (1995) reported that some extrahepatic human CYPs have
key roles in maintaining homeostasis and signal transduction as well as drug metabolism.
For example, lungs and nasal tissues contain a considerable amount of CYP, and these
sites may be important in the oxidation of xenobiotics entering the respiratory system.
Renal CYPs may have a significant role in processing compounds generated in the
kidneys or transported there from the liver. Moreover, one of the extrahepatic tissues with
an important CYP activity is the small intestine (Orton and Parker, 1982) where CYP3A4
is abundant (Tamburini et al, 1984). It plays a major role in the metabolism of many
orally administered drugs (Hardwick et al, 1987; Reddy et al, 1986). As a consequence, it
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may considerably inactivate these drugs and reduce their bioavailability. The functions of
CYPs in different human subfamilies are shown in Table 1 (Hasler et al, 1999).
CYP isoform

Metabolic functions

CYP1A and B

Polycyclic hydrocarbons. Nitrosamines

CYP2A

Drugs. Alcohols. Steroids

CYP3A

Drugs. Antibiotics. Flavenoids

CYP4

ω-oxidation fatty acids

CYP5

Thromboxane synthase

CYP7A

7α-Hydroxylase. Bile Acids

CYP8A and B

Prostacyclin Synthase. Bile Acids

*CYP11A and B

Cholesterol side-chain cleavage. Aldosterone synthesis

CYP51

Cholesterol Biosynthesis. 14-demthylase

*CYP40

Vitamin D3- 1α Hydroxylase

*CYP27

Bile Acid Synthesis

CYP26

Retinoic Acid Hydroxylase

*CYP24

Vitamin D degradation

CYP21

Progesterone 21-Hydroxylase

CYP19

Estrogen Biosyhthesis. Aromatase

CYP17

Steroid 17 α-Hydroxylase. Steroid C17/21 Lyase
Table 1: The human CYP subfamilies and their metabolic functions. An asterisk

next to an isoform indicates mitochondrial enzymes. (Adapted from Hasler et al, 1999).
1.F. Biological Importance of CYPs and Their Role in Carcinogenesis
CYPs are important in the metabolism of xenobiotics and in the critical steps of
steroid hormone biosynthesis.

Because of these important roles, the regulation and

mechanism of these enzymes have occupied a central place in the interests of
pharmacologists and toxicologists.

Accordingly, it was not surprising that when

recombinant DNA technology emerged, CYPs were one of the first classes of enzymes to
be cloned. The CYP1A1 cDNA (Kawajiri et al, 1986) and gene (Jaiswal et al, 1985a,
1985b; Kawajiri et al, 1986) have been cloned, sequenced, and localized on chromosome
15 near the MPI locus (Hildebrand et al, 1985).
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Carcinogens that enter the body by different routes are metabolized by two major
enzymatic systems: phase I and phase II enzymes (Mucci et al, 2001). Generally, phase I
enzymes function by attaching specific groups to the compound thereby producing
intermediate metabolites that are usually more reactive and carcinogenic than the original
compound. Phase II enzymes also act to attach additional groups. These modifications
detoxify or inactivate the reactive intermediate and prepare them for breakdown or
excretion in a less lipophilic form (Mucci et al, 2001).
Human lung cancer often involves exposure to procarcinogens mainly contained
in cigarette smoke, although the association of cigarette smoking with lung cancer differs
by histological types. Most chemical procarcinogens require activation by Phase I
enzymes, CYPs, to become reactive electrophilic forms that exert toxic or carcinogenic
effects. Thus, CYPs are the key enzymes responsible for the initial metabolism of various
procarcinogens present in our environment. Although several species of CYPs have been
linked to lung carcinogenesis, CYP1A1 is one of the most important. It is expressed in
human lung tissue and can metabolize PAHs in cigarette smoke such as benzo[a]pyrene
(Hasler et al, 1999). In addition to its role in the production of electrophilic intermediate
metabolites, CYP1A1 is also involved in the formation of highly reactive oxygen free
radical species, such as hydroxyl radicals or superoxides as byproducts. These alterations
may result in toxic responses or cellular damage and eventual carcinogenesis (Hasler et
al, 1995).
1.G. The Inducibility of CYPs
Some of the CYP enzymes can be induced by substrate binding, thereby allowing
the cells to adapt to changes in their chemical environment and maintain homeostasis
(Denison and Whitlock, 1995). Drug and xenobiotic metabolism can be altered by
induction of CYPs and other metabolizing enzymes. For example, the tolerance to
barbiturates is a common body reaction associated with induction of drug metabolizing
enzymes (James and Whitlock, 1999). Similarly, chemical carcinogenesis may be
attenuated or inhibited by enzyme induction that increases the rate of detoxification
(James and Whitlock, 1999). Consequently, enzyme induction can be a protective
mechanism by which the cells metabolize the lipophilic compounds; otherwise they will
accumulate to deleterious levels that overcome the defense mechanisms. By contrast,
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induction can be disadvantageous in some instances. The enzyme induced by one
substrate may increase the metabolism of a drug leading to attenuation of drug effects
(Guengerich, 1997). Moreover, CYPs induction may lead to toxicity or neoplasia as a
result of the oxygenation of PAHs (PAHs), present in cigarette smoke and other
combustion products, producing highly reactive electrophiles called arene oxides that
bind covalently to the cellular macromolecules resulting in carcinogenesis (Conney,
1982; Miller and Miller; 1981; Phillips, 1983)
2-Cytochrome P450 1A1 (CYP1A1)
(Family 1, subfamily A, polypeptide 1)
2.A. Introduction
CYP1A1, an inducible CYP (Hasler et al, 1995), is a member of the human
P4501A subfamily which includes only 2 members, CYP1A1 and CYP1A2 (Ortiz de
Montellano, 1995). These 2 isoforms have 70% similarity in their amino acid sequence
(Ortiz de Montellano, 1995). In addition to liver (Whitlock, 1986; Issemann and Green,
1990; Gottlicher et al. 1992), CYP1A1 has also been detected in lungs (Antilla et al,
1991), placenta (Song et al, 1985), brain (Yun et al, 1998), and lymphocytes (Jaiswal et
al, 1985b). CYP1A1 enzyme is involved in the metabolism of PAHs, whereas CYP1A2
is involved in the metabolism of arylamines (Peterson et al, 1991). It has been
demonstrated that high inducibility of CYP1A1 is considered a risk factor for lung cancer
in tobacco smokers (Anttila et al, 2001; Ishibe et al, 2001). Because smokers are
exposed to carcinogenic PAHs, their CYP1A1 expression is induced (Willey et al, 1997).
2.B. Genetic Polymorphisms of CYP1A1
Since CYP1A1 participates in the biochemical activation of PAHs to produce
mutagenic and carcinogenic derivatives, genetic polymorphism in CYP1A1 activity may
alter susceptibility to PAH-associated diseases, such as lung cancer in smokers (James
and Whitlock, 1999). Phenotypic polymorphism in the inducibility of CYP1A1 was
originally described by Kellermann et al (1973) when he found that 10 % of Caucasians
showed much higher lymphocytic CYP1A1 activity after exposure to an inducer than the
rest of the group. In genotyping studies, two closely linked polymorphisms of the
CYP1Al gene have been demonstrated in Caucasian and Oriental populations (Hasler et
al, 1995). These include a 3'-flanking region Msp1 site (also called m2 allele) and the
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exon 7 Ile-Val substitution (Val allele). The m2 allele has been associated with increased
CYP1A1 inducibility in some studies whereas the Val allele is associated with enhanced
enzyme activity in vitro (Hayashi et al., 1991, 1992). A new CYP1A1 polymorphism has
been observed among black populations called Msp I AA (Kawajiri, 1999) and has a
striking association with breast cancer risk (Taioli et al, 1995; Taioli et al, 1999).
2.C. Induction of CYP1A1
CYP1A1 induction was first discovered because it was observed that PAHs
mediate their own metabolism. The studying of its induction mechanism was facilitated
by several important observations (James and Whitlock, 1999). First, its induction is
strong and evident compared to the background level. Second, the induction is affected
by genetic polymorphisms, which made the genetic analysis possible. Third, CYP1A1
induction has been demonstrated in cell cultures, which facilitates the gene transfer
experiments. Experiments involving induction-defective mouse hepatoma cells
demonstrated various groups of genes that synergistically contributed to the induction
mechanism (Hankinson, 1995; Whitlock et al, 1996). It has been demonstrated that
inducer binding was reduced in one mutant associated with low levels of aromatic (aryl)
hydrocarbon receptor (AhR), which is an intracellular protein essential for the initiation
of the induction process (Gonzalez et al, 1996; Okey, 1994). Another mutant defective in
a protein called Ah receptor nuclear translocator (Arnt) showed disturbance of nuclear
localization of liganded AhR (Whitlock et al, 1996). The studying of these mutants
highlighted the possible role of different proteins in the mechanism of CYP1A1 induction
(Hankinson, 1995; Whitlock et al, 1996).
2.D. Mechanism of CYP1A1 Induction
It is well known that genomic DNA is associated with histones and other DNAbinding proteins to form chromatin, whose basic units are called nucleosomes. Chromatin
configuration plays a key role in gene expression in that the presence of nucleosomes
represses transcription (Grunstein, 1997; Wu, 1997; Kadonaga, 1998; Struhl, 1998;
Gregory and Horz, 1998). It is important that transcription factors such as AhR and Arnt
gain access to their cognate recognition sites on the chromatin to overcome the repressive
effect of nucleosomes on gene expression (James and Whitlock, 1999). In uninduced
cells, the CYP1A1 enhancer/promoter region been suggested to be bound by nucleosome
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according to indirect end-labeling analysis in mouse hepatoma cells (Morgan and
Whitlock, 1992). The apparent cause of the low levels of CYP1A1 in uninduced cells is
that the enhancer/promoter region is not accessible to transcription factors, particularly
when the DNA binding sites are facing inward toward the histone (James and Whitlock,
1999). The induction process is initiated by binding of the inducer, such as PAHs to the
AhR, which is usually located in the cytoplasm complexed with hsp90 and the AhRinteracting protein (AIP) (Ma and Whitlock, 1997). This binding results in the
dissociation of the hsp90 and AIP followed by translocation of the AhR to the nucleus
where it is conjugated with Arnt forming a heterodimer complex. The process of
heterodimerization may be enhanced by phosphorylation at particular sites most probably
on AhR (Career et al, 1992). The AhR/Arnt heterodimer binds to the xenobiotic
responsive element (XRE) on the CYP1A1 enhancer region resulting in gene transcription
(Figure 3)
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Figure 3. CYP1A1 induction mechanism (Adapted from James and Whitlock, 1999). The binding of ligand to the AhR results in
dissociation of the AhR-associated cytoplasmic proteins (Hsp90 and AIP) followed by translocation of AhR to the nucleus where it
dimerizes with Arnt. AhR/Arnt heterodimer binds to the xenobiotic responsive element (XRE) at the enhancer region of CYP1A1 gene
stimulating chromatin changes, binding of initiating complex and CYP1A1 induction.
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2.E. The CYP1A1 Inducers
Constitutive (background) expression of CYP1A1 is very low in contrast to the
inducible expression which is extremely robust. Most CYP1A1 inducers are also
substrates metabolized by that enzyme which suggest that the induction process is an
adaptive reaction of the body to enhance the detoxification process, particularly with the
low concentrations of the inducers (James and Whitlock, 1999). Inducers for CYP1A1
are also ligands for the AhR, since most of the inducers, such as 2,3,7,8tetrachlorodibenzo-p-dioxin (TCDD) have an extraordinary affinity for the AhR (Poland
et al, 1986). Based on studies of structure-activity relationships, it was suggested that the
AhR ligands are planar and interact with a hydrophobic pocket in AhR (Poland and
Knotson, 1982). However, it was found that CYP1A1 expression can be mediated by the
binding of compounds of different structure and lipophility to the AhR (Denison et al,
1998). Ligands for AhR may include specific indoles and other compounds from ingested
food which suggests a relationship between diet and cancer prevention because ingestion
of inducer-containing food may enhance the detoxification or activation of other potential
chemical carcinogens (Bjeldanes et al, 1991; Fahey et al, 1997). Ligands for AhR also
include PAHs, such as 3-methylcholanthrene, benzo(a)pyrene, polyhalogenated aromatic
hydrocarbons, such as the 2,3,7,8-tetrachlorodibenzo p-dioxin (TCDD), and certain
congeners of polyhalogenated biphenyls (Ke et al, 2001).
2.F. The role of CYP1A1 in carcinogenesis
The most commonly described mechanism of CYP1A1-mediated carcinogenesis
involves the oxidation of benzo(a)pyrene (in cigarette smoke) into the intermediate
reactive metabolite, benzo[a]pyrene diol epoxide (BPDE) (Bjelogrlic et al, 1993; Liang et
al, 2003). This unstable epoxide is able bind to the DNA nucleotide bases, mainly
adenine and guanine, producing stable adducts (Figure 4) that result in DNA mutations
(Szeliga and Dipple, 1998). When such a mutation involves a critical gene, such as p53, it
can lead to lung cancer (Vogelstein and Kinzler, 1992; Denissenko et al, 1996; Wang et
al, 1995). A positive correlation has been established between DNA adducts and human
lung cancer (Denissenko et al, 1996). Denissenko and his co-workers demonstrated that
the DNA adducts caused by BPDE are distributed along exons of the P53 gene in Hela
cells and bronchial epithelial cells, particularly at guanine positions in codons 157, 248,
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ad 273. These positions are the same main mutational hotspots observed in human lung
cancer (Denissenko et al, 1996).

Figure 4: Mechanism of carcinogenesis induced by CYP1A1-catalyzed reaction (Adapted
from: Geacintov, NE: http://www.nyu.edu/projects/geacintov/images/WEB_Figures/WEB_PAH3.htm).
2.G. Modification of CYP1A1 induction
2.G.1. Effect of Nuclear Factor Kappa B (NF- κB) and Tumor Necrosis Factor- α
(TNF- α)
NF-κB is a pleiotropic transcription factor that plays important roles in the
regulation of diverse physiological processes, such as inflammatory reactions, immune
responses, cell proliferation, apoptosis, and developmental processes (Ke et al, 2001;
Baldwin, 1996). NF-κB is a heterodimer which basically consists of a p65 (RelA) and a
p50 (NF-κB -1) subunit, with RelA being the subunit conferring robust transcription
activity. Some recent studies indicate a reciprocal inhibitory interaction between the AhR
and NF-κB signaling pathways (Tian et al, 1999) which suggests that the NF-κB plays a
key role in suppression of CYP1A1 expression by inflammatory responses associated
with exposure to different agents.
Four different mechanisms have used to describe the regulation of CYP1A1
induction by NF-κB and TNF-α: (A) the interaction between NF-κB and the AhR
repressor (AhRR), (B) the interaction between NF-κB and AhR itself, (C) the inhibition
of histone acetylation of CYP1A1 promoter by NF-κB, and (D) the suppression of
CYP1A1 transcriptional elongation by NF-κB.
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2.G.1.a. Effect of NF-κB on aryl hydrocarbon receptor repressor (AhRR)
AhRR is a member of the bHLH/PAS superfamily of transcription factors that is
associated with the repression of AhR function (Baba et al, 2001, Mimura et al, 1999).
This polypeptide (AhRR) represses AhR’s function as a transcription factor by
competing with it in forming a heterodimer complex with Arnt capable of binding to the
XRE sequence. In addition, the expression of AhRR is induced by the AhR/Arnt
heterodimer binding to an upstream XRE enhancer sequence; consequently regulation of
AhR function is mediated by feedback inhibition of AhRR (Mimura et al, 1999). The
AhRR gene has been localized to mouse chromosome 13C2, rat chromosome 1p11.2, and
human chromosome 5p15.3 by fluorescence in situ hybridization analysis (Baba et al,
2001). Screening of the promoter sequence of the AhRR revealed multiple enhancer DNA
elements: three XRE sequences (at the -45, -388, and -1296 position), three GC box
sequences (at -36, -53, and -58), and one NF-κB binding site (at -28) (Baba et al, 2001).
Since the binding of NF-κB to its cognate enhancer sequence of the AhRR gene
upregulates AhRR expression, it was suggested that NF-κB downregulates CYP1A1
induction via repression of the AhR functional activity (Baba et al, 2001). This
suggestion was supported by the suppressive effect of different cytokines, such as TNF-α,
interleukin-1β, and interferon-γ on CYP1A1 induction (Barker et al, 1992, Calleja et al,
1997) since NF-κB is an upstream regulator of these cytokines (Scheidereit, 1998).
2.G.1.b. Direct Effect of NF-κB on AhR
Physical association between the RelA subunit of NF-κB and AhR has been
demonstrated by an immunoprecipitation study (Tian et al, 1999). It was suggested that
the non-activated AhR and NF-κB are retained in the cytoplasm and are kept apart by
their association to their respective regulatory proteins [hsp90 associates with AhR
(James and Whitlock, 1999) and IκB associates with RelA (Zhong et al, 1997)] resulting
in compartmentalization. Upon extracellular activation signals, such as TCDD or BNF
for AhR, and TNF for NF-κB, the AhR and NF-κB subunits dissociate from their
respective regulatory proteins and interact with each other by physical association (Tian
et al, 1999) producing an inactive complex that prevents AhR from binding to the
enhancer sequences of CYP1A1 (Ke et al, 2001). This physical association could explain
the downregulation of CYP1A1 induction by the activated NF-κB.
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2.G.1.c. Effect NF-κB on Histone Acetylation at the CYP1A1 Promoter.
NF-κB has been demonstrated to inhibit the ligand-induced acetylation of histone
H4 at the CYP1A1 promoter, especially around the TATA box region. This prevents the
AhR/Arnt heterodimer from binding to the XRE and results in downregulation of
CYP1A1 expression (Tian et al, 2002). This mechanism was illustrated by using the
chromatin imunoprecipitation assay (Ke et al, 2001). Histone acetylation is known to
enhance transcriptional activation (Strahl and Allis, 2002) which is brought about by
assembly of the initiation complex (Ke et al, 2001). Silencing of gene expression has
been associated with hypoacetylation. Therefore, NF-κB-induced suppression of histone
acetylation is associated with silencing of CYP1A1 gene expression. It has been
suggested that the acetylation state of a histone is the result of 2 different intracellular
processes; acetylation and deacetylation (Ke et al, 2001). Accordingly, the inhibition of
the acetylation of histone H4 at the CYP1A1 promoter could be attributed to either
decreased histone acetyl transferase (HAT) activity or increased deacetylation by the
histone deacetylase (Ke et al, 2001).
2.G.1.d. TNF-α Suppresses CYP1A1 Transcriptional Elongation
Treatment of mouse Hepatoma (Hepa1c1c7) cells with dioxin resulted in an
increase in the phosphorylation of the C-terminal domain of RNA polymerase II (Tian et
al, 2003). This phosphorylation is essential for CYP1A1 elongation. Treatment of the
same cell line with TNF-α suppressed the phosphorylation of the C-terminus of RNA
polymerase II, particularly at serine 2, resulting in interference with CYP1A1 elongation
(Tian et al, 2003).
2.G.2. Effect of Inflammation on CYP1A1 Induction
The effect of inflammation on CYPs has been extensively studied in rat
hepatocytes (Morgan, 1997) which reflect responses detected in vivo in most cases
(Morgan, 2001).

The response of the body to infection or inflammation has been

associated in most cases with suppression of CYPs, particularly in liver (Morgan, 1997).
It was suggested that the suppression of CYPs expression during inflammation is not an
adaptive or homeostatic response, rather the priority of the liver to assign its
transcriptional machinery for synthesis of specific proteins necessary for controlling the
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systemic inflammatory response (Morgan, 1989). However, different CYPs isoforms are
regulated by different mechanisms and different cytokines (Morgan, 1997).

In

extrahepatic tissues, the CYPs are preferentially regulated by different inflammatory
stimuli (Morgan, 2001). For instance, CYP1A1 is downregulated in brain inflammation
whereas CYP2E1 is upregulated in astrocytes (Tindberg et al, 1996).

Also the

intracerebroventricular injection of bacterial lipopolysaccharides (LPS) suppresses
CYP1A functional activity (Renton and Nicholson, 2000).
2.G.2.a. Effect of the Reactive Oxygen Species
It has been demonstrated that incubation of human hepatocytes with human serum
obtained during the acute phase of infection and inflammation or with rabbit serum from
turpentine-injected rabbits decreased the CYP2A1-associated theophylline metabolism
without a reduction in CYP1A1 and CYP2A1 protein level (El-Kadi, 2000). Such a
reduction in the catalytic activity of these CYPs was partially prevented by addition of
antioxidant

and

exacerbated

by

antioxidant

inhibitors

(El-Kadi,

2000).

The

downregulation of CYPs associated with oxidant injury is a response of the body to
prevent further generation of reactive oxygen species and minimize tissue damage
(Morgan, 2001). Reactive oxygen intermediates (ROI), such a H2O2 (hydrogen peroxide),
that are generated during some inflammatory processes might interact with the CYP1A1associated Fe2+ resulting in heme destruction and enzyme inactivation (Karuzina and
Archakov, 1994; Archakov et al, 1998). An alternative mechanism of CYP1A1downregulation by reactive oxygen intermediates is mediated via direct phosphorylation
of the isoform by kinases resulting in inactivation of the CYPs (Rhee, 1999). ROI,
particularly oxygen radicals and hydrogen peroxides, stimulate protein kinase A (Suzuki
et al, 1997), protein tyrosine kinase (Bae et al, 1997; Lowe et al, 1998), protein kinase C
(Boyer et al, 1995), and mitogen-activated protein kinases (Goldstone and Hunt, 1997).
The mechanism of the CYP1A1 inactivation by phosphorylation is not yet understood,
although phosphorylation enhances the uncoupling of CYP1A1 from NADPH-dependent
hydroxylation during xenobiotic metabolism (Mkrtchian and Andersson, 1990).
2.G.2.b. Effect of Reactive Nitrogen Species
Nitric oxide is produced by the inducible NO synthase (iNOS) during
inflammatory responses (Morgan, 1997b). Evidence of involvement of NO in regulating
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phenobarbital-induced CYP2B1 has been provided by Khatsenko et al (1997) when he
showed that the administration of the NG-nitro-L-arginine methyl ester (L-NAME), a
nitric oxide synthase inhibitor, to rats simultaneously treated with Phenobarbital
(CYP2B1 inducer) and lipopolysaccharide (LPS) prevented the down-regulation of
CYP2B1 and CYP2B2 activity, mRNA, and protein. This relationship was further
supported by Roberts et al (1998) who found that the in vitro incubation of CYP2B1 and
peroxynitrite resulted in the nitration of tyrosines at either residue 190 or 203 or at both
residues of CYP2B1 which coincided with a loss of 2B1-dependent activity. In addition,
it has been demonstrated that the addition of nitric oxide to the V79-derived cell lines,
which are known to constitutively express rat and human CYP1A1 and CYP1A2,
inhibited the CYP1A1 activity in a dose-dependent manner (Stadler et al, 1994).
Different mechanisms of NO-associated CYP1A1 downregulation have been
proposed. The most commonly accepted one is that nitric oxide binds to the heme moiety
of the CYP1A1 forming an iron-nitrosyl complex in rat hepatic cells in a reversible
phase, subsequently preventing the binding of oxygen which normally occurs at the
catalytic site, and suppression of CYP1A1 functional activity (Wink et al, 1993). The
same study also showed irreversible inhibition of CYP1A1 and CYP2B1 activity due to
destruction of the integrity of the primary structure of hemeprotein, resulting from the
action of nitrogen oxides produced from the oxidation of nitric oxide by oxygen. Not
only does nitric oxide inhibit the CYP1A1 activity, but also downregulates the CYP1A1
expression by inhibition of CYP1A1 promoter activity as reported by studies on Hepa I
cells (Kim and Sheen, 2002).
2.G.2.c. Effect of Inflammatory Mediators on CYP1A1 Expression
The inflammatory mediators or cytokines that are released in inflammatory
conditions play an important role in the suppression of CYPs and their mRNAs (Bleau et
al, 2001). For example, interleukin-6 (IL-6) suppresses CYP1A1, 1A2, 2D, 3A4, and
4A1, and IL-1β depresses 1A2, 2C11, 2D6, 2E1 and 3A in vitro (Fukuda et al, 1992;
Trautwein et al, 1992; Donato et al, 1997; Parmentier et al, 1997). Moreover, TNF-α
downregulates CYP1A1 by inhibiting its transcriptional elongation in mouse Hepatoma
cells (Tian et al, 2002).
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Therefore, in a broad sense, inflammation is mostly associated with
downregulation of CYPs by changing the activity and expression levels of different
isoforms.
3-Anatomy, Histology and Physiology of Lung
3.A. Anatomy of Lung
Lungs are paired organs that occupy a large space in the thoracic cavity. Each
lung is encapsulated by a thin-film membrane called pleura where it is free to move
within this pleural sac (Getty, 1975). Generally, the lung has 2 lobes, the right and left,
each one receives one of the major bronchi. It consists of a bronchial tree that starts with
the major bronchi and ends in the terminal bronchioles (minute bronchi). Following the
terminal bronchioles are the lung alveoli, which are sac-like structures (Figure 5) lined by
respiratory epithelial cells and capillary endothelial cells. Lung alveoli are the major sites
of gas exchange, where most of the blood capillaries are located.

Figure 5: Schematic diagram showing the anatomical structure of lungs. The trachea
bifurcates into right and left bronchi. Each major bronchus branches into smaller bronchi
until ended by the terminal bronchioles. The terminal bronchioles open into the alveolar
duct which leads to the alveoli. The alveoli are sac-like structures consisting of an
alveolar wall that encloses the alveolar lumen. The alveolar wall is lined by alveolar
epithelium.
(Adapted from: http://www.schoolscience.co.uk/content/4/biology/glaxo/pm3ast1.html)
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3.B. Histology of Pulmonary Alveoli
Lung parenchyma is composed of many different cell types (Figure 6) with
different pulmonary functions (Sorokin, 1970). The alveolar epithelium consists of 2
morphologically distinct cell types called alveolar type I cells (membranous
pneumocytes) and alveolar type II cells (granular pneumocytes), which rest on a
basement membrane (Dobbs, 1990, Castranova, 1988). The alveolar epithelial cells have
tight intercellular junctions (Schneeberger, 1978). Alveolar type I cells appear long
(squamous) with thin cytoplasmic extensions as indicated by transmission electron
microscopy (Castranova et al, 1988). Alveolar type I cells comprise 96% of the epithelial
surface area (Castranova et al 1988; Crapo et al, 1978) and 8-10 % of all lung cells
(Crapo et al, 1978). These cells, being thin, facilitate and maximize gas exchange as they
reduce the space between the air in alveolar spaces and the pulmonary blood capillaries
(Castranova, 1988). On the other hand, AT-II cells are spherical (cuboidal) cells which
are about 9 µm in diameter (Jones et al, 1982, Haies et al, 1981). This size is an
intermediate size between the smaller endothelial cells and the larger macrophage and
alveolar type I cells (Grapo et al, 1982; Crapo et al, 1978; Haies et al, 1981). These
pneumocytes constitute 15 % of all lung cells (Dubbs, 1990) but cover less than 5 % of
the alveolar surface (Dobbs, 1990, Castranova, 1988). Clara cells are a third type of
epithelial cells present in lungs and are located at the end of the conducting airways near
the alveolus and have important nonrespiratory functions (Devereux et al,, 1982). These
cells are non-ciliated terminal bronchiolar epithelial cells containing extensive
endoplasmic reticulum, abundant mitochondria and osmiophilic granules that distinguish
them from other epithelial cells (Devereux, 1984; Plopper et al, 1980). The Clara cells
have extremely high levels of xenobiotic metabolizing enzymes (Boyd, 1977).
Other cells with important biological functions are the alveolar macrophages
(AMs). They are considered as part of the innate immunological defense system because
they migrate and attack inhaled particles shortly after exposure (Kleinman et al, 2003).
AMs are free migrating cells localized on the surface of the small airways and alveoli
(Weibel, 1973). The reaction of AMs to the inhaled particles consists of progressive
attacking steps. Following recognition, the AMs phagocytize these foreign particles in
phagolysosomes and try to digest them by releasing lysosomal enzymes into phagocytic
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vacuoles (Myrvik and Evan, 1967). Eventually, the digested foreign substances are
excreted to the outside medium. Contact of AMs with the inhaled foreign particles or
bacteria, results in a release of superoxide anions (Sweeney et al, 1981), which can be
monitored by the measurement of AM chemiluminescence (Miles et al, 1978; Castranova
et al, 1980).

Figure 6: Schematic diagram showing that cells of alveolar wall include AT-II, alveolar
type I, fibroblast, macrophages and capillary endothelial cells (Adapted from:
http://www.biology.arizona.edu/chh/problem_sets/lung_toxicology/02t.html.)
3.C. Functions of Alveolar Epithelial Cells
The alveolar type I and AT-II cells enclose a space called the alveolar space
(Castranova, 1988). Alveolar type I cells, which constitute the majority of alveolar
surface help the gas exchange between the pulmonary blood capillaries and the alveolar
spaces. The AT-II epithelial cells are multifunctional pneumocytes (Castranova, 1988).
One important function of AT-II cells, is to synthesize and secrete surfactant,
which is a mucoid film surrounding the alveolar epithelium (Macklin, 1954). The
alveolar lining material (surfactant) is composed of phospholipids, proteins, and
carbohydrates (Dobbs and Mason, 1979; Brown and Longmore, 1981) and its major
function is to reduce surface tension (Pattle, 1961). A reduction of surface tension is
biologically important because it reduces the work required for lung inflation, maintains
alveolar stability and prevents alveolar edema (Clements et al, 1959; Stub, 1966). AT-IIassociated surfactant has been demonstrated to enhance phagocytosis and killing of
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bacteria by alveolar macrophage (LaForce et al, 1973; Juers et al 1976). It also protects
the lungs from potentially toxic inhaled particles (Wallace et al, 1985).
A second prominent function of AT-II cells occurs during the recovery of lungs
from oxidant injury (Castranova, 1988). In contrast to type I cells, which are susceptible
to oxidant injury, AT-II cells are resistant to oxidants and physical injuries (Cross, 1974;
Crapo et al, 1982). Alveolar type I cells seem to be highly sensitive to the pulmonary
toxicants because they were damaged first at a cellular level following pulmonary
exposure to foreign toxicant (Weibel, 1974). This could be attributed to their relatively
large surface area, which may approach 4500 µm2 (Haies et al 1981) and their attenuated
cytoplasm (Miller and Hook, 1990). Following injury of alveolar type I cells, AT-II cells
proliferate (hyperplasia) (Stanley et al, 1992) and differentiate into type I cells in order to
repair the alveolar epithelium and maintain the alveolar architecture (Melloni et al, 1995;
Adamson et al, 1988; Thet et al, 1984) as shown by pulse label experiments (Castranova
1988). This is necessary because alveolar type I cells are incapable of dividing (Weibel,
1974), and because they are terminally differentiated cells. The process of differentiation
of AT-II into type I cells occurs within 2 days of injury (Evans et al, 1973). The
resistance of AT-II cells to the oxidant injury is attributed to the transport of vitamin C
(an antioxidant) into these cells. Castranova et al (1983) demonstrated that AT-II cells
contained a sodium-ascorbate cotransport system that allows the accumulation of the
antioxidant ascorbate in AT-II cells, therefore increasing their resistance to oxidant
injury.
In addition to the aforementioned functions, AT-II cells also play an important
role in the metabolism of foreign compounds (xenobiotics) such as drugs and
environmental pollutants because of their content of CYP monooxygenase system
(Devereux et al, 1979; Jones et al, 1983; Raboveskey et al, 1986; Baron and Kawabata,
1983). They are rich in endoplasmic reticulum and sensitive to the exposure of toxic
agents (Baron and Kawabata, 1983). Xenobiotic metabolism by AT-II cells is not
restricted to inhaled foreign compounds but also includes circulating xenobiotics since
these cells are in close proximity to capillary blood supply (Castranova, 1988).
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Alveolar macrophages are migratory phagocytic cells located on the surface of the
small airways and the alveoli (Weibel, 1973). These cells act as the lung’s first line of
defense against the toxic effects of inhaled particles, as they play a major role in the
protection of lung against these particles. The reaction of alveolar macrophages to the
inhaled particles is complex. Upon contact with the particles, AMs release superoxide
anion (Sweeney et al., 1981), which could be monitored by measurement of
chemiluminescence (Miles et al, 1978; Castranova et al, 1980). Eventually, AMs engulf
these foreign particles and attempt to digest them by releasing lysosomal enzymes into
phagocytic vacuoles (Myrvik and Evan, 1967).
4-Distribution and Localization of CYP1A1 and Other Isoforms in Pulmonary
Alveoli of Different Animal Species
4.A. Human
In humans, CYP1A1 is constitutively expressed in very low level and the
intensity of expression varies within different pulmonary cells (Antilla et al, 1991). By
immunohistochemistry, CYP1A1 is mainly localized in the epithelium of the peripheral
airways, the ciliated columnar epithelium of the bronchioles and the cuboidal and
columnar cells of the terminal bronchioles (Antilla et al, 1991). Immunohistochemical
staining was also observed in AT-II cells and in a few cases, within type I cells (Antilla et
al,

1991).

Pulmonary

vascular

endothelium

infrequently

showed

CYP1A1

immunopositive staining but the alveolar macrophages were always negative (Antilla et
al, 1991). Another important CYP isoform in humans is CYP1B1. CYP1B1 is regulated
through the AhR and its mRNA was detected in liver, lymphocytes, cells of
bronchoalveolar lavage and endometrium, but not in lung (Hakkola et al, 1997).
However, by immunohistochemistry, CYP1B1 was localized only in a range of malignant
tumors, such as tumors of the breast, colon, lung, esophagus, skin, lymph node, brain, and
testis and there was no detectable immunostaining for CYP1B1 in normal tissues (Murray
et al, 1997). Therefore, CYP1B1 seems to be constitutively expressed in tumors (tumor
specific) but undetectable in most normal tissue although CYP1B1 mRNA is present
(McFadyen et al, 2003). Other isoforms, such as CYP2B6, CYP2E1, CYP2J2, and
CYP3A5 proteins are expressed in human lung (Hukkanen et al, 2002).
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4.B. Rodents
In rodents, the CYP activity of the lung has been demonstrated mostly in
epithelial and endothelial cells (Pairon et al, 1994). CYP protein expression and activity
has been identified in three main types of cells: Clara (terminal non-ciliated) cells in the
bronchiolar epithelium, AT-II cells in the alveolar spaces, and endothelial cells in the
vascular compartment (Serabjit-Singh et al, 1980; 1988; Plopper et al, 1987; Lacy et al,
1992; Jones et al, 1983; Kheith et al, 1987; Overby et al, 1992). Various materials of the
lungs have been used to demonstrate the protein expression and activity of CYP isoforms
in the lungs of rodents, such as the microsomes (Domin et al, 1986; Keith et al, 1987;
Guengerich et al, 1982; Vanderslice et al, 1987; Tindberg and Ingelman-sundberg, 1989;
Sesardic et al, 1990; Carlson and Day, 1992), isolated lung cell fractions of untreated or
pretreated animals (Devereux et al, 1982; Lacy et al, 1992; Jones et al, 1983; Chichester
et al, 1991), and tissue preparation for ultrastructural analysis (Serabjit-Singh et al, 1988;
Overby et al, 1992; Aida et al, 1992). The predominant form of CYP in the uninduced rat
lung is CYB2B1 (Guengerich et al, 1982), which is mainly localized in Clara cells and to
a lesser extent in AT-II cells (Baron and Voigt, 1990; Kheith et al, 1987). In contrast to
lung, the hepatic CYP2B1 is induced by Phenobarbital (Kim and Kemper 1997). Other
CYP isoforms, such as 1A1 (Pairon et al, 1994), 2A3, 3A2, and 4B1, are also expressed
in lung but in very small quantities (Foster et al, 1986; Voigt et al, 1990; Kimura et al,
1989; Keith et al, 1987; Vanderslice et al, 1987). The CYP2E1 protein is another isoform
expressed only in rat lungs after being induced by substrates such as acetone or ethanol
(Tindberg and Ingelman-Sundberg, 1989; Carlson and Day, 1992).
By

immunohistochemistry

and

in

situ

hybridization

techniques,

3-

methylchlolantherene (3MC) - induced rat CYP1A1 was localized primarily in Clara
cells and AT-II cells, with some labeling observed in other alveolar wall cells. These cells
could not be specifically identified microscopically and were believed to be either
alveolar type I cells or capillary endothelial cells (Pairon et al, 1994). In humans, similar
results have been demonstrated without detection of any activity in the endothelial cells
(Marcus et al, 1990).
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4.C. Rabbits
In rabbits, the pulmonary CYP monooxygenase system includes three main
isoforms of CYPs; 2B4, 4B1 and 1A1, which were previously classified as forms 2, 5 and
6, respectively (Daniels and Massey, 1992). CYP1A1 was demonstrated by
immunohistochemistry in rabbits induced by TCDD using a polyclonal goat anti-rabbit
CYP1A1 antibody and was localized mainly in the endothelial cells of the interalveolar
septa (Overby et al, 1992).

Within the endothelial cells, only the perinuclear area

associated with endoplasmic reticulum was labeled with the antibody, and no labeling of
the plasma membrane was detected (Overby et al, 1992). Minimal CYP1A1 labeling was
detected in alveolar type I and AT-II cells with absence of macrophage immune reactivity
(Overby et al, 1992). A dense CYP1A1 staining has been observed in the terminal nonciliated bronchiolar epithelial (Clara) cells which are considered the primary pulmonary
site of cytochrome P-450-dependent monooxygenase activity (Domin et al, 1986;
Plopper et al, 1987; Serabjit-Singh et al, 1980).

This could be attributed to the

enrichment of the Clara cells with large amount of agranular (smooth) endoplasmic
reticulum to which the CYPs are associated (Plopper, 1983). Although the CYP1A1 was
not

detected

in

the

alveolar

macrophages

of

TCDD-induced

rabbit

by

immunohistochemistry (Overby et al, 1992), it was detected in the microsomal fraction of
alveolar macrophages from rabbits administered with TCDD (Domin et al, 1986). While
the major constitutive isoform of CYPs in rabbit lung is CYP2B4, this isozyme is present
in very low concentrations in the liver of this animal species (Williams et al, 1991).
However, treatment of rabbits with phenobarbital induces CYP2B4 in liver but has no
effect on the levels in lungs (Williams et al, 1991). In contrast to CYP2B4, CYP1A1 can
be induced in rabbit lungs by beta-naphthoflavone) using a dose of 80 mg/kg by
intraperitoneal injection (Daniels and Massey, 1992).
4.D. Food Producing Animals
In food-producing animals, such as sheep and cattle, CYP1A1 is rarely
investigated and little information is available about its expression and localization in
pulmonary tissue (van't Klooster et al, 1993a).

Knowledge about the CYP

monooxygenase system in agricultural species is not only useful for describing the
xenobiotic metabolism comparable to humans, but also extremely important for the risk
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assessment of the applied veterinary pharmacotherapy and public health concern,
particularly when these animals are considered as a main source of many foods (van't
Klooster et al, 1993a; 1993b). This is particularly crucial because of the presence of drug
residues and/or their metabolites in the foods of animal origin (van't Klooster et al,
1993b; Juskevich, 1987). The induction of CYP1A has been observed in cattle treated
with pentachlorophenol (PCP), particularly in the liver and lung microsomes of the new
born calves which were more responsive to induction than adults (Shull et al, 1986). The
first CYP isoform purified from sheep lungs was the CYP2B, which was the most
abundant form constitutively expressed in sheep lungs (constituting 75 % of the total
CYPs) (Williams et al, 1991). Moreover, CYP1A1 and CYP2B1 have been induced in
sheep hepatic microsomes after a single dose of ivermectin, a common antiparasitic drug
in Veterinary Medicine (Skalova et al, 2001). In goats, the subcutaneous injection of
beta-naphthoflavone (BNF) significantly induced CYP1A1 and CYP2B1 in liver
microsomes as assessed by measurement of 7-ethoxyresorufin deethylase (EROD) and
7-pentoxyresorufin deethylase (PROD), respectively (van't Klooster et al, 1993b). BNF
induces CYP1A1 in cultured hepatocytes isolated from sheep, goat, and cattle (van't
Klooster et al, 1993b).
5-Pathological Alterations Associated with Respirable Particle Exposure
Lungs, being at the interface between the body and the environment, are major
targets of many chemicals. They are exposed to xenobiotics carried by the inspiratory air
and the blood (Pairon et al, 1994). The response of different alveolar cells to respirable
particles is a complex process. Exposure to coal dust, silica, and/or other related
inorganic particulates can activate alveolar macrophages to secrete cytokines, such as
TNF-α and interleukin-1 (Kelley, 1990), fibronectin (Davies and Erdogdu, 1989), and
other soluble mediators that act in situ (Kelley, 1990) producing acute cellular injury and
initiating lung fibrosis (Davis, 1986). TNF-α plays a key role in the cellular response to
particulate inhalation as it enhances the synthesis of other chemokines, such as
interleukin-8 (IL-8), macrophage inflammatory protein 2 (MIP-2), MIP-1, and monocyte
chemotactic protein 1α (MCP-1α) by alveolar macrophages, epithelial cells, endothelial
cells and fibroblasts. In addition, TNF-α stimulates the endothelial expression of the
adhesion molecules, such as vascular cell adhesion molecule 1 (VCAM-1), intercellular
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adhesion molecule 1 (ICAM-1), and E-selectin. The intravascular inflammatory cells are
recruited into the lung interstitium and alveolar spaces by interaction with the endothelial
adhesion molecules and chemotactic gradients (Driscoll, 1996) (Figure 7).

Figure 7. Proposed mechanism of pulmonary inflammation following exposure to
respirable particles (Adapted from Driscoll, 1996).
Alveolar type I cells are more vulnerable to toxic and physical injury than AT-II
cells (Lee et al, 1994). The damage of these cells usually leads to denudation of the
subepithelial basement membrane (Evans et al, 1973; Adamson et al, 1974) with
subsequent leakage of the plasma constituents, such as albumin, from the pulmonary
vasculature to the alveolar spaces (Crouch, 1990).
AT-II cells generally respond to exposures of respirable particles, such as silica
and coal dust, by increasing their number (hyperplasia) and size (hypertrophy) (Panos et
al, 1990). The mechanism of cellular proliferation in response to particle exposure is
unclear. Interestingly, carbon black, which has a minimum cellular toxicity, has been
shown to produce a persistent AT-II cellular hyperplasia and neutophilic inflammation in
rats (Harkema et al, 2003). A possible role of the extracellular signal-regulated kinases
(ERKs) was suggested by Albrecht et al (2001) when they found a chronic activation of
phosphorylated ERKs in immunohistochemical examination of lung sections of coal dustexposed rats. The release of alveolar macrophage-produced mitogenic factor by activated
macrophages is another possible role that enhances the cell cycle proliferation and DNA
synthesis in rabbit AT-II cells (Brandes and Finkelstein, 1989). However, other factors in
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the bronchoalveolar lavage (BAL) of normal rats have been shown to stimulate the DNA
synthesis in the primary culture of rat AT-II cells (Leslie et al, 1989). This discrepancy
was solved by Panos et al (1990) by demonstrating a similar mitogenic effect of BAL
fluid collected from normal and silica-treated rats suggesting that other factors may be
involved in the silica-associated AT-II hyperplasia. The AT-II hypertrophy associated
with particle exposure could be attributed to cellular enlargement during cell division
(Miller et al, 1986), an increase in cytoplasm during preparatory stage of differentiation
and transition from AT-II to type I cells, or edema and degeneration associated with cell
death (Miller et al, 1986; Baserga, 1985). It is well known that the cell size is increased
during DNA synthesis and mitosis (Baserga, 1985) and the cell component should be
duplicated during each cell cycle to maintain a uniform cell size between generations
(Fraser and Nurse, 1978; Killander and Zetterberg, 1965). Furthermore, during lung
injury and particle exposure, the AT-II cells can differentiate into type I cells, which have
a volume of 2-5 fold greater than that of AT-II cells but are not considered hypertrophied
AT-II cells (Crapo et al, 1983).
6-Respirable Particles Affecting Lung
6.A. Coal Dust Particles
6.A.1. Origin and Composition
Coal is produced by progressive coalification of swampy vegetation throughout
the world. Although coal is composed mainly of carbon, coal mine dust also contains
oxygen, hydrogen, nitrogen, trace elements and inorganic minerals and crystalline silica.
Trace elements include copper, cadmium, boron, nickel, antimony, iron, lead, and zinc
(Castranova and Ducatman, 1997). Some of these trace elements can be cytotoxic and
carcinogenic in experimental models (Castranova and Vallyathan, 2000). The mineral
contaminants may include kaolin, quartz, mica, calcite and pyrite. The rank of coal varies
according to its carbon contents. As rank increases, the ratio of carbon to other mineral
and chemical contaminants increases. Generally, higher rates of pneumoconiosis have
been associated with anthracite coal mining than that found in bituminous miners.
(Ortmeyer et al, 1973; Bunnet et al, 1979). This was attributed to the higher surface free
radicals in anthracite than bituminous coal (Dalal et al, 1990; 1991; and 1995).
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Moreover, anthracite has higher crystalline silica than bituminous coal (Wallace et al,
1994).
6.A.2. Exposure Conditions
There are two principal types of exposures in mining, surface and underground,
that result in pulmonary exposure. Surface exposure usually occurs outdoors with
inhalation of low levels of coal mine dust. Underground exposure is more frequently
associated with inhalation of a significant amount of coal dust and development of
pneumoconiosis. (Castranova and Ducatman, 1997). Mixed exposures are common in
underground coal mining. For example, the pulmonary exposure to silica in roof bolters
occurs during drilling processes into the noncoal ceiling of mines. Moreover, diesel
equipment in coal mines produces mixed exposures to coal dust and diesel particulates
(Castranova and Ducatman, 1997).
6.A.3. Pathological Reaction to Coal Mine Dust Exposure
Inhalation of coal mine dust is associated with several diseases in humans such as
coal workers’ pneumoconiosis (CWP), bronchitis, emphysema, Caplan disease and
silicosis (Kleinerman et al, 1979; Green and Vallyathan, 1998).
6.A.4. Coal Workers’ Pneumoconiosis (CWP)
6.A.4.i. Forms of CWP
CWP is classified according to severity into simple and complicated CWP.
Simple CWP is characterized by black dust macules which are usually concentrated in
the upper lung lobes. Coal nodules consist of coal dust and dust-laden macrophages
usually localized at the bifurcations of respiratory bronchioles. These nodules can be
palpable and have a diameter of 2-5 mm. This syndrome can progress to complicated
CWP. With increasing time and dust exposure complicated CWP develops, that is,
progressive massive fibrosis (PMF). In PMF, the lesions are bigger (1 cm diameter),
more numerous, and usually localized in upper and posterior portions of the lungs. These
lesions mainly contain increased collagen, coal dust, and inflammatory cells. The Federal
Coal Mine Health and Safety Act of 1969 legislatively defined "black lung disease" to
include not only CWP but also other chronic pulmonary diseases affecting coal miners,
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such as chronic bronchitis and other obstructive pulmonary diseases (Castranova and
Ducatman, 1997).
6.A..4.ii. Radiographic Picture of CWP
Simple pneumoconiosis is not always reflected in radiographic changes
(Kleinerman et al, 1979). The sensitivity of the chest radiograph is affected by many
factors, such as the lesion size, background density, contrast effect and thickening of the
chest wall (Parkes, 1982; Morgan, 1984).

When radiographic changes are present,

radiographic opacities 0.001-l.0 cm in diameter may appear and are most frequently
round opacities. With progression of CWP, the distribution of the opacities increases. As
the PMF develops, there is an increase in the number of irregular opacities as well as an
increase in nodular size to exceed 1.0 cm in diameter (Castranova and Ducatman, 1997;
Rossiter et al, 1967). Chest radiographs are ranked by the size, shape, and profusion of
the opacities. In simple CWP, rounded opacities are ranked by increasing size as p, q, and
r. A scale of s, t, and u is used to rank irregular opacities. Distribution of lesions is
designated as upper, middle, and/or lower lung zones. Profusion, which means increased
density of opacities, has a rank of 0, 1, 2, or 3 (Vallyathan et al, 1996; Castranova and
Ducatman, 1997).

It has been demonstrated that profusion category has a direct

relationship to dust burden in the lungs. PMF is categorized radiographically as A, B, or
C as opacities progressively increased (Castranova and Ducatman, 1997).
6.A.4.iii. Pathology of CWP
The pulmonary pathological changes of CWP range from simple dust
accumulation to fibrosis of varying degrees (Green and Vallyathan, 1998). Early coal
dust exposure is manifested by aggregation of particles within the cytoplasm of intraalveolar macrophages and is a marker of recent exposure. With time, the dust is localized
around the walls of bronchi, lymphatics, and pulmonary vessels, and in the walls of
respiratory bronchioles, without detectable fibrosis. The first distinctive lesion of CWP is
the appearance of coal macules that are typically found in the walls of respiratory
bronchioles, particularly at bifurcations.

The coal dust macule is defined as an

aggregation of coal dust-laden alveolar macrophages, in a size that range from 0.5 to 6
mm within the wall of respiratory bronchioles and adjacent alveoli (Vallyathan et al,
1996).

Coal dust accumulation is accompanied by a variable degree of collagen
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deposition. However, at this stage, the macule cannot be palpated (Castranova and
Ducatman, 1997). With extended exposure, the fibrotic nodules can develop. As with
macules, varying degrees of fibrosis and pigmentation can be found. When there is a
central zone of concentric collagen fibers (rather than interlacing bundles of collagen),
the nodules should be classified as silicotic nodules. The nodules are defined as an area
of fibrosis and are firm when palpated. The nodules are usually located in a background
of coal dust macules, however they can be an isolated finding. Nodules can be found in
subpleural and peribronchial connective tissues as well as respiratory bronchioles. Focal
emphysema is a specific form of emphysema seen in coal miners which is associated with
distention and over expansion of alveolar spaces near fibrotic respiratory bronchioles
(Castranova and Ducatman, 1997).
6.A.4.iv. Epidemiology of CWP
Epidemiological data suggests a direct relationship between the mass of
respirable coal dust and the incidence of CWP in miners (Walton et al, 1977). A
sequence of events has been supported by the epidemiological data during initiation and
progression of CWP, which includes the following steps (Castranova and Ducatman
1997):
i) Coal dust is inhaled and deposited at the bifurcations of the respiratory bronchioles;
(ii) Localized inflammation begins and alveolar macrophages engulf coal dust particle to
become dust laden. Aggregation of dust-laden macrophages forms a coal macule;
(iii) Coal macules enlarge and congregate to form coal nodules with further dust
deposition and inflammation;
(iv) Pulmonary emphysema may follow when the lesions contract, tearing surrounding
tissue; and
(v) Progressive massive fibrosis is the result of subsequent collagen deposition at sites of
coal deposition.
6.A.4.v. Progressive Massive Fibrosis (PMF)
PMF is defined as a zone of fibrosis that has a diameter of greater than 1 cm, and
can appear as single or multiple lesions (Vallyathan et al, 1998). Grossly, PMF lesions
appear as hard, black masses which may be round, oval, or irregular but generally with a
fairly sharp demarcation from the surrounding parenchyma. PMF often demonstrates
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central cavitation that could be detected during sectioning. Microscopically, PMF is
recognized either as an amorphous zone of collagen or aggregation of multiple nodules,
which commonly co-occur with silicosis. The lesions usually contain a large quantity of
coal pigment, cholesterol crystals and debris. PMF is a destructive and progressive lesion
that distorts and obliterates functional lung tissue (Castranova and Ducatman, 1997). The
PMF-induced distortion of the lung parenchyma is usually accompanied by compensatory
emphysema (Vallyathan et al, 1996).
6.A.4.vi. Relationship between Coal Dust Exposure and Lung Cancer
Exposure to coal mine dust and the development of CWP has not been associated
with lung cancer (Rooke et al, 1979). On the contrary, an epidemiologic study of US coal
miners suggests that they have a lower than normal risk of lung cancer (Costello et al,
1974). Moreover, no relationship has been found between coal dust exposure and lung
cancer type (Vallyathan et al, 1985). On the other hand, a higher than normal incidence
of stomach cancer has been associated with coal dust exposure (Enterline, 1964). Ong et
al, (1985) proposed a particular mechanism for developing stomach cancer associated
with coal dust exposure. Initially, after the coal dust is swallowed and reaches the
stomach, it intermixes with nitrite content of the food. The coal-associated organic
material then undergoes a nitrosation under the acidic condition in the stomach. This
nitrosation product has been demonstrated to induce the neoplastic transformation of a
mammalian cell line (Wu et al, 1990).
6.A.4.vii. Mechanisms of Coal Dust-Induced Cellular Toxicity
Four main mechanisms of toxicity were proposed for initiation and progression of
CWP (Castranova 2000). The first is the direct cytotoxicity of coal dust resulting in cell
damage with subsequent release of proteases and lipases. The second mechanism
includes over-production of oxidants by alveolar phagocytes, such as macrophages with a
rate overwhelming the antioxidant defenses resulting in protein nitrosation and tissue
injury. The third mechanism involves the activation of cytokines (chemical mediators)
from alveolar epithelium and alveolar macrophages. These mediators recruit excessive
numbers of polymorphonuclear leukocytes (PMN) and macrophages into the alveolar
spaces with production of more oxidant, enhancing the pulmonary oxidant stress. The
fourth mechanism is associated with fibroblast proliferation, enhancement of collagen
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synthesis, and induction of pulmonary fibrosis upon stimulation by the growth and
fibrogenic factors secreted from alveolar macrophages and alveolar epithelial cells in
response to coal dust exposure
6.A.4.vii.a. Direct Cytotoxicity:
Coal dust has been shown by in vitro and animal studies to cause hemolysis (red
blood cell lysis) and release of lactate dehydrogenase (LDH) from alveolar macrophages
(Harrington 1972, and Amadis and Timilar, 1978). The direct cytotoxic effect of coal
dust is affected by its metal content, such as nickel (Christian and Nelson, 1978) and iron
(Dalal et al, 1995). Moreover, coal dust fracturing has been associated with the
generation of surface radicals that can injure the biological membranes. However, these
radicals are less bioactive that those generated during fracturing of silica (Vallyathan et
al, 1995).
6.A.4.vii.b. Alveolar Macrophages-Stimulated Oxidant Production
A relationship has been established between the pathogenicity of the coal dust,
pulmonary damage, and the ability to enhance oxidant production (Backford et al, 1997).
Coal mine dust has been demonstrated to stimulate alveolar macrophages to increase the
synthesis of reactive oxygen and nitrogen species such as superoxide, hydrogen peroxide,
and nitric oxide (Castranova, 2000). These reactive oxygen species (ROS) induce cellular
damage and injury (Weiss and Buglo, 1982). Moreover, coal dust may contain stable
radicals that can produce ROS in the biological fluids resulting in direct oxidative
damage in a non-cellular mechanism (Schins and Borm, 1999).
6.A.4.vii.c. Stimulation of the Proinflammatory Mediators Release
Coal dust exposure in animals elicits pulmonary inflammation that is
characterized as infiltration of alveolar macrophages (AM) and polymorphonuclear
leucocytes (PMN) in the alveolar spaces (Castranova et al, 1985, Bowden and Adamson,
1978). Once the phagocytic cells are recruited into the alveolar spaces, they stimulate the
production of chemotactic cytokines and chemokines by AM and AT-II epithelial cells
(Driscoll et al, 1993). The most common chemotaxins for PMNs are Leukotriene B4,
platelet-activating factor (PAF), and interleukin (IL)-1 (Driscoll, 1997). Tumor necrosis
factor alpha (TNF-α) may not have a direct chemoattractant effect. However, it is a
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potent chemokine stimulant, with effects on macrophage inflammatory protein (MIP-1 or
MIP-2) and cytokine-induced neutrophil chemoattractant (Driscoll et al, 1995).
When the PMN are recruited into the alveolar spaces, they are stimulated by
several inflammatory cytokines, such as TNF-α, PAF, and IL-1, to increase oxidant
production resulting in excessive oxidant burden in the lung. The accumulation of
oxidant may overwhelm the antioxidant defenses resulting in lung injury, scarring and
fibrosis (Castranova 2000). In oxidative stress, The NF-κB is activated (Shukla et al,
2000), and upregulates the proinflammatory cytokines such as TNF- α (Kim et al, 2003)
that aggravate the inflammatory process. Moreover, the released TNF- α activates the
NF-κB by enhancing the phosphorylation and degradation of the inhibitor IκB as
previously mentioned. Although there is little data on NF-κB in coal dust exposure, the
NF-κB is activated by TNF- α in silicosis as shown by increasing of its DNA binding
activity (Vallyathan et al, 1998).
6.A.4.vii.d. Stimulation of Growth and Fibrogenic Factors Production by AM
The fibrogenic factors produced by the alveolar macrophages and pneumocytes
under the effect of coal mine dust exposure were detected in the bronchoalveolar lavage
(BAL) of miners affected with CWP (Castranova, 2000). The most important of these
growth and fibrogenic mediators that promote the lung response to fibrosis was the TNFα, which has direct proliferative effects and enhances the secretion of platelet derived
growth factor (PDGF) (Hajjar et al, 1987). Other mediators, such as transforming growth
factor (TGF) α and β, and insulin-like growth factor (IGF) are released from AM and
epithelial cells, and were found to stimulate the proliferation of mesenchymal cells
(Bonner et al, 1991; Madtes et al, 1988; Moses et al, 1990; Rom et al, 1988). The
glycoprotein, fibronectin, can stimulate fibroblast proliferation and greatly contribute to
particle-associated pulmonary fibrosis (Rennard et al, 1981; Bitterman et al, 1983).
6.B. Crystalline Silica Particles
Exposure to crystalline silica, the crystalline form of silicon dioxide causes severe
occupational lung disease in coal miners called silicosis (Castranova and Ducatman,
1997). Silicosis is a chronic inflammatory fibrotic lung disease (Miles et al, 1993) that is
characterized by the development of silicotic nodules, chronic debilitation, and eventual
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death in some cases (Driscoll and Guthrie, 1997). Crystalline silica has several
polymorphs; those commonly investigated are the quartz, cristobalite, tridymite, coesite,
and stishovite. The most toxic forms of crystalline silica are tridymite and cristobalite
followed by quartz (Seaton, 1984). Chemically, silica is composed mainly of silicon
dioxide (SiO2) and some other cations may occur in trace amounts, such as aluminium,
iron, and titanium. The iron content of silica may be involved in the production of
reactive oxygen radicals through a Fenton-type reaction (Goodglick and Kane, 1986;
Mossman and March, 1989) (Fe 3+

Fe 2+ + e-) that may greatly contribute to silica

cytotoxicity (Razzaboni and Bolsaitis, 1990).
6.B.1. Mechanisms of Silica-Induced Cytotoxicity and Fibrosis
The cytotoxic effect of the silica is attributable to 4 major mechanisms. These
mechanisms have been discussed in detail under the coal dust effect. However, in
silicosis, the cytotoxic effect is more robust than coal dust for the following reasons:
1- The silanol group (SiOH), which is uniquely present on the surface of silica
particulate, acts as an H donor. Therefore, it interacts with the biological
membranes by forming a hydrogen bond resulting in injuries of these membranes
(Nash et al, 1966). This was suggested because the polyvinylpyrilidine-N-oxide
was found to reduce the silica toxicity by acting as proton acceptor, consequently
protecting the biological membranes from the surface SiOH group.
2- The presence of the negative surface charge of the SiO- group is crucial for silicainduced cytotoxicity (Nolan et al, 1999; Castranova and Vallyathan, 2000). This
negative group could enhance the interaction of silica with the scavenger
receptors on the surface of alveolar macrophages (Nolan et al, 1981; Kobzek,
1985).
3- Silica radicals, such as Si. and SiO., are usually produced at the fracture planes
during fracturing of silica (Vallyathan et al, 1988). These radicals may participate
in induction of oxidative stress, particularly when they come in contact with
aqueous medium that results in the production of hydroxyl radicals (Vallyathan et
al, 1988). It has been demonstrated that lipid peroxidation has a direct relationship
with the hydroxyl radicals produced by silica in vitro (Vallyathan et al, 1988;
Dalal et al, 1991) and in vivo (Castranova et al, 1996; Vallyathan, 1995).
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4- The presence of surface iron in silica augments the production of hydroxyl
radicals by silica exposure and enhances the cytotoxicity in vivo and in vitro
(Vallyathan et al, 1988; Castranova et al, 1997).
6.B.2. Pathological and Inflammatory Responses to Silica Exposure
Pulmonary cytotoxicity in silicosis has been demonstrated on a large scale in
animals and humans (Holland, 1990; Saffioti and Stinson, 1988, Green and Vallyathan,
1995). Different clinical types of silicosis have been identified based upon the intensity
and the period of exposure or upon the chest radiographic picture (Driscoll and Guthrie,
1997; Green and Vallyathan, 1995, Ziskind et al, 1986; Seaton, 1984).
Radiologically, simple silicosis and progressive massive fibrosis can be identified.
Simple silicosis is characterized by the presence of small opacities (silicotic nodules)
(Ziskind et al., 1986; and Seaton, 1984) with a diameter of less than 10 mm (Weissman
and Wagner, 2002) without respiratory impairment unless accompanied by tuberculosis
(Snider, 1978 and Craighead et al., 1988). Simple silicosis may develop into progressive
massive fibrosis (PMF) when congregation of these silicotic nodules occurs followed by
destruction of lung tissue and a significant disturbance in lung function (Snider, 1978).
Until now, 3 different types of silicosis are recognized: chronic, accelerated, and acute
(Weissman and Wagner, 2002). The occurrence and development of these forms is
determined by the amount of exposure and the total cumulative silica inhalation (Green
and Vallyathan, 1995; Ziskind et al, 1986; Seaton, 1984). Chronic silicosis is
characterized by the appearance of simple silicotic nodules 10-30 years post exposure
(Weissman and Wagner, 2002) because it usually progresses very slowly. However, in
some cases, nodules may congregate to form PMF (Weissman and Wagner, 2002).
Accelerated silicosis, which develops in less than 10 years after exposure to silica
(Weissman and Wagner, 2002), is accompanied by a rapid progression to PMF, severe
lung dysfunction, and is life threatening (Ziskind, 1986; Seaton, 1984). Acute silicosis,
on the other hand, is the form that develops very rapidly [(a few weeks to 5 years post
exposure (Weissman and Wagner, 2002)] after exposure to high concentrations of silica
(Banks et al, 19981; Suratt et al, 1977; Xipell, 1977) and is associated with severe
alveolar and interstitial inflammation, alveolar proteinosis, and rapid respiratory failure
(Driscoll and Guthrie, 1997).
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7-Difference between CWP and Silicosis
CWP was originally thought to be a variant form of silicosis because of the
similarity of chest radiographs of coal miners and silicotic people. A differentiation
between CWP and silicosis was first proposed by Collis and Gilchrist (1928). They
reported that Welsh stevedores who trimmed coal in the holds of ships developed nodules
in the chest which were indistinguishable from those of underground coal miners.
Histological examination of autopsied lungs from these coal trimmers showed lung
lesions distinct from the characteristic whorled nodules of silicosis (Gouph, 1940). In
1947, Heppleston demonstrated that the histological pulmonary lesions in coal trimmers
were similar to those in underground coal miners. In 1954, he showed that, these
pulmonary lesions, in contrast to silicosis, consisted of black stellate dust macules
surrounded by dilated respiratory bronchioles. In general, silicosis is more progressive
than CWP and may initiate, develop and progress more rapidly (Scarisbrick, 2002).
8-Interaction Between PAH, AhR and Apoptotic Pathways
8.A. Role of AhR in Cellular Apoptosis
Apoptosis, or programmed cell death is a genetically-controlled process that
occurs as a response of the cell to environmental (such as radiation) and developmental
(e.g. embryogenesis) stimuli ending by programmed death of the cells (Wylie, 1980;
Orren et al, 1997). Therefore, apoptosis is a negative selection mechanism by which the
organism gets rid of damaged or unneeded cells (Buckley, 1998). Apoptosis plays an
important role in tissue remodeling (Stanley et al, 1992) and eliminating cells that are
excessively developed, improperly developed, or genetically damaged (Thompson,
1995). For example, the remodeling of certain epithelial cells, such as AT-II cells
(Bardales et al, 1996) during the repair process following acute lung injury was attributed
solely to the occurrence of apoptosis in these cells (Polunovsky et al, 1993).
Cellular death by apoptosis has characteristic hallmarks that start with
condensation of the cytoplasm, loss of the plasma membrane microvilli, and nuclear
condensation followed by fragmentation (Buckley, 1998). Apoptosis can be differentiated
from necrosis by the presence of activated endogenous proteases, disruption of the
cytoskeleton, cell shrinkage and formation of membrane blebbing, condensation of the
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nucleus with DNA fragmentation forming oligonucleosomes, and elimination of the
damaged cells without any inflammatory response (Thompson, 1995).
Apoptotic pathways initiate via different entry sites, such as death receptor
(receptor pathway) or mitochondria (mitochondrial pathway) (Fulda, and Debtain, 2002).
Both pathways result in the activation of effector caspases (cysteine aspartate proteases)
(Kaufmann and Earshaw, 2000). The receptor pathway is associated with stimulation of
death receptors of the tumor necrosis factor (TNF) receptor (TNFR) superfamily such as
CD95 (APO1/Fas) resulting in receptor aggregation and recruitment of the adaptor
molecule Fas-associated death domain (FADD) and caspase-8 (Sprick et al, 2000). The
end result is the activation of caspase-8 that initiates apoptosis by direct cleavage of
downstream effector caspases (Peter and Krammer, 1989). In the mitochondrial pathway,
apoptogenic factors such as apoptosis inducing factor (AIF), cytochrome c, and caspase2 or caspase-9 are released from mitochondria into the cytoplasm to activate caspase-3
by the formation of apoptosome complex (cytochrome c/Apaf-1/caspase-9) (Kroemer and
Reed, 2000). This is followed by a downstream mitochondrial activation of caspase-8
resulting in further cleavage of effector caspases and apoptosis (Fulda, and Debtain,
2002) (Figure 8). Bax is a member of Bcl-2 family that comprises different proteins
involved in controlling apoptosis and induced by a variety of stimuli (Desagher et al,
1999). Bax interacts with Bid, another preapoptotic protein belonging to Bcl-2 family
resulting in conformational changes that drive Bax to translocate from cytosol to the
mitochondria, increasing the release of cytochrome c and initiating apoptosis (AibaMasago et al, 2002) (Figure 8). However, Bax may be expressed in many tissues without
demonstration of any apoptotic features (Olive and Ferrer, 1999, Penault-Llorca et al,
1998) suggesting that Bax has other cell functions (Aiba-Masago at al, 2002). Peptide
caspase inhibitors Z-Asp-Chz-DCB and zVAD-fmk have been shown to inhibit apoptosis
induced by overexpression of Bax in COS-7 cells suggesting that Bax induces apoptosis
in a caspase-dependent mechanism (Kitanaka et al, 1997).
The DNA fragmentation associated with apoptosis was demonstrated by agarose
gel electrophoresis that showed a ladder appearance at 200 base-pair intervals (Compton,
1992). More recently, Gavrieli et al, (1992) were able to localize the DNA fragmentation
by visualization of apoptosis in situ using routine immunohistochemistry of paraffin
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embedded tissue sections. This in situ apoptosis assay (ISAA) depends upon the binding
of the terminal deoxynucleotide transferase to the 3/-OH end of the fragmented DNA and
incorporating biotinylated deoxyuridine at the sites of DNA breaks. The localization of
apoptosis was then visualized by binding of fluorescein- or peroxidase labeled avidine
(Bardales, 1996; Gouchuico et al, 1997). The ISAA, which is also described as terminal
deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) proved more
sensitive than the laddering assay in detecting apoptosis in different cells (Hagimoto et al,
1997).
Exposure of female mice to PAHs enhanced the expression of Bax in the oocyte,
which was accompanied by induction of apoptosis. This was confirmed by the prevention
of PAHs-mediated ovarian damage by selectively antagonizing the AhR by αnaphthoflavone (Shiromizu and Mattison, 1985; Mattison and Nightingale, 1980) or
inactivation of Bax (Matikainen et al, 2001).
Apoptosis is considered the main cellular mechanism through which oocyte
depletion is induced under both physiological and pathological conditions (Morita and
Tilly, 1999; Perez et al 1997; 1999; Morita et al 2000; Pru and Tilly, 2001). Computerbased scanning of the promoter sequences of a number of regulatory genes involved in
apoptosis showed that mouse Bax promoter has two core AhR response elements
(AhRE1 and AhRE2) (Matikainen et al, 2001). In addition, increasing Bax mRNA levels
and accumulation of its protein in quiescent (primordial) and early growing (primary)
oocytes followed a single intraperitoneal injection of 9,10-dimethylbenz[a]anthracene
(DMBA), a prototypical PAH (Matikainen et al, 2001). It is possible that Bax expression
is directly regulated by the PAH-activated AhR which is indicated by the simultaneous
expression of both AhR and Arnt in oocytes (Matikainen et al, 2001).
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Figure 8. Diagram showing the apoptotic pathway through receptor dependent and
mitochondrial dependent mechanisms (adapted from Fulda and Debtain, 2002; Spickle et
al, 2000; Kroemer and Reed, 2000).
Although apoptosis remained detectable in Hepa-1 cells after blocking the
CYP1A1 activity by 1-aminobenzotriazole (Mann et al, 1999), the MCF-7 human breast
cancer cells are resistant to the dimethylbenz(a)anthracene-induced apoptosis due to
reduction of CYP1A1 expression (Ciolino et al, 2002). The role of CYP1A1 in induction
of dimethylbenz(a)anthracene-induced apoptosis in MCF-7 was attributed to its
metabolization of this compound into a genotoxic forms that are able to bind to DNA
leading to apoptosis (Ciolino et al, 2002).
8.B. Role of AhR in Cellular Proliferation
Interestingly, the AhR increases cellular proliferation (hyperplasia) by stimulating
c-myc expression (Kim et al, 2000). The proposed mechanism involves the association of
the AhR with the Rel A subunit of the NF-κB producing a complex that was able to
cotransactivate the c-myc expression in non-malignant MCF-10F breast epithelial and
malignant Hs578T breast cancer cells (Kim et al, 2000).
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9-Role of AT-II Cell Apoptosis in Remodeling of Lung Parenchyma
Apoptosis or programmed cell death is known to play a role in tissue remodeling,
as shown by remodeling of lung mesenchymal cells during the reparative phase of acute
lung injury in humans (Polunovsky et al, 1993). Apoptosis is responsible for resolution of
AT-II cell hyperplasia in patients with acute lung injury (Bardales et al, 1996). AT-II
cell proliferation can be induced in different animal models by exposure to oxygen,
ozone, asbestos, LPS (Ulich et al, 1994) silica (Albrecht et al, 2001; Friemann et al,
1999; Williams et al, 1993; Panos et al, 1990), coal dust (Friemann et al, 1999) and
carbon black (Harkema et al, 2003). Recently, apoptosis has been demonstrated in the
human epithelial cell line A459 and primary rat AT-II cells following exposure to
ambient air particles of different sizes (Hetland et al, 2003).
10- Modification of CYP1A1-Induced Carcinogenesis by Exposure to Particles
The effect of respirable particles, such as silica and coal dust, on CYP1A1
induction has been studied to improve risk assessment for lung cancers in smoking coal
miners. In one epidemiological study, the lung cancer risk in smoking miners was not
significantly different or even less than other smoking populations (Costello et al, 1974).
Recent epidemiologic studies have suggested that lung cancer in coal mine workers may
not be detected because of the healthy worker-survivor effect (Albrecht et al, 2002).
The International Agency for Research in Cancer (IARC), has classified
crystalline silica, in the form of quartz or cristobalite, as a carcinogen (IARC, 1997). Nine
of the studies done by the IARC showed a higher risk of human lung cancer associated
with silicosis (Castranova and Vallyathan, 2000). Previous findings were suspicious
about the carcinogenicity of silica because of the limited evidence of carcinogenicity in
humans, although there was sufficient evidence for carcinogenicity in animals (Holland,
1990).
It has been demonstrated that intratracheal exposure to silica alone without
exposure to CYP1A1 inducers enhances the CYP1A1-dependent enzymatic activity (7ethoxyresorufin-o-deethylase, EROD) in rat lung microsomal fraction (Miles et al, 1993).
A recent case control study showed that occupational exposure to coal dust significantly
enhanced the lung cancer risk in women (Rachtan, 2002). However, lung cancer was
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mostly absent in people exposed concomitantly to silica and other lung carcinogens, such
as PAH of cigarette smoke (Cocco et al, 2002). Based upon abundant epidemiological
studies, Chechoway and Franzblau (2000) came up with the conclusion that risk
assessment should interpret and manipulate silicosis and lung cancer as distinct entities
whose cause/effect relationships are not necessarily associated.
The CYP1A1 induction is sometimes modified in mixed exposures relative to
single exposures. For example, exposure to kerosene soot significantly increased the
induction of CYP in rat lung; however, the co-exposure of the kerosene and chrysolite
(asbestos) simultaneously significantly depleted the microsomal content of CYPs (Arif et
al, 1994). Also, exposure to occupational crystalline silica dust decreased the activity of
the CYP1A1-dependent enzymatic process, 7-ethoxyresorufin-O-dethylase (EROD), in
rat lungs (Battelli et al, 1999) and rabbit lungs (Ghanem et al, 2003) exposed to a potent
CYP1A1 inducer, beta-naphthoflavone. Furthermore, EROD activity was suppressed in a
dose-dependent manner by intratracheal exposure to respirable, poorly soluble, coal dust
particles in rats (Ghanem et al, 2003).
11-Pattern of CYP1A1 Expression in Cellular Proliferation
The CYP1A1-dependent enzymatic activity, EROD, was undetectable in
proliferating cultures of mouse lung epithelial cells, but the level became detectable once
cultures were confluent (Reiners et al, 1992). It was suggested that EROD expression
was regulated as a function of the proliferative process of the cell culture. An inverse
relationship between cellular proliferation and CYP expression was suggested by the
observation that proliferative regeneration of hepatic cells following partial hepatectomy
was associated with lower CYP protein levels and activities than normal liver (Hino et al,
1974; Presta et al, 1980; Klinger and Karge, 1987; Ronis et al, 1992). It seems that
hepatic cells are allocated to replication, rather than transcription, with a main function of
DNA being proliferate and regenerate the cells after hepatectomy (Liddle et al, 1989;
Waxman, 1989; Morgan et al; 1985; Steer, 1995). Moreover, an inverse relationship
exists between another form of CYP, CYP2B1 apoenzyme, and the proliferation level of
AT-II cells, as previously concluded (Lag et al, 1996). The CY2B1 apoenzyme was
lowest in AT-II cell culture during the most active proliferative stage, which coincided
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with presence of largest number of cells in S-phase and highest proliferating cell nuclear
antigen (PCNA) expression (Lag et al, 1996).

46
CHAPTER 3
RESPIRABLE COAL DUST PARTICLES MODIFY CYTOCHROME P4501A1
(CYP1A1) EXPRESSION IN RAT ALVEOLI
ABSTRACT
Cytochrome P450 1A1 (CYP1A1) plays a critical role in the metabolism of
cigarette

smoke-containing

organic

compounds,

such

as

polycyclic

aromatic

hydrocarbons (PAHs), producing highly reactive intermediates that bind to cellular DNA
and trigger lung tumors. Epidemiological studies report that coal miners, most of whom
are smokers, have a lower risk of developing lung cancer than non-miner smokers
(Costello et al, 1974). Therefore, we hypothesized that exposure to coal mine dust (CD)
might be a modifying factor for development of pulmonary carcinogenesis by altering
cell-specific CYP1A1 induction. To investigate this hypothesis, we evaluated the ability
of CD particles (less than 5 microns) to prevent induction and activity of pulmonary
CYP1A1. For that purpose, male, Sprague Dawley rats (220-270g) were intratracheally
instilled with 0, 2.5, 10, 20, 40 mg coal dust/rat or vehicle (saline).

Eleven days later,

the pulmonary CYP1A1 was induced in all rats by intraperitoneal (IP) injection of βnaphthoflavone (BNF: 50mg/kg IP), as a well-known potent CYP1A1 inducer. After 3
days, rats were sacrificed and the metabolic activity of CYP1A1 was measured as 7ethoxyresorufin-O-deethylase (EROD) activity in fresh lung microsomes. The amount of
CYP1A1 protein in lung microsomes was quantified by Western blot using a polyclonal
rabbit anti-rat CYP1A1 antibody. Cell-specific expression of CYP1A1 was quantified by
dual immunofluorescent staining of CYP1A1 and cytokeratins 8/18, cytoskeletal proteins
highly expressed in alveolar type II (AT-II) cells. Our data showed a dose-dependent
suppression of EROD activity by CD exposure (r2= 0.399, p=0.0028). Western blot
CYP1A1 protein was significantly lower in rats exposed to the highest dose (40 mg/rat)
of CD and BNF than rats treated with BNF alone (p=0.031). Immunoflourescent
examination showed a significant reduction of CYP1A1 area colocalized in AT-II cells in
rats exposed to CD 20 and 40 mg and BNF compared to rats treated with BNF alone.
These findings suggest that CD exposure modifies BNF-mediated CYP1A1 induction by
altering its cell specific localization in pulmonary alveoli and interferes with CYP1A1
metabolic activity.
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INTRODUCTION
Studies of CYPs have recently received a great interest because these enzymes
play critical roles in metabolism of drugs, carcinogens, dietary xenobiotics and steroid
hormones (James and Whitlock 1999). The CYP proteins are heme-containing proteins,
which are members of a gene super-family that contains almost 1000 members in species
ranging from bacteria to plants and animals (Hasler et al, 1999). Cytochrome P4501A1
(CYP1A1) has garnered particular interest because of its involvement in the conversion
of organic compounds, like polycyclic aromatic hydrocarbons (PAH) in cigarette smoke,
into carcinogenic intermediate species (Crespi et al, 1989; Shimada et al, 1989; Eaton et
al, 1995) that can initiate lung cancer development.

Moreover, the expression of

CYP1A1 can be induced at the transcriptional level by its substrates. The transcriptional
regulation of the CYP1A1 gene by polycyclic aromatic hydrocarbons (PAH) is mediated
through ligand-dependent activation of the aryl hydrocarbon receptor (AhR), which
translocates to the nucleus upon activation, dimerizes to the aryl hydrocarbon receptor
nuclear translocator (Arnt) protein and binds to the xenobiotic responsive element (XRE)
in the regulatory region of the CYP1A1 gene (Ma and Whitlock 1997; Tian et al, 1999,)
Coal is a fossil fuel mined all over the world. Coal mine dust generated during
underground coal mining results in significant respiratory exposure to coal miners.

In

addition to the carbon, which is the main component of coal, it also contains oxygen,
nitrogen, hydrogen, and trace elements, including non-coal minerals. The trace elements
may include copper, nickel, cadmium, boron, antimony iron, lead, and zinc (Sorenson et
al, 1974).

Some of these trace elements can be cytotoxic and carcinogenic in

experimental models (Castranova 2000). Mineral contaminants include quartz, kaolin,
mica, pyrite and calcite (Parkes, 1994).

Coal dust inhalation is associated with

development of a respiratory disease of coal miners called coal workers’ pneumoconiosis
(CWP). CWP is categorized according to severity into simple and complicated CWP. In
the simple form, black dust macules appear and consist of dust-laden macrophages
concentrated near respiratory bronchioles.

In complicated CWP, also described as

progressive massive fibrosis (PMF), the nodules are larger (exceeding 1 cm diameter),
and more numerous. These nodules contain increased amount of collagen, coal dust, and
inflammatory cells (Castranova, 2000).
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Epidemiological studies demonstrated that lung cancer in coal miners occurs less
frequently than in general population after adjustment for age and smoking (Meijers et al,
1991; Kuempel, 1995). Instead, coal dust exposure is associated with lung scarring
(pulmonary fibrosis) and accumulation of particles in dust-laden alveolar macrophages
(Castranova, 2000). Most of the studies of lung cancer in coal miners are difficult to
interpret because most of the miners are smokers. This means that they are exposed to a
mixed exposure of the coal dust particles and the carcinogenic compounds of cigarette
smoke. Recent studies from our laboratory suggest that exposure to another occupational
dust, crystalline silica, decreases the activity of the CYP1A1-dependent enzymatic
process, 7-ethoxyresorufin-O-dethylase (EROD), in rat lungs exposed to a potent
CYP1A1 inducer, beta-naphthoflavone (Battelli et al, 1999). Silicosis in rats is also
associated with the appearance of new population of alveolar epithelial cells without
detectable expression of CYP1A1 or CYP2B1, even after exposure to inducers of
CYP1A1 (Battelli et al, 1999; Levy et al, 1997). If other fibrogenic inhaled particulates,
such as coal dust, also reduce the activity of carcinogen-activating CYP1A1-dependent
enzymatic processes, the expected result would be a reduction in the lung cancer
attributable to chemical carcinogens activated by CYP1A1, such as the PAH in cigarette
smoke. Therefore, we investigated the effect of coal dust inhalation on the metabolism of
chemical carcinogens in lungs of rats. These studies will help determine if the effect of
silica on CYP1A1 is a unique feature of silica dust or is a characteristic of pulmonary
exposure to other respirable particles, which cause alveolar epithelial cell hypertrophy
and hyperplasia, such as coal dust. For that purpose, we designed a dose response
experiment in rats to investigate the dose-dependent effect of CD. We injected betanaphthoflavone (BNF) of the PAH family, as a potent and specific CYP1A1 inducer (Lee
et al, 1998). The study utilized the immunofluorescent localization of critical proteins and
morphometric analysis of immunofluorescent-stained tissue to investigate the effect of
coal dust on the expression of CYP1A1 in the deep lung. We also determined the
CYP1A1-dependent enzymatic activity in lung microsomes. Lungs from the same rats
were microscopically examined to determine histopathological alterations associated with
changes in cell specific protein expression. The amount of CYP1A1 protein in the lung
microsomes of control and exposed rats was determined by Western blot analysis using
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polyclonal rabbit anti-rat CYP1A1 antibodies. To our knowledge, we demonstrated for
the first time that CD exposure inhibits the PAH-induced CYP1A1-dependent enzymatic
activity in a dose responsive fashion. This suppression was also observed in pulmonary
alveoli of CD exposed rats in immunofluorescent-stained section. In addition, the amount
of CYP1A1 detected by western blot in lung microsomes was also diminished.
MATERIALS AND METHODS
Animals
Male Sprague-Dawley rats (~220-270g) were purchased from Hilltop Labs
(Scottsdale, PA). Upon arrival, the rats were kept in an AAALAC-approved barrier
animal facility at NIOSH. Food and water were supplied ad libitum. Rats were housed in
Shoebox cages on autoclaved hardwood and cellulose (Alpha-Dri) bedding in HEPA
filtered laminar-flow, ventilated cage racks (Thoren). Rats were allowed to acclimatize in
their cages for at least 7 days before the experiment.
Experimental Design
By using a research randomizer program (www.randomizer.org), rats were
randomized into five groups, of 4 rats each. Each group was intratracheally (IT) instilled
with 0, 2.5, 10, 20, or 40 mg CD /rat (~ 0, 1, 4, 8, and 16 mg/100 gm BW) suspended in
sterile saline. Eleven days later, rats were intraperitoneally (IP) injected with the
CYP1A1 inducer beta-naphthoflavone (BNF) (50 mg/kg BW) suspended in filtered corn
oil. Three days after BNF injection, rats were euthanized and the right lung lobes were
homogenized for collecting the lung microsomes whereas the left lungs were inflated
with 10% neutral buffer formalin for histopathology.
Coal Dust Particles:
The size of these particles was less than 5 microns with surface area 7.4 m2/g. The
particles contained 0.34 % total iron of which 0.119 % is surface iron. The particles were
weighed, placed in a scintillation vial, covered with foil and heat sterilized in an oven at
160 ºC for 2 hours. Coal dust suspensions were prepared from heat-sterilized samples
using non-pyrogenic sterile saline (Abbott Laboratories, North Chicago).
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Intratracheal Instillation
The coal dust particles were suspended in sterile saline at a concentration of 8.3,
33.3, 66.6, and 133.3 mg/ml. Rats received either 0.3 ml of this suspension (~2.5, 10, 20,
and 40 mg/rat) or equivalent dose of saline (vehicle). The rats were anesthetized by
intraperitoneal (IP) injection of sodium methohexital (Brevital, Eli Lilly Indianapolis, IN)
and were intratracheally instilled using a 20-gauge, 4-inch ball-tipped animal feeding
needle as previously described ( Porter et al, 2002)
Beta-Naphthoflavone (BNF) Preparation
Solutions of 5 % BNF (Sigma, St. Louis, MO) in corn oil (50 mg/ml) were prepared
one day before intraperitoneal (IP) injection. Prior to use, the corn oil was filtered with
non-pyrogenic Acrodisc 25 mm syringe filter (0.2 µm in diameter) (Pall Gelman
sciences, Ann Arbor, MI) to assure sterility. The solution suspension was vortexed until
the particles were evenly suspended and then sonicated in Ultronics sonicator (Mahwa,
NJ) for 15 minutes before injection. BNF solutions were injected once, IP, at a dose of
50 mg/kg 3 days before sacrifice.
Euthanasia
Euthanasia was induced by IP injection of 0.5 ml 26% sodium pentobarbital
(Sleepaway®, Fort Dodge Animal Health, Fort Dodge, IA) 2 weeks after CD exposure.
Necropsy
The lungs and attached organs including tracheobronchial lymph node, thymus,
heart, aorta, and esophagus were removed. The right lung lobes were collected and
weighed at necropsy for microsomal preparation while the left lung lobe was inflated
with 3 cc of 10% neutral buffered formalin (NBF). Tracheobronchial lymph nodes, liver,
spleen, and right and left kidneys were also fixed in 10 % NBF. Fixed tissues were
trimmed the same day, routinely processed in a tissue processor and embedded in paraffin
the following morning. Tissue sections of left lung were stained with Hemotoxylin and
Eosin (H&E). Additional 5-micrometer sections were used for immunofluorescence.
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Microsomal Preparation
Lung microsomes were prepared for determination of EROD activity as an
indicator of the CYP1A1-dependent enzymatic activity, 7-pentoxyresorufin-O-deethylase
(PROD) activity as an indicator of the CYP2B1-dependent enzymatic activity, and for
Western blot analysis of CYP1A1 and CYP2B1 proteins. Microsomes were prepared as
previously described (Flowers and Miles, 1991; Ma et al, 2002). At the necropsy, the
right lung lobes were weighed and chopped 4 times with a Mc1Iwain tissue chopper
(Mickle Engineering Co., Gomshall, Surrey, UK) set at slice thickness of 0.5 mm. Then,
the chopped lung tissues were suspended in ice-cold incubation medium (145 mM KCL,
1.9 mM KH2PO4, 8.1 mM K2HPO4, 30 mM Tris-HCL, and 3 mM Mg Cl2; pH 7.4) at a
ratio of 1gm lung to 4 ml incubation medium. The suspended solution was homogenized
using a Teflon-glass Potter-Elvejhem Homogenizer (Emerson, NJ) through 16 complete
passes. The cell nuclei and debris were removed by centrifugation of the homogenate at
2500 rpm for 10 minutes in a Sorvall Model RC2-B refrigerated centrifuge (Ivan Sorvall
Co., Northwalk, CT).

Mitochondria were slowly deposited by three sequential

centrifugations for 20 minutes each at 5,000, 9,000, and 13,000 rpm to reduce the
mitochondrial contamination of the microsomes. The resulting supernatant was ultracentrifuged at 40,000 rpm for 75 minutes in a Beckman Model L5-50 Ultracentrifuge
(Beckman Instruments, Palo Alto, CA) to get the microsomal fraction (Figure 1). The
pellet was re-suspended in the incubation medium in a ratio equal to the original lung
weight (i.e. 1gm lung/ 1ml medium) and frozen at -80C until assayed.
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Figure 1. Four main steps involved in the microsomal preparation of rat lungs. The
process included (1) Collecting the right lung lobes, (2) Chopping the lungs, (3)
Homogenizing lungs, and (4) Centrifugation of lung homogenate to remove the cellular
and nuclear debris and to reduce the mitochondrial contamination of the microsomal
fraction
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Determination of the Total Lung Proteins
The protein content of lung microsomes was measured by the bicinchoninic acid
(BCA) method as previously described (Smith et al, 1985, Ma et al, 2002) using the BCA
protein assay kit (Pierce, Rockford, IL) in a spectra Max 250 Spectrophotometer
(Molecular Devices Corporation, Sunnyvale, California). Bovine serum albumin was
used as the standard.
Measurement of EROD and PROD activities
EROD and PROD activities were measured as previously described (Burke et al,
1985 and Ma et al, 2002) using a luminescence spectrometer model LS-50 (PerkinElmer, Norwalk, CT). A 10 µM concentration of 7-ethoxyresorufin (Sigma, St. Louis,
MO) solution prepared from 2.35 µg 7-ethoxyresorufin in 1 ml DMSO was used for the
standard curve following each run. EROD and PROD activities were expressed as
picomoles of the produced resorufin per minute per milligram microsomal protein
(pmol/min/mg protein).
Western Blot Analysis
Western Blot analysis of lung microsomes was conducted as previously described
(Ma et al, 2002). Each gel received 75 µg of microsomal protein for CYP1A1 and 20 µg
for CYP2B1. The nitrocellulose membrane was probed using a polyclonal rabbit anti-rat
CYP1A1 antibody (Xenotech, Kansas city, KS) or a monoclonal mouse anti-rat CYP2B1
antibody (Xenotech) at 4ºC overnight. Blocking of non-specific binding was made by
incubating the membrane with a solution of 1% dry milk in tris-buffered saline/tween
(TBS/T) for 1 hour at room temperature with rocking. The membranes were then
incubated for 1 hour at room temperature with a goat anti-rabbit antibody (Santa Cruz
Biotech. Inc., Santa Cruz, CA) for CYP1A1 or goat anti-mouse antibody (Santa Cruz
Biotech. Inc., Santa Cruz, CA) for CYP2B1. For positive control, liver microsomes of
BNF-treated rat (Xenotech) were used for CYP1A1 or liver microsomes of
phenobarbital-treated rats (Amersham, Piscataway, NJ) for CYP2B1. The CYP1A1 and
CYP2B1 proteins were detected by enhanced chemiluminescence (ECL) reagent kit
(Amersham). The x-ray films (Fuji Film Corp., LTD., Tokyo, Japan) containing protein
bands were scanned by the Eagle Eye II scanner (Stratagene, La Jolla, California 92037)
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with Eagle Sight software. The scanned images were quantified by ImageQuant software
version 5.1 (Molecular Dynamics, Sunnyvale, CA). The quantification of western blot by
this software calculates the volume under the surface area created by a 3-D plot of the
pixel locations and pixel intensities. Each sample was quantified three times, and then
the averages of the values were used to calculate the individual measurement. The data
were expressed as a percentage of the CYP1A1 or CYP2B1 positive controls.
Dual Immunofluorescence Technique
Paraffin-embedded, formalin-fixed sections from the left lung lobe were used for
immunofluorescent detection of CYP1A1 and cytokeratins 8/18, which are cytoskeletal
proteins used as markers of AT-II cells (Kasper et al, 1993).

Briefly,

immunofluorescence was a two-day procedure (Figure 2) where in the first day the slides
were first heated in the oven at 60 ºC for 10 to 20 minutes. The slides were deparaffinized
and rehydrated in xylene in 3 sequential 6 minute immersions, a 3 minute immersion in
100 % alcohol, 3 minutes in 90 % alcohol, 3 minutes in 80 % alcohol, and 5 minutes in
distilled water. The antigenicity of hidden epitopes was retrieved using 0.01M disodium
ethylenediamine tetraacetate (Fischer Scientific, Fair Lawn, New Jersey), pH 8 in a
microwave heating procedure. Specifically, slides in the EDTA solution were heated for
1 minute and 45 seconds in the microwave on high and then for 6 minutes on defrost.
EDTA solution was then added to replenish the solution which had been evaporated and
the slides were reheated for 6 additional minutes on defrost. To avoid the non-specific
binding of the primary antibodies, the slides were blocked with 5 % BSA in PBS (IgG
free) (Sigma) for 10 minutes at room temperature (RT). Then the slides were rinsed with
distilled water and blocked with 5% pig serum in PBS (Biomeda Corporation, Foster city,
CA) for 10 minutes at RT. The slides were then rinsed with distilled water and primary
antibodies were applied.

We used a polyclonal Guinea pig anti-cytokeratins 8/18

antibody (RDI, Flanders, NJ) for staining of cytokeratins 8/18 at a 1:50 dilution in PBS.
For CYP 1A1 staining, a polyclonal, affinity purified, highly cross-absorbed rabbit antirat CYP1A1 antibody (Xenotech,) was used at a 1:5 dilution. Both primary antibodies
were applied by utilizing the capillarity generated between each pair of slides in a
microprobe holder (Fischer Scientific).

The slides were kept at room temperature

overnight during which the primary antibodies were allowed to bind to the antigen
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(CYP1A1 and cytokeratins 8/18). On the second day, the slides were incubated in the
oven at 37 ºC for 2 hours after which they were thoroughly rinsed with distilled water and
the secondary antibodies were dropped onto the slides. A FITC-labeled, donkey antiGuinea pig IgG (Research Diagnostic Inc., Flanders, NJ) was used to detect cytokeratins
8/18 at a 1:50 dilution with PBS. For CYP1A1 detection, Alexa 594-conjugated goat
anti-rabbit antibody (Molecular probes, Eugene, Oregon) was applied at a dilution of 1:20
with PBS. The secondary antibodies were allowed to bind to the primary antibodies for 2
hours in the dark. For the negative control, the primary antibodies were omitted and
replaced by rabbit serum. Slides were rinsed with distilled water, cover slips were
applied using gel mount (Biomeda Corp., Foster City, CA), and the slides were allowed
to dry for 2 hours. Ten images were captured using a digital camera (Quantix
Photometrics, Roper Scientific Inc, Trenton, NJ ) fitted on an Olympus photomicroscope
(OlympusAX70, Olympus American Inc., Lake Success, NY) by a researcher blinded to
the exposure status. For each slide, 5 images were captured from proximal alveolar
regions (PAR) where most of the dust particles tend to accumulate (Nikula et al, 1997).
Another 5 images were obtained from random alveolar (RA) regions, which were not
located near visible alveolar ducts. The aim of selecting those 2 areas is to assure
sampling of the alveolar regions representative of the site of coal dust particle deposition.
Five images were also captured from the terminal bronchiolar region to count the number
of CYP1A1-positive bronchiolar epithelial cells. The digital camera settings for contrast,
brightness, and gamma were held constant for all slides. The staining was described as
being specific due to the absence of background staining, distinct cellular localization of
CYP1A1 and cytokeratins 8/18, and absence of the staining in the negative control slides
where rabbit serum was applied instead of the primary antibodies.

56

Figure 2. Immunofluorescent technique for staining tissue sections. The procedure
included:
1- Preparation of tissue section of 4 µm thickness from paraffin embedded tissue.
2- Deparafinization and rehydration of tissue sections by emersion in xylene and
alcohol.
3- Retrieval of protein epitopes by using EDTA and microwave heating.
4- Blocking the non-specific antibody binding by pig serum and bovine serum
albumin.
5- Addition of the primary antibody to allow binding to the antigen then labeling the
primary antibody with fluorescent-conjugated secondary antibody.
6- Examination of the fluorescent emission from the secondary antibody under
fluorescent microscope at standard settings.
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Quantification of CYP1A1 and Cytokeratins 8/18 by Morphometric Analysis
The lung area occupied by red fluorescence (representing CYP1A1 expression),
green fluorescence [representing cytokeratins 8/18, which are cytoskeletal proteins highly
expressed in primitive epithelia such as the cuboidal AT-II cells (Kasper et al, 1993)],
and colocalized (concomitantly occurring) red and green fluorescence were quantified by
using commercial morphometry software (Metamorph Universal Image Corp.). The area
of CYP1A1 colocalized with cytokeratins 8/18 in AT-II cells was obtained by the
following formula:
C = R x T where;
C stands for the area of CYP1A1 that co-expressed (colocalized) with
cytokeratins 8/18 in AT-II cells,
R stands for the percent of CYP1A1 expressed in AT-II cells measured by the
Metamorph software, and
T stands for the total CYP1A1 area expressed in the whole alveolar septum
(including AT-II and alveolar non-type II cells) measured by the Metamorph software.
Moreover, the proportional CYP1A1 expression in AT-II cells, which is the
relative area of CYP1A1 to cytokeratins 8/18 expression, was calculated from the
following formula:
P = R x T where;
G
C, R, and T as defined above and,
G is the total green area of cytokeratins 8/18 expressed in AT-II cells.
P is the proportional CYP1A1 expression within areas occupied by the AT-II marker, and
adjusts for increases associated with AT-II hyperplasia.
By this method, we were able to analyze the expression pattern in AT-II cells.
Moreover, the hyperplasia of AT-II cells was also determined by measuring the area
containing the FITC expression (green area), which represents the expression of
cytoskeletal proteins 8/18 by AT-II cells. The threshold ranges for red and green colors
were held constant during morphometric analysis of all images.
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Histopathology:
Slides were interpreted by a board-certified veterinary pathologist blinded to the
exposure status of the individual slides. Changes assessed in each slide included: AT-II
cell hyperplasia and hypertrophy, alveolitis (inflammation), and hyperplasia of bronchusassociated lymph tissue. Histopathologic changes were scored for severity and
distribution from zero to five as previously described (Hubbs et al, 1997). Briefly,
severity was scored as none (0), minimal (1), mild (2), moderate (3), marked (4), or
severe (5). Distribution was scored as none (0), focal (1), locally extensive (2), multifocal
(3), multifocal and coalescent (4), or severe (5). The pathology score is the sum of the
severity and distribution score.
Statistical Analyses
The dose responsive effects of coal dust instillation on EROD, PROD, and
Western blot for CYP1A1 and CYP2B1 were assessed using linear regression analysis.
Pairwise comparisons of each dose to the control group were analyzed using one-way
analysis of variance followed by Dunnett’s test. AT-II hyperplasia and hypertrophy based
on immunofluorescence were analyzed using one-way analysis of variance followed by
Dunnett’s test to compare each dose to the control group. Pathology scores were analyzed
using the nonparametric Kruskal-Wallis test followed by the Wilcoxon Rank-sum test for
pairwise comparisons. All differences were considered statistically significant at P<0.05.
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RESULTS
Effect of Coal Dust Exposure on EROD and PROD
The IT instillation of coal dust suppressed the CYP1A1-dependent enzymatic
activity (EROD) in a dose-dependent fashion (r2=0.399, p=0.0028) (Figure 3). Rats
exposed to 40 mg/rat CD with BNF had a significant lower EROD activity than those
exposed to control saline with BNF (p=0.036). Similarly, CYB2B1-dependent enzymatic
activity (PROD), the major CYP isoform in rat lungs, showed a dose-dependent reduction
by CD exposure using linear regression (r2= 0.458, P=0.001). PROD was significantly
reduced in rats exposed to 20 and 40 mg/rat CD with BNF compared to control, saline
with BNF (p 0.017) (Figure 4).
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Figure 3. BNF-induced CYP1A1-dependent enzymatic activity (EROD) is suppressed in
a dose dependent fashion by intratracheal exposure of rats to 0, 2.5, 10, 20, or 40 mg coal
dust suspended in the vehicle (saline). EROD activity is significantly reduced at 40
mg/rat CD exposure comparing to the control saline. Values are means and standard error
of 4 rats /group. EROD was measured as pmol/min/mg microsomal protein. All rats
received 50 mg/kg BNF IP 3 days before sacrifice. The linear regression best fit curve
showing the reduction of EROD activity with increasing CD exposure. * Significantly
different from control at p<0.05.
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Figure 4. Lung microsomal CYP2B1-dependent enzymatic activity (PROD) is reduced in
a dose-dependent manner by CD exposure. Values are means and standard error of 4 rats
/group. PROD was measured as pmol/min/mg microsomal protein. All rats also received
IP BNF (50mg/kg) 3 days prior to sacrifice. The linear regression best fit curve showing
the reduction of PROD activity with increasing CD exposure. * Significantly different
from control at p<0.05.
Western Blot Analysis
CYP1A1
A representative Western blot of the pulmonary microsomal preparations is
shown in Figure 5A. The results were expressed as the percentage of the CYP1A1
positive control. The amount of CYP1A1 quantified by Western blot in CD and BNFexposed was less than in rats exposed to BNF without CD. Groups treated with the
highest dose of CD (40mg/rat) showed a significant reduction of CYP1A1 protein
compared to control (p=0.03) (Figure 5A and B).
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Figure 5. In A, a sample of Western blot showing significant repression of CYP1A1
protein in lung microsomes by coal dust exposure (p=0.029) at high dose of CD
(40mg/rat) analyzed by linear regression. Microsomal protein (75 µg) from a positive
control (liver microsomes of BNF-treated rats) (lane 1), pulmonary microsomes from
BNF-treated rats (lane 2 & 4) and CD and BNF-exposed rats (2.5mg CD lane 3, 10mg
CD lane 5, 20mg CD lanes 6 &7, and 40 mg CD lane 8) were subjected to SDS gel
electrophoresis using Tris-glycine SDS running buffer and blotted to nitrocellulose
membranes. The membranes were probed with rabbit anti-rat CYP1A1 antibody
overnight at 4ºC then goat anti-rabbit antibody as described in the materials and methods.
Lane 9 is the molecular weight standard. In B, the data from multiple Western blots is
expressed as the percentage of CYP1A1 positive control from quantification of four
different samples from each exposure group. The values represent means ± SE, n=4.
*significantly different from control group at P < 0.05.
CYP2B1
The CYP2B1 protein, the major isoform of CYP subfamily in the rat lung, was
measured in the lung microsomes. CYB2B1 is not inducible by BNF in rat lungs but can
be induced in liver by phenobarbitals. The amount of lung CYP2B1 detected by Western
blot was numerically, but not significantly, less in CD-exposed rats than control rats (6A
and B). The results were expressed as the percentage of CYP2B1 positive control.
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Figure 6. The effect of coal dust on CYP2B1 in the lungs of BNF-exposed rats assessed
by Western blot using linear regression analysis. Microsomal protein (20 µg) from
control rats (saline and BNF) and exposed (CD and BNF) rats were subjected to SDS gel
electrophoresis using Tris-glycine SDS running buffer and blotted against nitrocellulose
membrane. The membranes were probed with mouse anti-rat CYP2B1 antibody
overnight at 4ºC then goat anti-mouse antibody as described in the materials and
methods. The amount of lung CYP2B1 detected by Western blot is decreased, although
not significantly, by coal dust exposure. In A, the first lane (c) is the positive CYP2B1
control (liver microsomes of Phenobarbital-treated rats), the last lane is the molecular
weight standard, while all other treatments are indicated above the lanes. In B, 4 different
samples for each treatment were quantified and the data expressed as a percentage of
positive CYB2B1 control. Values are means ± SE, n=4.
Effect of CD Exposure on Histopathological Changes of Lung Alveoli
AT-II cell hyperplasia (increased cell number) and hypertrophy (increased cell
size), alveolitis (alveolar inflammation), and lymphoid hyperplasia of tracheobronchial
lymph node were the major histopathological changes assessed in sections stained by H
and E. Accumulation of dust-laden macrophages in the alveolar spaces was a noteworthy
finding in coal dust exposed alveoli (Figure 7). Rats exposed to CD (2.5, 10, 20, and
40mg/rat) showed significant hyperplasia and hypertrophy of AT-II cells compared to
control (p<0.001 in all treatment doses); Figure 8. In addition, alveolitis (alveolar
inflammation) was significantly increased in rats exposed to 2.5, 10, 20, and 40mg/rat
CD (p=0.01, p=0.006, p=0.002, p=0.002, respectively) (Figure 8)
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A

Figure 7. Microphotograph of tissue section stained with H & E showing AT-II cellular
hyperplasia and hypertrophy. Dust-laden macrophages are also shown as dark spots in the
alveolar spaces. These histopathological changes are absent in control (B). The bar is 20
µm.
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Figure 8: Histopathological changes in rat lungs after intratracheal exposure to coal dust.
Changes were scored for severity and distribution of alveolitis and AT-II hyperplasia and
hypertrophy as described in the material and methods. * indicates that alveolitis is
significantly higher than control (saline/BNF) at p < 0.05. + indicates that AT-II
hyperplasia and hypertrophy are significantly higher than control (saline/BNF) at p <
0.05. Data were analyzed by the non-parametric Kruskal-Wallis test followed by
Wilcoxon Rank-Sum test for pairwise comparisons. Values are means ± SE, n=4.
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Results of dual Immunofluorescence:
The result of immunofluorescent changes by CD exposure is summarized in Table
1.
I-Pattern of CYP1A1 Expression in Alveolar Region of the Lung
A specific pattern of rat CYP1A1 expression was observed in the alveolar region
of the lung by immunofluorescence examination. In rats exposed to BNF alone (control
rats), the CYP1A1 expression (red-labeled area in Figure 9) was mostly localized to the
endothelium of the pulmonary vasculature and in cells of the alveolar septum.
Statistically, areas of CYP1A1 expression were significantly smaller in AT-II cells than
in other cells (NT-II cells) of the alveolar septum (p=0.003) (Figure 9B and C).
II-Pattern of Cytokeratins 8/18 Expression in the Alveolar Region of the Lung
The green fluorescent Cytokeratins 8/18 were clearly expressed in the cytoplasm
of cuboidal cells that were mainly localized on the corners of the alveolar septum (Figure
9A). These cells have the plump morphology characteristic of AT-II cells of the alveolar
septa. No green fluorescence was visualized in the other types of cells of the alveolar
septum, which were then designated as alveolar NT-II cells (Figure 9A).
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III-Effect of CD on AT-II Cell Proliferation by Immunofluorescent Examination
The area of expression of cytoskeletal proteins (cytokeratins 8/18), which are
highly expressed in the cytoplasm of AT-II was quantified morphometrically and
expressed as square micrometer. In the proximal alveolar (PA) regions, this area was
significantly larger in rats exposed to 20 and 40 mg CD/rat and BNF than control (Figure
10A), indicating hyperplasia and hypertrophy of AT-II cells ( p= 0.027 and p=0.02,
respectively) (Figure 10 A and 11B). On the contrary, no significant change of AT-II
hyperplasia and hypertrophy was detected in the random alveolar (RA) regions of CDexposed rats compared to control (Figure 10B and Figure 12B,).
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Figure 10. Morphometric quantification of area of cytokeratins 8/18 expression in AT-II
cells. In A, the area was quantified in the PA regions and showed a significant increase of
cytokeratins 8/18 expression in rats exposed to 20 and 40 mg/rat coal dust and BNF
compared to control. In B, no significant change was detected in cytokeratins 8/18
expression of the RA regions of rats exposed to CD vs. control. Data were analyzed by
one way analysis of variance followed by Dunnett’s test. * indicates significant
difference from control at p<0.05. Values are means ± SE, n=4.
IV-Effect of CD exposure on CYP1A1 Expression by Alveolar Non-Type II (NT-II)
Cells
1-CYP1A1 Expression by Alveolar NT-II Cells in Saline vs. Coal Dust Exposed Rats:
A- In proximal Alveolar (PA) Regions
The area of expression of CYP1A1 (measured in square micrometer) by alveolar
NT-II cells (all cells in the alveolar septum except for AT-II cells) of PA regions (regions
of coal dust accumulation) was significantly lowered in groups exposed to 20 mg and 40
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mg/rat CD and BNF compared to BNF control group (p=0.007, p=0.008, respectively)
(Figure 11A). This was indicated by the reduction of the red-labeled area that is not coexpressed with green-labeled area (NT-II cells stained red only for CYP1A1) as shown in
Figures 12A and B.
B- In Random Alveolar (RA) Regions
No significant change was detected in the area of CYP1A1 expression by alveolar
NT-II cells of RA regions (regions of minimum particle aggregation) of groups exposed
to CD and BNF compared to control group. This result was illustrated by morphometric
quantification of CYP1A1 expression in alveolar NT-II cells where none of the
cytokeratins 8/18 were localized with CYP1A1 (Figure 11B and Figure13A and B).
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Figure 11. Morphometric quantification of immunofluorescent-stained sections for
CYP1A1 and cytokeratins 8/18 of NT-II cells of the PA and RA regions of control and
CD-exposed rats. In A, the CYP1A1 expression area in alveolar NT-II cells is
significantly reduced in groups exposed to 20 and 40 mg/kg CD and BNF compared to
that exposed to BNF alone. However in B, no significant changes in the area of CYP1A1
expression in NT-II cells of the RA regions of CD-exposed rats compared to control.
Values are means ± SE, n=4. * Significantly different from control at p<0.05.
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2-CYP1A1 Expression by Alveolar NT-II Cells in PA Regions vs. RA Regions of CDExposed Rats:
CYP1A1 expression by alveolar NT-II cells was compared in 2 different alveolar
regions, the proximal versus random alveolar regions. The area of CYP1A1 expression
measured in alveolar NT-II cells of PA regions was significantly reduced compared to the
RA region in rats exposed to 20 and 40 mg/kg CD and BNF (p=0.048, p=0.022,
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Figure 14. Morphometric quantification of CYP1A1 expression in NT-II cells of PA
regions vs. RA regions. The area was measured in square micrometer. * indicates that
CYP1A1 expression is significantly lower in NT-II cells of PA regions compared to RA
regions in rats exposed to 20 mg/rat CD and BNF at p<0.05. indicates that CYP1A1
expression is significantly lower in NT-II cells of PA regions compared to RA regions in
rats exposed to 40 mg/rat CD and BNF at p<0.05. Values are means ± SE, n=4.
V-Effect of CD Exposure on CYP1A1 Expression by AT-II Cells
1-CYP1A1 Expression by AT-II Cells in CD-Exposed Rats vs. Control in the PA
Regions
A- Relative Area (proportion) of CYP1A1 Expression in green AT-II Cells
The relative area of red fluorescent CYP1A1 expression to the green fluorescent
area of cytokeratins 8/18 expression was calculated by the formula described in the
materials and methods section, and was designated as proportional CYP1A1 expression,
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which determines the amount of CYP1A1 expression within AT-II cells with correction
for changes in AT-II cell number. The proportional CYP1A1 expression in AT-II cells of
PA regions was significantly reduced in rats exposed to 20 mg (p=0.005) and 40 mg
(p=0.003) CD and BNF compared to control (Figure 15A).
B- Area of CYP1A1 Colocalized with Cytokeratins 8/18 in AT-II Cells
The expression of CYP1A1 in AT-II cells is visualized as a yellow fluorescence
due to concomitant expression of the red-fluorescent CYP1A1 and green-fluorescent
cytokeratins 8/18 (Figure 9C). The expression (co-localization) of CYP1A1 in AT- II
cells of the PA regions measured in µm2 was significantly lowered in rats exposed to 20
mg/rat (p=0.007) and 40 mg/rat (p=0.002) CD and BNF compared to control (Figure
15B). This was indicated by the reduction of the red areas that colocalized (co-expressed)
with green areas in rats receiving higher exposures of CD (Figure12B).
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Figure 15. Morphometric quantification of proportional CYP1A1 expression (A) and
colocalization area (B) in AT-II cells. In A, * indicates significant reduction of fractional
CYP1A1 expression in AT-II cells in the PA regions of rats exposed to 20 and 40 mg/rat
CD with BNF compared to the PA region of BNF-treated rats at p<0.05. in B, * indicates
significant reduction of area of CYP1A1 expression in AT-II cells (colocalization area) in
PA region exposed to 20 and 40 mg/rat CD with BNF compared to control at p<0.05.
2-CYP1A1 Expression by AT-II cells in CD-Exposed Rats vs. Control in RA Regions
The expression of CYP1A1 in AT-II cells (either the co-localization or the
proportional expression) was not significantly affected by CD exposure in RA regions
(data not shown).
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3-CYP1A1 Expression by AT-II Cells in PA Regions vs. RA Regions of CD-Exposed
Rats:
The area of CYP1A1 expression measured in AT-II cells showed no significant
changes in PA regions when compared to RA regions in CD-exposed groups compared
with BNF-exposed groups (data not shown)
IV-Effect of CD Exposure on CYP1A1 Expression in the Whole Alveolar septum:
The area of CYP1A1 expression was measured in the alveolar septum as a total
red area, which represent the expression by all different types of cells at the septum. A
significant reduction was detected with 20 and 40 mg/rat CD in PA regions (Figure 16A).
However, there was no change observed in RA regions (Figure 16B). In addition, in rats
exposed to 20 and 40 mg of CD, CYP1A1 expression in RA regions was significantly
less than in PA regions (Figure 17).
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Figure 16. Morphometric analysis of area of CYP1A1 expression in the whole alveolar
septal cells of the PA (A) and RA (B) regions. In A, the total CYP1A1 area localized in
PA regions lung alveoli of rats exposed to 20 and 40 mg CD and BNF is significantly
lower than BNF-exposed . In B, however, no significant change is observed Values
represent means ± SE (n=4). *Significantly different from control saline/BNF at P<0.05.
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Figure 17: Quantitative analysis of the total alveolar area expressing CYP1A1 in PA
regions vs. RA regions. The total CYP1A1 area expressed in all alveolar cells of PA
regions is significantly decreased in rats exposed to 20 and 40 mg CD and BNF
compared to that of the RA regions. The letter a above the bar indicates a significant
difference from RA regions of rats exposed to 20 mg CD and BNF at p<0.05. the letter b
above the bar indicates a significant difference from RA regions of rats exposed to 40 mg
CD and BNF at p<0.05. Values represent means ± SE (n=4).
IIV-Effect of CD on CYP1A1 Expression by the Non-Ciliated Bronchiolar Epithelial
(Clara) Cells
The number of the CYP1A1-positive non-ciliated bronchiolar epithelial cells was
counted per micrometer of the basement membrane. No significant change in the number
of CYP1A1-positively stained cells was observed in BNF and CD-exposed rats compared

Number of CYP1A1 positive cells/um basement membrane

to BNF-exposed rats (Figure 18 and 19).
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Figure 18. Effect of CD exposure on CYP1A1 expression by terminal non-ciliated
bronchiolar (Clara) cells. The number of Clara cells positive for the CYP1A1
immunofluorescent signal per µm of basement membrane showing no significant
difference between CD exposed rats and control. Values represent means ± SE (n=4).
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Table 1. Summary of morphometric quantification of immunofluorescent-stained sections
against CYP1A1 and cytokeratins 8/18 in rat lungs exposed to coal dust.
saline
Region

CD 2.5 mg

CD 10 mg

CD 20 mg

CD 40 mg

PA

RA

PA

RA

PA

RA

PA

RA

PA

RA

471.1
±
152.6
124.5
±
40.4
0.274
±
0.043
540.9
±
76.86

509.1
±
133.7
79.2
±
54.5
0.260

236.7
±
152.6
75.5
±
40.4
0.319
±
0.043
471.2
±
76.86

44.8
±
133.7
67.7
±
54.5
0.163

907.2
±
152.6
129.9
±
40.4
0.141
±
0.043
372.1
±
76.86

421.2
±
133.7
57.3
±
54.5
0.175

829.5*
± 152.6

462.4
±
133.7
87.8
±
54.5
0.187

1160* ±
152.6

512.8
±
133.7
181.9
±
54.5
0.275

353.9
±
127

136.1*☼
±
76.86

328.9
±
127

144.2*☼
±
76.86

parameter
Cytokeratins 8/18
expression
Area of CYP1A1 in
AT-II cells (µm2)
proportional CYP1A1
expression in AT-II
cells
Area of CYP1A1 in
NT-II cells (µm2)
Area of CYP1A1 in
all alveolar cells
(µm2)
CYP1A1
positive
Clara cells/µm

665.4

711.5
±
127

575.0
±
±
103.0 173.6
0.0482 ±
0.0062

328.8
±
127

546.8

498.7

411.3
±
±
103.0 173.6
0.0525 ±
0.0018

396.4
±
±
103.0 173.6
0.0446 ±
0.00482

35.4
±
40.4
0.039*
± 0.043

*☼

416.8
± 103.0
±
173.6
0.0513 ±
0.00784

171.4

24.0 ±
40.4
0018* ±
0.043

537.2
±
127

*☼

719.2
±
173.6
0.0317 ±
0.00785

168.2

± 103.0

The values presented are means ± SE, n=4. * means significant difference from the
control (saline) regarding the same region.

☼

indicates significant difference of PA

regions from RA regions of the same treatment group.
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DISCUSSION
Some epidemiological studies report that coal miners, primarily smokers, have a
lower risk of developing lung cancer compared with control non-miners (Costello et al,
1974). Moreover, lung cancer risk in workers exposed to the more toxic particles, such as
silica, was mostly absent when workers were concurrently exposed to other workplace
lung carcinogens, such as polycyclic aromatic hydrocarbons (PAHs) (Cocco et al, 2001).
Such data concerning lung cancer in miners are difficult to interpret because miners are
exposed to a mixture of environmental pollutants; such as the coal dust particles and the
PAH in cigarette smoke
Using rats with induced CYP1A1, as it is in cigarette smokers, our EROD data
showed that coal dust exposure suppressed induced CYP1A1 activity in a dose-dependent
fashion (Figure 3). Previous studies in our laboratory showed that IT exposure of rat
lungs to crystalline silica (20mg/rat) significantly suppressed induced EROD activity
(Battelli et al, 1999). Although coal dust is less cytotoxic than silica (Castranova, 2000),
it is able to inhibit the CYP1A1-dependent enzymatic activity (EROD) in a dose
responsive manner suggesting that CD particles are among the toxic respirable
compounds, that include silica, that interfere with CYP1A1 metabolic activity in rat
lungs. Western blot analysis was performed using a polyclonal rabbit anti-rat CYP1A1
antibody to detect CYP1A1 protein expression in the lung microsomes. The amount of
CYP1A1 protein in the gel was reduced at all doses of CD treatment, but was significant
only in the highest dose (40 mg/rat) (Figure 5A and B). This suggested that the reduction
in the CYP1A1 activity upon exposure to CD is partly attributed to the reduction of
CYP1A1 expression and protein synthesis by different pulmonary cells.
The activity of CYP2B1, measured in lung microsomes as PROD activity,
showed a dose-dependent reduction by exposure to coal dust (Figure 4). CYP2B1 is the
major constitutive isoform of cytochrome P450s in rat lungs (Martin et al, 1993;
Guengerich et al, 1982). CYP2B1 expression is not inducible in the rat lung (Guengerich
et al, 1982). BNF, a specific CYP1A1 inducer, significantly up-regulates CYP1A1
expression in the lung parenchyma (Lee et al, 1998, Jones et al, 1983, and Sesardic et al,
1990). Western blot analysis for CYP2B1 showed a reduction of the protein, albeit not
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significant, in BNF and CD-exposed rats compared to rats receiving BNF alone. This
suggested that CD exposure modified not only the CYP1A1 expression and activity but
also the activity of CYP2B1 in the rat lung.
Cell-specific expression and localization of CYP1A1 were studied by
immunofluorescence

followed

by

quantification

using

morphometric

analysis.

Immunofluorescence was employed in this study because preliminary studies indicated
that it was more sensitive than enzymatic immunohistochemistry and useful for localizing
the sites of pulmonary CYP1A1 through double labeling (Battelli et al, 2001).
Morphometric analysis of immunofluorescent-stained sections for CYP1A1 demonstrated
that within the alveolar septum, CYP1A1 expression area was generally localized to
flattened cells morphologically suggestive of alveolar type I cells (Figure 9D). By using
colocalization to sites of cytokeratins 8/18 expression to determine AT-II CYP1A1
expression, it was demonstrated that most of the alveolar area expressing CYP1A1 is not
occupied by AT-II cells. This was not surprising because alveolar type I epithelial cells
cover greater than 90% of the internal surface area of the lungs (Wang et al, 2002;
Gonzalez and Dobbs, 1998) whereas type II epithelial cells account for less than 10%
(Castranova et al, 1988). Moreover, it has been observed by in situ hybridization in the
lungs of 3-methylcholanthere-induced rats that CYP1A1 labeling was visualized in other
alveolar wall cells that could be either capillary endothelial cells or alveolar type I
pneumocytes (Pairon et al, 1994). An overall reduction of CYP1A1 expression within
the alveolar septum was observed in BNF-induced rats exposed to 20 mg and 40 mg
CD/rat compared to those exposed to BNF induction and saline. These results were
consistent with EROD activity, suggesting that both CYP1A1 protein expression in the
alveolus and its metabolic function throughout the lung are suppressed by CD exposure.
Localization of CYP1A1 in terminal non-ciliated bronchiolar epithelial (Clara) cells was
also investigated because Clara cells are considered the major area of CYP1A1
expression in lungs since they are rich in agranular endoplasmic reticulum (Plopper,
1983) where CYP1A1 is localized. The number of CYP1A1-positive cells was counted
per micrometer of the basement membrane. This number did show a significant change in
rats exposed to CD and BNF compared to the control. This result suggested that CD
modified CYP1A1 expression at the alveolar rather than the bronchiolar level,
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presumably because the CD particles tend to aggregate in alveolar regions adjacent to the
alveolar duct.
Previous morphometric studies demonstrated that the alveolar tissue represents
87% of the total lung volume in rats where the volume of alveolar type I cells is more
than twice that of alveolar type II cells (Carpo et al, 1983 and Perkinton, et al, 1982).
Following lung injury at the alveolar level, the damage of type I pneumocytes is repaired
by progenitor alveolar type II cells that can proliferate and regenerate the damaged
alveolar surface and may differentiate into type I cells, thus reconstituting the alveolar
architecture (Melloni et al, 1995; Wang et al, 2002). The hypertrophy and hyperplasia of
AT-II cells were obvious in immunofluorescence (Figure 12B) and histopathology
(Figure 7A). Despite the increasing numbers (hyperplasia) and size (hypertrophy) of ATII cells, AT-II cell-specific CYP1A1 expression decreased as many of these cells were
devoid of detectable CYP1A1 (Figure 12B). This suggested that coal dust exposure was
associated with the appearance of new populations of AT-II cells but that many of these
cells did not contain detectable amounts of CYP1A1. A number of investigators have
reported that CYP activities and the level of CYP apoproteins decreased after partial
hepatectomy and regeneration of hepatic cells (Hino et al, 1974; Presta et al, 1980;
Klinger and Karge, 1987; Ronis et al, 1992). The priority of hepatic cell function during
regeneration is the key factor where the replication, but not the transcription, is the main
function of DNA regenerating the cells (Liddle et al, 1989, Waxman, 1989, Morgan et al,
1985, and Steer, 1995). One possible explanation for our findings may be that like
regenerating hepatocytes, AT-II cells during the hyperplasia and hypertrophy, are mainly
devoted to proliferation and not to expressing CYP1A1. Consistent with that were the
higher levels of CYP2B1 protein expression and mRNA in freshly isolated AT-II cells,
but these levels diminished in the cell culture (Lag et al, 1996).
Histopathological changes assessed in stained sections showed that CD exposure
enhanced the pulmonary inflammatory response (Figure 7B and 8). Lung inflammation
was characterized by intra-alveolar and interstitial accumulation of macrophages and rare
neutrophils. The dust-laden macrophages were enlarged and often aggregated in clumps
of two or more cells. The alveolar inflammation was often centered around alveolar ducts
where CD particles were deposited. These findings were consistent to those described by
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Nikula et al, (1997). It has been demonstrated that the ability of the liver to metabolize
drugs in rodents is impaired following inflammatory stimuli that are accompanied by a
depletion of total hepatic CYP content and a declined microsomal metabolism of drug
substrates (Ghezzi et al, 1986; Bissell and Hammaker, 1976). In other similar studies, the
experimentally-induced inflammatory reactions resulted in a reduction of the microsomal
CYP concentration and their metabolizing activity in the liver (Beck and whitehouse,
1974; Mahu and Feldman 1984; Endo et al, 1981; Baer and Green, 1981). In addition,
exposure of cultured hepatocytes to inflammatory stimuli decreased the total microsomal
CYP, CYP-catalyzed enzyme activities, and levels of CYP proteins and mRNAs
(Morgan, 1997). Although relatively little data describes the effect of inflammation on
extrahepatic CYP expression and some evidence suggests that extrahepatic CYPs are
likely to be differentially regulated by different inflammatory stimuli (Morgan, 2001).
The CD-induced pulmonary inflammation shown in our experiment was associated with
suppression of pulmonary CYP1A1 induction and CYP2B1expression and activity in the
rats. Studies of possible roles of pro-inflammatory mediators are underway.
In conclusion, our data showed for the first time that CD exposure had a
modifying effect on the BNF-induced CYP1A1 expression via altering its cell specific
localization in rat lung. CD was able to suppress the activity and expression of CYP1A1
as demonstrated by the dose-dependent reduction of EROD activity and diminution of
CYP1A1 apoprotein measured by Western blot analysis. Not only was CYP1A1
induction modified by CD exposure, but the activity of another CYP isoform, CYP2B1,
was suppressed in a dose-dependent fashion. The overall results suggested that coal dust
exposure was a complex modifier of the CYP1A1 induction in rat lungs and had the
ability to trigger pulmonary inflammation and reduction of CYP1A1 induction and
activity.
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CHAPTER 4
SUPPRESSION OF RABBIT PULMONARY CYP1A1 INDUCTION BY
RESPIRABLE CRYSTALLINE SILICA
ABSTRACT
Silicosis is an inflammatory and fibrosing occupational lung disease which is also
associated with increased risk of developing lung cancer. However, inflammation
interferes with the biological activation of polycyclic aromatic hydrocarbon (PAH)
procarcinogens to ultimate carcinogens by cytochrome P450 1A1 (CYP1A1). In addition,
the carcinogenic effects of crystalline silica and cigarette smoke, which contains PAHs,
are subadditive in some epidemiologic studies. Investigating the modifying effect of
silicosis on PAH metabolism will facilitate interpretation of epidemiologic studies of
mixed exposures to cigarette smoke and crystalline silica. We have, therefore,
investigated the hypothesis that acute and chronic silicosis can modify PAH-induced
pulmonary carcinogenesis by altering cell specific induction of pulmonary CYP1A1.
Acute or chronic silicosis were induced in male New Zealand White rabbits by
intratracheal instillation of 300 mg respirable crystalline silica 2 weeks or 1 year prior to
sacrifice, respectively. Chronic silicosis was principally localized to one side of the lung
to minimize the signs of respiratory diseases. Control rabbits received intratracheal
instillation of saline. CYP1A1 was induced in all exposure groups by intraperitoneal
injection of beta-naphthofalvone (BNF, 80mg/kg IP) 2 and 3 days prior to sacrifice.
CYP1A1 function as assessed by 7-ethoxyresorufin-O-deethylase (EROD) activity was
significantly lower in BNF-exposed rabbits with acute (p=0.01) or chronic (p=0.02)
silicosis than in rabbits receiving BNF alone. By Western blot, CYP1A1 protein was
significantly reduced in acute (p=0.02) but not chronic silicosis. Cell specific expression
of CYP1A1 was assessed in sections of lung by immunofluorescent double labeling for
CYP1A1 and cytokeratins 8/18, cytoskeletal proteins expressed in Alveolar type II (ATII) and airway epithelial cells. In the alveolus, total septal expression of CYP1A1 per unit
area was decreased in both acute and chronic silicosis. In terminal bronchioles, both acute
and chronic silicosis resulted in a decrease in the number of Clara cells expressing
CYP1A1 per mm basement membrane. These results suggest that silicosis suppresses the
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induction of CYP1A1 activity and alters the alveolar and bronchiolar cellular expression
of CYP1A1 in rabbits.
INTRODUCTION
CYP1A1 is the microsomal enzyme responsible for the bioactivation of procarcinogenic compounds such as benzo[a]pyerene, producing biologically active
intermediates that bind to the DNA to produce adducts and lung cancer (Gelboin, 1980;
Crepsi et al, 1989; Shimada et al, 1989; Anttila et al, 1991; Eaton et al, 1995). CYP1A1
is associated with the endoplasmic reticulum of many cells, particularly those of
xenobiotic-metabolizing organs such as liver and lungs (Anttila et al, 1991). It is well
known that CYP1A1 is induced via an aryl hydrocarbon receptor (AhR)-ligand binding
mechanism. The binding of a ligand, such as a PAH, causes dissociation of a 90-KDa
heat-shock protein (Hsp90) and other cytoplasmic factors such as the AhR-interacting
protein (AIP) (Ma and Whitlock, 1997) from the AhR in the cytoplasm, which leads to
translocation of the AhR to the nucleus where it dimerizes with another structurally
related protein, AhR nuclear translocator (Arnt). This heterodimer binds to the xenobiotic
responsive element (XRE) in the regulatory region of the CYP1A1 gene initiating its
expression and induction (Takahashi et al, 1996; Abbot et al, 1999; Ke et al, 2001;
Hayashi et a., 1994). The promoter region of CYP1A1 assumes a particular nucleosomal
configuration in un-induced cells that could explain its barely detectable constitutive
expression (Morgan and Whitlock, 1992; Whitlock, 1999). Upon induction, the CYP1A1
promoter undergoes a change in chromatin structure and loss of the nucleosomal
configuration that facilitates the attachment of promoter-binding proteins (Wu and
Whitlock, 1992).

The changes in the chromatin structure and configuration at the

CYP1A1 promoter area are AhR-dependent and Arnt-dependent processes (Whitlock,
1999).
Silicosis is an occupational lung disease resulting from exposure to the crystalline
form of the mineral silicon dioxide or silica (Driscoll and Guthrie, 1997). Silicosis is
characterized by inflammation and fibrosis in the lower respiratory tract. Because silica is
one of the most abundant minerals in the earth’s crust, there are significant opportunities
for exposure particularly in occupations or activities involving cutting, shaping, or
polishing of rock. The increase in silicosis during the past years is mainly attributed to the

82
development of tools and processes that generate high concentrations of fine particles
(<10µm in diameter), which are able to penetrate into the deep lung tissues, and elicit
their toxic effects (Craighead et al, 1998; Castranova et al, 1996; Peters 1986).
Crystalline silica is toxic to a wide range of animal species including humans (Holland,
1990; Saffiotti and Stinson, 1988; Green and Vallyathan, 1995). In humans, there are
different forms of silica-induced lung disease differentiated according to the nature and
progression of the lung pathology (Driscoll and Guthrie, 1997). Radiologically, simple
and progressive massive fibrosis can be identified. Simple silicosis is characterized by the
presence of small opacities (silicotic nodules) (Ziskind et al, 1986; Seaton, 1984) with a
diameter of less than 10 mm (Weissman and Wagner, 2001) without respiratory
impairment unless accompanied by tuberculosis (Snider, 1978; Craighead et al, 1988).
Simple silicosis may develop into progressive massive fibrosis (PMF) when congregation
of these silicotic nodules occurs followed by destruction of lung tissue and a significant
disturbance in lung function (Snider, 1978). Different types of silicosis are recognized;
chronic, accelerated, and acute silicosis (Weissman and Wagner, 2002). The occurrence
and development of these forms is determined by the amount of exposure and the total
cumulative silica inhalation (Green and Vallyathan, 1995; Ziskind et al, 1986; Seaton,
1984). Chronic silicosis is characterized by the appearance of simple silicotic nodules 1030 years post exposure (Weissman and Wagner, 2002) because it usually progresses very
slowly. However, in some cases, nodules may congregate to form PMF (Weissman and
Wagner, 2001). Accelerated silicosis, which develops in less than 10 years after exposure
to silica (Weissman and Wagner, 2002), is accompanied by a rapid progression to PMF,
severe lung dysfunction, and is life threatening (Ziskind, 1986; Seaton, 1984). Acute
silicosis, on the other hand, is the form that develops very rapidly [a few weeks to 5 years
post exposure (Weissman and Wagner, 2002)] after exposure to high concentrations of
silica and is associated with severe alveolar and interstitial inflammation, alveolar
proteinosis, and rapid respiratory failure (Driscoll and Guthrie, 1997).
In a recent study by Cocco and co-workers, (Cocco et al, 2001) who worked with
modifications of silica-associated lung cancer by other workplace lung carcinogens, lung
cancer risk in miners exposed to respirable silica alone was higher than those exposed to
silica and PAH. The effect of crystalline silica exposure on the CYP1A1- mediated

83
metabolism of pulmonary chemical carcinogens, such as those in cigarette smoke is
unclear.

Addressing this effect is biologically important because many chemical

carcinogens, such as PAHs in cigarette smoke are metabolized in the lung by CYP1A1
enzyme systems to produce more active carcinogens (Crepsi et al, 1989; Shimada et al,
1989; Eaton et al, 1995) that may result in an increased risk of developing lung cancer.
Recent studies from our laboratory suggest that silicosis decreases the activity of
CYP1A1-dependent enzymatic activity, 7-ethoxyresorufin-O-deethylase (EROD), in the
lungs of rats exposed to a potent CYP1A1 inducer, beta-naphthoflavone (Battelli et al.,
1999). Cell specific studies on CYP1A1 expression and localization showed that silicosis
led to the appearance of a new population of hypertrophied and hyperplastic alveolar
epithelial cells without immunohistochemically detectable CYP1A1 or CYP2B1 (Levy et
al, 1995; Battelli et al, 1999).
However, a debate concerning the species differences between rats and humans
regarding their response to inhaled particles has emerged (Mauderly, 1997). Moreover,
the pattern of particle retention as well as the lung tissue response to respirable particles
in rats may not be predictive of those of primates who are exposed to poorly soluble
particles particularly at high occupational exposures (Nikula et al, 1997). Such debates
necessitate the need for investigating the effect of respirable crystalline silica on the
induction of the carcinogen-activating system, CYP1A1, in the lung by conducting a
study on a non-rodent model. Rabbits were used to investigate our hypothesis because a
model of rabbit silicosis has been previously established (Dale, 1973a; 1973b; Wallace et
al, 2002). Moreover, a high degree of homology between rabbits and human has been
reported regarding the critical proteins involved in CYP1A1 induction process, such as
the AhR and Arnt. (Takahashi et al, 1996). Based upon the homology studies of AhR
and Arnt between rabbit and human, and the existence of a rabbit model of silicosis, the
rabbits were a suitable non-rodent model to illustrate the effect of silicosis on the
carcinogen-metabolizing enzymatic activity of CYP1A1.
In this study, we have investigated the hypothesis that acute and chronic silicosis
can alter cell-specific induction of CYP1A1 in the lung, thus modifying the metabolism
of carcinogenic polycyclic aromatic hydrocarbons in the lung. To avoid concerns about
differences between human and rodent pulmonary responses to respirable particles, we
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have investigated this hypothesis using a well-established rabbit model of silicosis
Wallace et al, 2002). In this model, silicosis progresses with time to produce a fibrosing
lung disease which occasionally includes silicotic nodules which are remarkably similar
to the human silicotic nodules, the pathognomonic lesion of silicosis in man. By using a
partially localized model of chronic silicosis, clinical disease was prevented which
permitted maintenance of these rabbits for a year. A more generalized model of silicosis
was used to model acute silicosis and was directly comparable to our previous rat
studies. Because constitutive CYP1A1 expression is extremely low in both animals and
man and because CYP1A1 activity is induced in people who smoke, CYP1A1 activity
was induced in all rabbits in the study using the model polycyclic aromatic hydrocarbon,
BNF. We have used antibodies to cytokeratins 8/18, proteins which are highly expressed
in airway epithelium and AT-II cells to help localize sites of expression of CYPIA1
within the deep lung by immunofluorescence and have found that alveolar expression of
CYP1A1 is principally localized in cells that are not AT-II cells, that the area of cells
expressing CYP1Al in the alveolus is reduced in both acute and chronic silicosis and
that the number of CYP1A1 expressing Clara cells per mm basement membrane is
reduced in both acute and chronic silicosis. Acute, but not chronic, silicosis caused
statistically significant reductions in the amount of induced CYPIA1 as determined by
Western blot. However, CYP1A1-dependent EROD activity induction was reduced by
both acute and chronic silicosis. Our findings support the hypothesis that acute and
chronic silicosis decrease CYP1Al induction and modify the cell-specific expression of
CYP1A1 in the rabbit lung.
MATERIALS AND METHODS
Rabbit Treatment and Experimental Procedure
Male New Zealand White rabbits (3-5 kg) were housed in the AAALACapproved Laboratory animal facility of Health Sciences Center of West Virginia
University. They were fed commercial rabbit pellets and provided water ad libitum. All
procedures were approved by WVU-ACUC under protocol number 9911-06. Ten of these
rabbits were designated for chronic exposure and were exposed to a single dose of silica
or saline using a predominantly unilateral model with lesser distribution to additional
lobes according to a previously published procedure (Wallace et al, 2002). A year later, 7
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additional rabbits were randomized into 2 groups, which were intratracheally exposed to
silica or saline and kept for 2 weeks as a model of acute exposure (i.e. in the chronic
model, rabbits were exposed once and kept for 380 days, while in the acute model, they
were kept for only 2 weeks). In the acute model, both lung lobes (right and left) were
diffusely exposed to silica to be comparable to previous rat studies. All rabbits, in both
acute and chronic models, were exposed to a single dose of crystalline silica suspension
(300 mg/rabbit in saline). CYP1A1 was induced in all rabbits by intraperitoneal (IP)
administration of 2 doses of BNF of 80mg/kg each suspended in sterile filtered corn oil 3
and 2 days before sacrificing.
Preparation of Silica for IT Instillation
Silica particles (< 5 microns) were weighed into scintillation vials, autoclaved at
23 PSI, 250 ºF, for 30 minutes on the dry cycle. Rabbits exposed to silica received 300
milligrams of heat-sterilized silica particles suspended in 3.0 ml non-pyrogenic saline
(0.9% sodium chloride, Abbott Laboratories, North Chicago, IL) and vortexed to achieve
a uniformly distributed suspension before IT instillation. The silica suspension used in
the study was endotoxin-free as shown by endotoxin analysis using the Limulus
Amebocyte Lysate assay (BioWhittaker; Walkersville, MD) as previously described
(Olenchock and Stephen, 1990; Porter et al, 1999).
Intratracheal Instillation (IT) in Rabbits
Rabbits were first weighed and anesthesized by intramuscular (IM) administration
of ketamine hydrochloride (Ketaset, Fort Dodge, IA) 5 mg/kg and xylazine hydrochloride
(Rompun, Bayer Pharma, West Haven, CT) 100 mg/kg. After induction of anesthesia,
which was marked by absence of palpebral reflex, an endotracheal tube of 3.0 mm
external diameter was placed into the trachea under the guidance of a laryngoscope
(Anesthesia Medical Specialties, Inc., Santa Fe Spring, CA) that was inserted through the
mouth until the arytenoid cartilages were visualized. The presence of the endotracheal
tube in the trachea was verified by feeling the expiratory air expelled out of its proximal
tip. A long polyethylene cannula with a 1.44 mm outer diameter (Becton Dickinson and
Company, Sparks, MD) was passed through the lumen of the endotracheal tube into the
trachea. A syringe containing saline or silica suspension was attached to the cannula and
the plunger was slowly pressed down. For acute silicosis, the cannula was inserted to the
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level of trachea and the rabbit was kept upright on the sternum. In chronic silicosis, the
model was predominantly unilateral where the intubated rabbit was placed on its right
side, the cannula was blindly inserted until it lodged in a bronchus, and then exposed
(Wallace et al, 2002). The acute exposure method was directly comparable to rat
intratracheal instillation. The chronic exposure method exposed both sides of the lung
(Wallace et al, 2002), but because severe lesions were limited to one side of the lung,
long-term humane maintenance of these rabbits was possible. Because the technique for
chronic exposure involves the blind passage of a cannula, the most affected lobes will not
always be in the same site. The advantage over bronchoscopy is less trauma, more rapid
recovery from anesthesia, and involvement of many lobes in mild disease with the more
severe lesions localized so that the rabbits remain healthy throughout the study but the
disadvantage is that the localization of the more severe silicotic lesions varies.
Necropsy
Rabbits were humanely killed by intravenous injection of pentobarbital
(Pentobarbital Sodium, Med-Pharmex, Inc., Pomona, CA) 1.5 ml/rabbit, followed
exsanguination via the abdominal aorta.

The lungs and attached organs including

tracheobronchial lymph nodes, thymus, heart, aorta, and esophagus were removed. At
necropsy, the right lung lobes were tied off, removed, and placed on ice for microsome
preparation. The left lung lobes were inflated with 30 ml of 10% neutral buffer formalin
(NBF) to prepare formalin fixed tissues for histopathology and immunofluorescence.
The fixed tissues were trimmed later the same day, and processed on a Hypercenter XP
tissue processor (Thermo Shandon, Pittsburgh, PA) over night. The processed tissues
were embedded in paraffin the following morning. Sections were routinely stained with
hematoxylin and eosin (H&E) and with trichrome stain. In addition, five-micrometerthick sections were placed on Probe On PlusTm slides (Fischer Scientific, Pittsburgh, PA)
for immunofluorescent double-labeling. In all rabbits, sampling for histopathology
involves areas with obvious gross lesions. Due to the presence of silicotic nodules in the
right lung lobes of two rabbits from the chronic silica-exposed group, the right lung lobes
from these two rabbits containing the gross morphologic changes of silicosis were used
for histopathologic examination, while the left lung lobes were used for microsome
preparation.
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Microsome Isolation
All steps of microsomal preparation were carried out at -4ºC to avoid possible loss
of microsomal activity. Microsomes were prepared as previously described (Ma et al,
2001; Flowers and Miles, 1991). Briefly, after necropsy, the right lung lobes (except for
the 2 rabbits in the chronic exposure group where the left lung lobes were used) were
weighed and chopped 4 times with a MacIlwain tissue chopper (Mickle Engineering Co.,
Gomshall, Surrey, UK) set at slice thickness of 0.5 mm. The minced lung tissues were
suspended in 4 times the lung weight of ice-cold incubation medium(1.9 mM
KH2PO4,145 mM KCL, 30 mM Tris-HCL, 8.1 mM K2HPO4, and 3 mM Mg Cl2; pH 7.4)
and homogenized by using a Teflon-glass Potter-Elvejhem homogenizer (Emerson, NJ)
through 16 complete passes. Differential centrifugation of the homogenate was used to
obtain the microsomal pellets. First, the cell nuclei and debris were sedimented by
centrifugation at 2500 rpm for 10 minutes in a Sorvall Model RC2-B refrigerated
centrifuge (Ivan Sorvall Co., Northwalk, CT).

To reduce the mitochondrial

contamination of the microsomes, Mitochondria were slowly sedimented by three
sequential centrifugations at 5,000, 9,000, and 13,000 rpm for 20 minutes each. To
collect the microsomal pellets, the supernatant was ultra-centrifuged for 75 minutes at
40,000 rpm in a Beckman Model L5-50 Ultracentrifuge (Beckman Instruments, Palo
Alto, CA). The microsomal pellets were re-suspended in the incubation medium at a ratio
equal to the original lung weight (1gm lung/ 1ml medium) and frozen at -80 ºC until use.
Determination of the Total Lung Proteins
The BCA (bicinchoninic acid) method was used to determine the protein content
of lung microsomes as previously described (Ma et al, 2002; Smith et al, 1985) using the
BCA protein assay kit (Pierce, Rockford, IL) and a spectra Max 250 Spectrophotometer
(Molecular Devices Corporation, Sunnyvale, California). Bovine serum albumin
was used as the standard.
Western Blot Analysis
The CYP1A1 protein in lung microsomes was determined by Western blot
analysis as previously described (Ma et al, 2002). Briefly, 60 µg of the lung microsomal
proteins, as measured by BCA method, were subjected to polyacrylamide gel
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electrophoresis followed by electroblotting of the gel to a nitrocellulose membrane based
on the manufacturer’s instruction (Invitrogen Corporation, Carlsbad, CA). The protein
transferred to the nitrocellulose membrane was detected by overnight incubation with a
polyclonal goat anti-rabbit CYP1A1 antibody (Oxford, Oxford, MI) at 4 ºC.

The

membrane was then incubated with a donkey anti-goat IgG-HRP (horse radish
peroxidase) conjugated secondary antibody (Santa Cruz Biotech. Inc., Santa Cruz, CA)
for 1 hour at room temperature. Liver microsomes of a BNF-treated rat (Xenotech,
Kansas city, KS) were used for a CYP1A1 positive control. The ECL MW (molecular
weight) marker (Invitrogen Life Technology, Carlsbad, CA) was used to determine the
size of the CYP1A1 band. CYP1A1 protein bound to the membrane was detected by the
enhanced chemiluminescence (ECL) method using the ECL detection reagent kit
(Amersham, Piscataway, NJ). Super RX Fuji Medical X-ray film (Fuji Film Corp., LTD.,
Tokyo, Japan) was then exposed at room temperature to the membrane. The intensity of
the bands on the X ray film was measured by the Strategen Eagle Eye II scanner (La
Jolla, California) with Eagle Sight software. The density on the scanned images was
measured using ImageQuant software version 5.1 (Molecular Dynamics, Sunnyvale,
CA). Each sample was quantified three times to get the averages of the individual
measurement, then the averages were used for statistical analyses. The Western blot
results were expressed as a percentage of the CYP1A1 positive control.
Measurement of the CYP1A1- and CYP2B4-Dependent Enzymatic Activities (EROD
and PROD)
Measurement of EROD and 7-pentoxyresorufin-O-deethylase (PROD) activities
were conducted as previously described, using 150 and 300 µl of microsomal suspension
(Ma, et al, 2002; Burke et al, 1985), respectively (suspension was prepared by adding an
amount of buffer equal to original lung weight). PROD is a measure of CYP2B4 activity
(Cawley et al, 2001). The CYP2B4 in rabbits is analogous to rat CYP2B1 (OeschBartlomowicz and Oesch, 2003). It is the major constitutively expressed CYP in rabbit
lung but is present in very minute quantities in liver (Serabjit-Singh et al, 1979;
Parandoosh et al, 1987). A standard curve was made after each assay by using a standard
solution of 2.35 µg of 7-ethoxyresorufin dissolved in 1 ml DMSO to get a 10 mM
concentration. EROD and PROD activities were measured by a luminescence
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spectrometer model LS-50 (Perkin-Elmer, Norwalk, CT) that measures the formation of
fluorescent resorufin catalyzed by CYP1A1 or CYP2B4 activities. EROD and PROD
activities were expressed as picomoles of the produced resorufin per minute per
milligram microsomal protein (pmol/min/mg protein).
Dual Immunofluorescence Technique for CYP1A1 and Cytokeratins 8/18
The formalin-fixed paraffin-embedded sections of left lung lobe were used for
double-label immunofluorescence. Immunofluorescence was conducted to localize the
CYP1A1 protein within alveolar and terminal non-ciliated bronchiolar cells (Clara). In
addition, immunofluorescence identified alveolar type II (AT-II) cells by localizing the
cytokeratins 8/18, which are cytoskeletal proteins expressed mainly in primitive epithelial
cells such as AT-II cells and airway epithelium. The double-label Immunofluorescence
was a two-day procedure. During the first day, the slides were heated and routinely
deparaffinized in xylene and rehydrated in alcohol as previously described (Dey et al,
1999). To maximize the antibody binding, the antigen was retrieved by using 0.01M
disodium ethylenediamine tetraacetate (EDTA) (Fischer Scientific, Fair Lawn, New
Jersey), pH 8.0. Slides immersed in EDTA solution were heated for one minute and 45
seconds on high in a microwave followed by 2 defrosting cycles of 6 minutes each.
Tissue slides were blocked with a filtered [(Acrodisc syringe filter with 0.2 µm pore
diameter (Pall Corporation, Ann Arbor, MI)], freshly prepared solution of 5 % BSA (IgG
free) (Sigma, St Louis, MO) in PBS (Ca++ and Mg++ free) (Sigma, St Louis, MO) for 10
minutes at room temperature (RT) to minimize the non-specific binding of the primary
antibodies. Additional blocking was applied by dropping of 5% fresh pig serum
(Biomeda Corporation, Foster City, CA) in PBS on slides for 10 minutes at RT. The
slides were then rinsed and incubated with a primary antibody mixture with a final
dilution of 1:50 of the polyclonal Guinea pig anti-cytokeratins 8/18 antibody (Research
Diagnostic Inc., Flanders, NJ) and the polyclonal goat anti-rabbit CYP1A1 antibody
(Oxford biomedical Research, Inc., Oxford, MI). The primary antibody mixture was
applied by holding the slides in pairs in a microprobe holder (Fischer Scientific, Fair
Lawn, NJ) and allowing the capillary action between each pair to pull the mixture onto
the slides. The microprobe holder carrying slides was placed in a humidity chamber and
incubated overnight at room temperature to allow binding of the primary antibodies to the
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antigen (CYP1A1 and Cytokeratins 8/18). On the second day, the humidity chamber
containing the microprobe holder was incubated in the oven at 37 ºC for 2 hours. The
excess and unconjugated primary antibodies were washed off by thorough rinsing with
distilled water. Then, a mixture of the secondary antibodies was applied by dropping on
the slides. The mixture was produced by equal volumes of a polyclonal FITC-conjugated
donkey anti-Guinea pig antibody (Research Diagnostic Inc.) at a dilution of 1:50 with
PBS, and Alexa 594-conjugated rabbit anti-goat antibody (Molecular probes, Eugene,
OR) for CYP1A1, diluted 1:20 with PBS. Before application, the mixture was
centrifuged for 5 minutes at 2000 rpm and the supernatant dropped onto the slides, and
the slides were incubated for 2 hours at RT in the dark. After rinsing the slides, cover
slips were applied using gel mount (Biomeda Corp., Foster City, CA) and slides were
allowed to dry for 2 hours. For the negative control, the same procedure was applied
except that the primary antibodies were replaced by rabbit serum (BioGenex, San Ramon,
CA).
Slides were examined using a fluorescent photomicroscope (OlympusAX70,
Olympus American Inc., Lake Success, NY) and images were captured using the 40x
objective and a Quantix cooled digital camera (Photometrics, Tucson, AZ) with QED
camera plugin software (QED Imaging, Inc., Pittsburgh, PA). Fifteen images were
captured per slide; five of which were taken from proximal alveolar (PA) regions located
adjacent to the alveolar duct where most of the silica particles tend to accumulate
(Warheit, 1989). The purpose of these samples was to assure that images were captured
from representative alveolar regions with silica deposition. Another five images were
obtained from random alveolar (RA) regions where no visible alveolar ducts are located.
An additional five images were obtained from the terminal bronchioles which are lined
by non-ciliated bronchiolar epithelial (Clara) cells. Since normal alveolar structure
granulomas and nodular fibrosis, areas showing granulomas and nodular fibrosis were
avoided during capture of images. The exposure settings of the digital camera were held
constant for during capture of images from all slides. For green fluorescence, a FITC
filter cube with an excitation wave length of 460-500nm was used. For red fluorescence,
a Texas Red filter cube with an excitation wave length of 432.5-487.5nm was used.
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Morphometric Analysis
A

specific

software

program

(MetaMorph

Universal

Imaging

Corp.,

Downingtown, PA) was employed to quantify and measure the area in µm2 of the red
fluorescence that represents CYP1A1 protein and the green fluorescence that represents
cytokeratins 8/18. Morphometric analysis was conducted on digital images captured
using a 40x objective producing a microscopic field with an area of 34466.1 µm2. The
threshold range for positive red or green fluorescence was constant throughout the
analysis process of all images. These thresholds were selected to measure the area
occupied by cells expressing green fluorescence in the cytoplasm (which in the alveolus
indicates AT-II cells), the area of cells demonstrating red fluorescent labeling of
CYP1A1 in the alveolar septum, and the co-localization of these proteins.

The

morphometric analysis quantified the following:
A-Quantification of CYP1A1 Expression in Alveolar Cells that are not AT-II Cells:
We have designated the alveolar cells without cytokeratins 8/18 expression as
alveolar non-type II (NT-II) cells. These cells are identified by their low affinity for
cytokeratins 8/18 staining, which is specific for primitive epithelial cells such as airway
epithelium and AT-II cells (Kasper, 1993). In the double labeled sections, cells
expressing CYP1A1 fluoresce red. By morphometric analysis, the percent of CYP1A1
that is not concomitantly stained with cytokeratins 8/18; that is the percent of area of
CYP1A1 expression in NT-II cells was estimated. To calculate the area of CYP1A1
expressed within NT-II cells, we multiplied this percent by the total red (CYP1A1) area
within alveolar septum. The resulting area was expressed in µm2.
B-Quantification of CYP1A1 Expression in AT-II:
By the aid of morphometric analysis, the CYP1A1 co-expression (co-localization)
in AT-II was quantified. Colocalization means concomitant expression of CYP1A1 and
cytokeratins 8/18 in AT-II. Two estimates were obtained to express this co-localization in
AT-II cells:
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1-The Area of CYP1A1 Colocalized to Cytokeratins 8/18:
This area was estimated, in a similar way as in alveolar non-type (NT-II) cells, by
multiplying the percentage of CYP1A1 that concurrently stained with cytokeratins 8/18
by the total septal expression of CYP1A1. This area was expressed in µm2.
2- The Proportional CYP1A1 Expression in AT-II Cells
Proportional CYP1A1 expression is a ratio of the area of CYP1A1 expressed in
AT-II to the total area of AT-II cells. This calculation was necessary because respirable
particles often cause AT-II cell hyperplasia in the lung. Thus the proportional CYP1A1
expression in AT-II cells corrects for increases in CYP1A1 in AT-II cells resulting from
simple increase in the number and area of lung occupied by AT-II cells. This fraction was
calculated from the following formula:
F = P x R where;
G
F= proportional CYP1A1 expression in AT-II
P= percentage of CYP1A1 colocalized to cytokeratins 8/18 (estimated by morphometry)
R= red area (total) of CYP1A1 in alveolar septum (measured by morphometry)
G= green area (total) of AT-II in alveolar septum (quantified by morphometry)
C-Determination of AT-II Cell Hypertrophy and Hyperplasia:
AT-II cell hypertrophy and hyperplasia were quantified by measuring the total
area of green fluorescence in the alveolar septum expressed in each 40x field (34466.1
µm2).
D-Determination of CYP1A1 Pattern of Expression in Clara Cells
The non-ciliated terminal bronchiolar (Clara) cells that stained positively for
CYP1A1 (red) were counted per micrometer of the basement membrane. Morphometric
settings helped standardize detection of positive cells consistently to avoid false positive
or false negative results. Therefore, this morphometric analysis provided a direct way to
determine the effect of silica particle exposure on the expression pattern of CYP1A1 in
AT-II cells, non-AT-II, and Clara cells.
Immunofluorescence analysis was used to compare the cell-specific localization
of CYP1A1 in silica and BNF-exposed groups versus the control (BNF only) group.
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Within the alveolus, cell-specific CYP1A1 has been compared in the PA regions (which
are exposed to more silica) and the RA regions (which are random alveolar samples, and
thus receive variable and lower silica exposure).
Histopathology:
Tissue sections from control and silica-exposed lungs were routinely stained with
hemotoxylin and eosin (H&E) for histopathology. The stained slides were examined and
interpreted by a board-certified veterinary pathologist while blinded to the exposure
status of the individual rabbit. The changes of interest to be evaluated were: alveolitis
(inflammation), AT-II cells hyperplasia and hypertrophy, and hyperplasia of bronchus
associated lymph tissue. The histopathologic changes were converted to quantitative
scores based upon the severity and distribution of the morphologic changes as previously
described (Hubbs et al, 1997). The pathology score for each slide is the sum of the
severity and distribution scores and the pathology score for each lung is the mean
pathology score for each slide from that lung (Table 1).
Table 1. Scoring system for histopathological changes caused by exposure of rabbit lungs
to silica.
Score

Severity

Distribution

0

None

None

1

Minimal

Focal

2

Mild

Locally extensive

3

Moderate

Multifocal

4

Marked

Multifocal and coalescent

5

Severe

Severe

Statistical Analyses
All analyses were performed with SAS version 8.2 and using Proc Mixed.
Comparisons between saline treated and silica treated rabbits were performed using oneway analyses of variance. Comparisons of CYP1A1 immunostaining between cell types,
and comparisons between compartments within the alveoli were performed using a 2
factor repeated measures analysis of variance (treatment by cell type and treatment by
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compartment). All pairwise comparisons were performed with Fisher’s LSD. All results
were considered statistically significant at p<0.05.
RESULTS
Activities of CYP1A1 and CYP2B4
EROD (indicator of CYP1A1-dependent enzymatic activity) measured as
pmol/min/mg of microsomal proteins was significantly reduced in rabbits with acute
(p=0.011) and chronic silicosis (p=0.0453) exposed to BNF compared to rabbits exposed
to BNF alone (Figure 1A and B, respectively). Acute exposure to silica particulates
significantly lowered (p=0.0099) the PROD activity (Figure1C) while chronic exposure
failed to induce any effect on the CYP2B4-dependent enzymatic activity (Figure 1D).
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Figure 1. Effect of silicosis on EROD and PROD activities. EROD and PROD activities
are expressed as pmol/min/mg protein. Acute silicosis significantly suppresses the BNFinduced-EROD (A) and PROD (C) activity. Chronic silicosis inhibits EROD activity (B)
and does not have any effect on PROD activity (D). * indicates significant difference
from control (rabbits received BNF alone) at p<0.05.

95
Western Blot Analysis
Western blot analysis demonstrated a reduction, albeit not significant, in CYP1A1
protein in the lungs of BNF-treated rabbits with acute silicosis when compared to the
lungs of rabbits exposed to BNF alone (Figure 2A and B). In chronic silicosis, no change
was observed (Figure 3A and B).
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Figure 2. Western blot analysis of CYP1A1 in lung microsomes of rabbits with acute
silicosis. 60 µg of microsomal protein were subjected to SDS gel electrophoresis using
Tris-glycine SDS running buffer and blotted to nitrocellulose membrane. The
membranes were probed with goat anti-rabbit CYP1A1 antibody overnight at 4 ºC. then
donkey anti-goat IgG-HRP was used to visualize the bands. In A, Lane 1 is a positive
control, while lane 12 is the molecular weight standard. Lanes 3, 4, and 5 are controls
(acute saline/BNF), whereas lanes 7, 8, 9 and 10 are acute silica/BNF. Lanes 2 and 6 are
empty. In B, the data expressed as the percentage of positive CYP1A1 control resulted
from quantifying of western blot of control and silica treated rabbits.
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Figure 3. Western blot analysis of CYP1A1 in lung microsomes of rabbits exposed to
chronic silicosis. Lane 1 is a positive control, while lane 14 is the molecular weight
(MW) standard. Lanes 3, 4, 5, 6, 7 are control (chronic saline/BNF), while lanes 9, 10,
11, 12, and 13 are chronic silica/BNF. Lanes 2 and 8 are empty. In B, the Western
analysis data were quantified and expressed as the percentage of positive CYP1A1
control. No significant change of CYP1A1 protein expression was observed in chronic
silicosis (silica/BNF) exposure versus control (saline/BNF).
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Dual Immunofluorescence for CYP1A1 and Cytokeratins 8/18
A- General Distribution of CYP1A1 in the Rabbit Alveolus
AT-II (AT-II) cells were identified as green fluorescent (due to the markers,
cytokeratins 8/18) plump cells localized at the corners of the alveoli, whereas NT-II cells
were visualized as flattened cells without green fluorescence occupying the majority of
alveolar septum using immunofluorescence visualization and a narrow beam FITC filter
cube for excitation. Cells expressing CYP1A1 fluoresced red using a Texas Red filter
cube for excitation. Superimposition of the red and green fluorescent images permitted
determination of where CYP1A1 was expressed in the same sites as cytokeratins 8/18
(Figure 4).
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Quantification of CYP1A1 by morphometric analysis of proximal alveolar (PA)
regions revealed its cell specific expression and localization within the alveolus. The area
of CYP1A1 expression within AT-II cells was significantly lower than that of NT-II cells
in all groups (acute saline/BNF, acute silica/BNF, chronic saline/BNF, and chronic
silica/BNF groups) with p values 0.0001, <0.0001, 0.0006, and 0.0171, respectively
(Figure 5A and C and Figure 6A and C, respectively). A similar pattern of expression has
been found in random alveolar (RA) regions where area of AT-II cells expressing
CYP1A1 is significantly lower than NT-II cells in all groups with p values 0.0097, <
0.0001, 0.0045, and <0.0001, respectively (Figure 5B and D and Figure 6A and D).
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Figure 5. Morphometric quantification analysis of CYP1A1 immunofluorecence in AT-II
cells versus NT-II cells of PA and RA regions BNF-treated rabbits acutely exposed to
saline or silica. The area of CYP1A1 expression within these cells is expressed in square
micrometer. * indicates significant difference from area of CYP1A1 expression in NT-II
cells at P<0.05.
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Figure 6. Morphometric quantification analysis of CYP1A1 immunofluorescence in ATII cells versus NT-II cells of PA and RA regions BNF-treated rabbits chronically exposed
to saline or silica. The area of CYP1A1 expression within these cells is expressed in
square micrometer. * indicates significant difference from area of CYP1A1 expression in
NT-II cells at P<0.05.
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B- Effect of Acute and Chronic Silicosis on CYP1A1 Expression by NT-II Cells in PA
and RA Regions.
In immunofluorescent-stained slides, the area of CYP1A1 expression quantified
by morphometric analysis within NT-II cells of the PA regions was significantly reduced
in rabbits acutely exposed to silica and BNF when compared to the control saline/BNF
(p=0.0005). The area of CYP1A1 expression within NT-II cells of RA regions of rabbits
acutely exposed to silica and BNF did not show a significant change compared to the
control saline/BNF (Figure 7A). A comparison of CYP1A1 expression within NT-II
cells in the PA versus the RA regions indicated a significant reduction in the PA regions
of rabbits acutely exposed to silica and BNF compared to the RA regions (p=0.0006)
(Figure 7A).
In rabbits with chronic silicosis and BNF, the area of CYP1A1 expression
quantified by morphometric analysis within NT-II cells of the PA regions was
significantly reduced when compared to control saline/BNF (p=0.0066) (Figure 7B).
However, the area of CYP1A1 expression within NT-II cells of RA regions of rabbits
chronically exposed to silica and BNF did not show a significant change compared to the
control saline/BNF. A comparison of CYP1A1 expression within NT-II cells in the PA
versus the RA regions indicated a significant reduction in the PA regions of rabbits
chronically exposed to silica and BNF compared to RA regions (p=0.0243) (Figure 7B).
Results of CYP1A1 expression in NT-II cells are summarized in Table 2.
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Figure 7. Morphometric quantification analysis of area of CYP1A1 expression measured
in µm2 within NT-II cells of the PA regions and RA regions in acute and chronic
silicosis. In A, the area of CYP1A1 expression within NT-II cells of the PA regions is
significantly lower in rabbits acutely exposed to silica and BNF than the control
saline/BNF (indicated by a above the bar). Also, the area of CYP1A1 expression within
NT-II cells of the PA regions is significantly lower than the RA regions in rabbits acutely
exposed to silica and BNF (indicated by b above the bar). In B, the area of CYP1A1
expression within NT-II cells of the PA regions is significantly lower in rabbits
chronically exposed to silica and BNF than the control saline/BNF (indicated by c above
the bar). Also, the area of CYP1A1 expression within NT-II cells of the PA regions is
significantly lower than the RA regions in rabbits chronically exposed to silica and BNF
(indicated by d above the bar). In RA regions, no significant change is observed between
acute and chronic silica with BNF compared to the control (saline/BNF). The letters a, b,
c, and d indicate significant difference at <0.05.
Table 2. Effect of silica exposure on CYP1A1 expression in NT-II cells of rabbit
alveoli.
Exposure
Acute saline with BNF
Acute silica with BNF
Chronic saline with BNF
Chronic silica with BNF

PA regions (µm2)
327.068 ± 42.257
44.417 ± 5.212a,b
528.445 ± 121.904
74.385 ± 26.452c,d

RA regions (µm2)
359.223 ± 110.968
454.661 ± 45.39
261.624 ± 76.238
382.002 ± 61.984

Values represent means ± SE, (n=3-5).
Superscript a indicates significant difference from acute saline with BNF of PA regions at
p<0.05.
Superscript b indicates significant difference from acute silica with BNF of RA regions at
p<0.05.
Superscript c indicates significant difference from chronic saline with BNF of PA regions
at p<0.05.
Superscript d indicates significant difference from chronic silica with BNF of RA regions
at p<0.05.
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C- Effect of Silica Exposure on CYP1A1 Expression in AT-II
1- Proportional CYP1A1 Expression in AT-II Cells
The proportional expression of CYP1A1 in AT-II cells was calculated by a
formula described in the Materials and Methods and measures expression of CYP1A1 in
AT-II cells corrected for increases in AT-II area. In acute silicosis with BNF, the
proportional CYP1A1 expression in AT-II cells of PA regions was significantly lower
(p=0.0293) than control saline with BNF (Figure 9A). Although, in rabbits exposed to
acute silica and BNF, the proportional CYP1A1 expression in AT-II cells of PA regions
was lower than that of RA regions (Figure 9A, Table 3), this reduction was not
statistically significant.
In chronic silicosis (chronic silica/BNF), by contrast, the proportional CYP1A1
expression in AT-II cells of the PA regions was not statistically distinguishable from
expression in the PA regions of the control saline/BNF but significantly lower than
expression in the RA regions of chronic silicosis/BNF (Figures 9B, Table 3).
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Figure 9. Morphometric analysis of proportional CYP1A1 expression in AT-II cells in
immunofluorescent-stained sections of rabbit lungs with acute and chronic silicosis. In A,
the proportional CYP1A1 expression within AT-II cells of PA regions is significantly
reduced in acute silicosis/BNF compared to control saline/BNF (as designated by the
letter a above the bar). In B, the proportional CYP1A1 expression within AT-II cells of
PA regions of chronic silicosis/BNF is significantly reduced compared to RA regions (as
designated by the letter b above the bar), but no significant change is observed when
compared to control saline/BNF. Values are means ± SE. The letters a and b indicate
significant difference at <0.05.
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Table 3. Effect of acute and chronic silicosis on proportional CYP1A1 expression in
AT-II cells of rabbit alveoli.
Exposure
Acute saline with BNF
Acute silica with BNF
Chronic saline with BNF
Chronic silica with BNF

PA regions
0.0295± 0.0100
0.00399 ± 0.000888a
0.208 ± 0.19
0.00618 ± 0.00285b

RA regions
0.0148 ± 0.00622
0.0583 ± 0.0292
0.0392 ± 0.0241
0.0524 ± 0.0193

Values are presented as means and SE
a
indicates significant difference from acute saline with BNF in PA regions at p<0.05.
b
indicates significant difference from chronic silicosis with BNF in the RA regions at
p<0.05
2- Area of CYP1A1 Colocalized (Co-Expressed) to Cytokeratins 8/18
The area of CYP1A1 concomitantly expressed (colocalized) with cytokeratins
8/18 per unit area of AT-II cells of PA regions was decreased and bordered ion statistical
significance (p=0.0507) in rabbits acutely exposed to silica and BNF compared to control
rabbits (acute saline/BNF exposure) (Figures 10A and 11, Table 4). This area was
significantly reduced when compared to RA regions of rabbits exposed to acute silica and
BNF (p=0.0475) (Figure 10A, Table 4). In chronic silicosis with BNF, the area of
CYP1A1 expression colocalized in AT-II cells was significantly decreased in the PA
region and compared to the RA regions and was reduced, albeit not significantly
compared to the control saline/BNF (Figure 10B, Table 4). In areas where granulomatous
inflammation and silicotic nodules were localized, the positive CYP1A1 cells were
completely absent (Figure 11C). These regions were not included in the morphometric
quantification.
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Figure 10. Morphometric quantification of area of CYP1A1 expression colocalized to
cytokeratins 8/18 in BNF-induced rabbits affected with acute and chronic silicosis. In A,
the letter a above the bar indicates that acute silicosis/BNF significantly reduced
CYP1A1 co-localization area in the PA regions compared to that in the RA regions. In B,
the letter b above the bar designates a significant reduction of CYP1A1 co-localization
area in PA regions compared to RA regions in rabbit alveoli with chronic silicosis/BNF.
a, b, and c indicate significant difference at p<0.05.
Table 4. Effect of silicosis on CYP1A1 colocalization in AT-II cells.
Exposure
Acute saline with BNF
Acute silica with BNF
Chronic saline with BNF
Chronic silica with BNF

PA regions (µm2)
9.8515± 3.5771
1.7618 ± 0.4897a
7.578 ± 3.264
3.776 ± 2.066b

RA regions (µm2)
5.362 ± 4.558
15.091 ± 5.002
9.83 ± 4.569
18.733 ± 6.995

Values represent means ± SE, (n=3-5).
a

indicates significant difference from acute silica with BNF of RA regions at p<0.05.

b

indicates significant difference from chronic silica with BNF of RA regions at p<0.05.
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D-Effect of Silicosis on Total CYP1A1 Expression in the Alveolar Septum
The total red-labeled area of CYP1A1 expression in the alveolar septum (both
AT-II and NT-II cells) of PA regions showed a significant reduction in both acute and
chronic silicosis compared to the control saline (p=0.0007; 0.0069, respectively) and that
of the RA regions (p=0.0006; p=0.0219, respectively) (Figure 12A and B, Table 4).
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Figure 12. Morphometric assessment of the total area of CYP1A1 expressed in all cells of
the alveolar septum. In A, the letter a above the bar indicates that the area of CYP1A1
expression in the alveolar septum of PA regions in acute silicosis/BNF is significantly
lower than control (acute) saline/BNF. A b above the bar indicates that the area of
CYP1A1 expression in the alveolar septum of PA regions in acute silicosis/BNF is
significantly lower than that of RA regions. In B, the letter c above the bar indicates that
the area of CYP1A1 expression in the alveolar septum of PA regions in chronic
silicosis/BNF is significantly lower than control (chronic saline/BNF). A d above the bar
indicates that the area of CYP1A1 expression in the alveolar septum of PA regions in
chronic silicosis/BNF is significantly lower than that of RA regions. Values are means ±
SE and significance level was set at p<0.05.
Table 5. Effect of acute and chronic silicosis on total CYP1A1 expression in alveolar
septal cells
Exposure
Acute saline with BNF
Acute silica with BNF
Chronic saline with BNF
Chronic silica with BNF

PA regions (
336.92 ± 45.818
46.353 ± 5.466a,b
536.023 ± 123.951
78.161 ± 27.931c,d

Random alveolar regions
364.584 ± 111.134
469.752 ± 49.67
271.453 ± 80.366
400.735 ± 64.027

Values are the means of expression area (µm2) ± SE (n=3-5)
a
indicates significant difference from PA regions of acute saline with BNF of at p<0.05.
b
indicate significant difference from RA regions of acute silica with BNF at p<0.05.
c
indicates significant difference from PA regions of chronic saline with BNF at p<0.05.
d
indicates significant difference from RA regions of chronic silica with BNF at p<0.05.
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E- Silica Exposure Produced AT-II Cell Hypertrophy and Hyperplasia
Rabbit silicosis caused AT-II cell hyperplasia and hypertrophy, which was
significant in chronic silicosis/BNF compared to control saline/BNF (p=0.046) (Figure
13A and B). Since cytokeratins 8/18 was indicated by green immunofluorescence, AT-II
hypertrophy and hyperplasia was indirectly calculated from the measurement of the total
green fluorescent areas in the alveolar septum (Figure 11).
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Figure 13. Morphometric analysis of immunofluorescent-stained sections showing the
effect of rabbit silicosis on hypertrophy and hyperplasia of AT-II cells. The area of
cytokeratins 8/18 is measured in square micrometer as indicator of type AT-II cell
hyperplasia and hypertrophy. Values are means ± SE. * significantly different from
chronic saline/BNF at p<0.05.
F-Acute and Chronic Silicosis Significantly Decreased CYP1A1 Expression in the
Terminal Non-Ciliated Bronchiolar (Clara) Cells:
The number of CYP1A1 immunoreactive Clara cells exceeding the red
fluorescent threshold for 1A1 expression was counted and standardized per micrometer
of the basement membrane. Clara cells were identified as a group of adjacent columnar
non-ciliated airway epithelial cells resting on the basement membrane of the terminal
bronchioles which stain green with cytokeratins 8/18 (Figure 14). They were
differentiated from the cuboidal AT-II cells, which are usually found in the alveolar
septa, by their morphology and location. Both acute and chronic exposure of rabbits to
silica resulted in a highly significant reduction of CYP1A1 positive Clara cells per µm
basement membrane compared to control (p=0.0005, p=0.00057, respectively) (Figures
14, 15).
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Figure 14: Effect of silicosis on CYP1A1 expression in rabbit non-ciliated terminal
bronchiolar (Clara) cells. In A, ** indicates a highly significant reduction of the number
of CYP1A1-positive Clara cells in acute silicosis and BNF than the control saline and
BNF (p<0.001). In B, ** indicates a highly significant reduction of the number of
CYP1A1-positive Clara cells in chronic silicosis and BNF compared to the control saline
and BNF (p<0.001). Values presented as mean ± SE. the significance level is set at
p<0.001
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Histopathological Changes
Tissue sections from control and silica-exposed rabbits were stained with
hematoxylin and eosin (H & E) and the histopathological changes were assessed and
scored (Figure 16). Histopathological changes include AT-II hyperplasia and
hypertrophy, pulmonary inflammation which was mostly histiocytic and suppurative to
necrogranulomatous bronchointerstitial pneumonia with thickening of the alveolar wall
(Figure 17). Alveolar lipoproteinosis was one of the common findings in silica-exposed
rabbit alveoli. In some rabbit lungs with silicosis, silicotic nodules appear as centrically
arranged collagen fibers surrounding necrotic foci (Figure 17B). These histopathological
changes were absent in the control rabbits (Figure 17 C).
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Figure 16: Alveolitis and AT-II cell hyperplasia and hypertrophy scored in H & E-stained
tissue sections. Both alveolitis and AT-II changes were significantly higher in rabbit
alveoli acutely and chronically exposed to silica particulate compared to control. * and _
indicate that in rabbits exposed to acute silicosis and BNF, alveolitis and AT-II changes
are significantly different from control (acute saline/BNF), respectively. a and b indicate
that in rabbits exposed to chronic silicosis and BNF, alveolitis and AT-II changes are
significantly different from control (chronic saline/BNF), respectively. Results represent
mean ± SE. All results are statistically significant at p<0.05.
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Figure 17: Photomicrograph showing the
histopathological changes in rabbit
silicosis. In A, AT-II cell hyperplasia and
thickening of the alveolar septum is
significant compared to the control (C).
In B, the silicotic nodule contains
concentrically
arranged
hyalinized
collagen (black arrows) around an area of
necrosis. A and C are sections stained
with hematoxylin and eosin (H & E). In
B, sections are stained by trichrome stain.
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DISCUSSION
This study investigates the modifying effect of silicosis on the polycyclic
aromatic hydrocarbon-associated induction and cell-specific localization of CYP1A1 in
the rabbit lung by exposure to silica. The use of the rabbit as a non-rodent model for this
particular study has several advantages. First, rabbit and human AhR and Arnt, which
are the 2 main proteins involved in CYP1A1 induction and gene expression, are highly
conserved between these two species (Takahashi et al, 1996). Moreover, a recent study
suggests that rabbit, as well as mouse, are among the species with CYP1A1 that is
comparable to human as determined by the inhibition of EROD activity in the lung
microsomes of these species by the antiserum to human CYP1A (Bogaards, et al, 2000).
Therefore, this suggests that the results of rabbit studies, particularly those investigating
the modification and alteration of CYP1A1 expression by exposure to environmental
toxicants could be comparable to the human response to these compounds. Second, the
rabbit as a non-rodent model helps resolve the debate concerning the use of the rat, to
investigate genetic and histopathological changes associated with particle exposures in
human lungs. Third, CYP1A1 is one of the major isoforms of CYP present in the lungs
of rabbit (Daniels and Massey, 1992). Fourth, CYP1A1 occurs in an amount of 1 to 3%
of total CYP in pulmonary microsomes prepared from untreated rabbits. However,
intraperitoneal injection of BNF produces a several fold induction of the CYP1A1 with
associated induction of EROD activity in rabbits (Serabjit-Sinh et al, 1983; Philpot et al,
1985). For all these reasons, rabbits were selected to fulfill the objectives of our study. In
our experiment, CYP1A1 was induced in rabbits by intraperitoneal (IP) injection of a
representative polycyclic aromatic hydrocarbon, BNF, (80 mg/kg) in corn oil as
previously determined (Mathews et al, 1985; Daniels and Massey 1992). BNF induces
CYP1A1 through a mechanism identical to the benzo(a)pyrene in cigarette smoke by
binding the aryl hydrocarbon receptors (AhR) (Ma and Whitlock, 1997) resulting several
fold increase in CYP1A1 content and EROD activity (Serabijt-Singh et al 1983; Philpot
et al, 1985).
Exposure to silica alone, without exposure to CYP1A1 inducers (such as BNF)
has been associated with increased CYP1A1-metabolic activity, EROD, in rats (Miles et
al, 1993, 1994). However, the effect of mixed exposure was not investigated in the
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previous study. At least one epidemiological study of mixed exposure to silica and PAH
concluded that lung cancer risk was higher among people exposed to silica than those
exposed to silica and other lung carcinogens, such as PAH (Cocco et al, 2001). This
suggests that silicosis may modify PAH-associated carcinogenesis. Because, CYP1A1
activity is associated with an increased risk of lung cancer in smokers (Anttila et al,
2001) and because smokers have induced CYP1A1 (Alexandrov et al, 2002; Willey et al,
1997), the effect of silicosis on CYP1A1 induction is important. EROD is a reaction
catalyzed in rabbits by CYP1A1 (Serabjit-Singh et al, 1979; Devereux et al, 1989). Our
data showed that CYP1A1-dependent EROD activity induction by BNF was significantly
suppressed by acute and chronic silicosis (Figure 1A and B).
To further investigate the effect of silica on BNF-induced CYP1A1 apoprotein
induction in rabbit lungs, Western blot analysis of lung microsomes was conducted using
goat anti-rabbit CYP1A1 antibody. We found a reduction of CYP1A1 protein in acute
silicosis compared to control (Figure 2A and B). This result supports downregulation of
the protein as well as activity by exposure to silica. In chronic silicosis, Western blot did
not show any change in the CYP1A1 protein compared to control (Figure 3A and B)
although the EROD activity was significantly reduced (Figure 1B). This observation
suggests that silica exposure in rabbits downregulates the induced pulmonary CYP1A1 in
a posttranscriptional process in which the enzyme protein is expressed, as shown in the
Western blot, but not active as shown in the suppressed EROD activity. A similar result
was obtained by Paton and Renton (1998) when they had a significant reduction of
EROD activity of Hepa 1 cells upon addition of tumor necrosis factor alpha directly to
the cell, while the Western blot CYP1A1 protein showed no change. It is also possible
that EROD activity is more sensitive indicator of changes of changes in CYP1A1 than
western blot. It is noteworthy to mention that chronic silicosis models was induced in
rabbits by a more localized exposure procedure to prevent respiratory impairment, and
accordingly, the acute and chronic models can not be compared to each other but each
one can be compared to its control. However, taken together, these results suggest that
exposure of rabbits to crystalline silica suppresses BNF-induced CYP1A1 activity.
PROD activity was also measured as an indicator of CYP2B4 activity in the
lungs. PROD is a specific indicator of the CYP2B4 activity (Cawley et al, 2001). The
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CYP2B4 in rabbits is the analog of rat CYP2B1 (Oesch-Bartlomowicz and Oesch, 2003)
which is the major isoform of CYP in rodents (Martin et al, 1993). Similar to rat
CYP2B1, rabbit CY2B4 is constitutively expressed in lung tissue in high levels and
considered the major CYP isoform in rabbit lung, but present in very minute quantity in
liver (Serabjit-Singh et al, 1979; Parandoosh et al, 1987). Statistically, PROD was
significantly lowered in rabbits with acute silicosis and BNF compared to the control
(Figure 1C). However, no significant change in PROD activity was observed in lung
microsomes from chronic silicotic rabbits (Figure 1D) compared to control. The
significant reduction of PROD activity in acute silicosis suggests that downregulation of
CYP activity in acute silicosis involves multiple isoforms.
In order to determine the pattern of CYP1A1 expression by different alveolar cells
upon acute and chronic exposure to crystalline silica, cell-specific localization of
CYP1A1 protein has been analyzed by double-labeling immunofluorescence. The dual
immunofluorescence includes a double staining of the CYP1A1 protein and cytokeratins
8/18 proteins, which are cytoskeletal proteins expressed in primitive epithelial cells of the
lungs, such as alveolar AT-II cells and used as markers for these cells (Kasper et al,
1993). A characteristic pattern of CYP1A1 expression has been detected by
morphometric analysis of immunofluorescence in rabbit alveoli. Apparently, the NT-II
cells (all alveolar cells except type II) in PA regions and RA regions, which were
identified as cytokeratins 8/18 negative alveolar cells, significantly express CYP1A1
protein more than AT-II cells, which were identified by their plump shape, and protrusion
into alveolar lumen and positive immunofluorescence for cytokeratins 8/18 (Figure
4A&B, 5, and 6). That observation suggests that alveolar AT-II cells are not the major
cell types involved in CYP1A1 expression in rabbit alveolus; other alveolar septal cells
are responsible for more area of CYP1A1 protein expression. Our findings are consistent
with those of Domin et al, 1986 who demonstrated that the majority of pulmonary
CYP1A1 (isoform 6) in rabbit lungs is localized in cells other than AT-II cells, Clara
cells, or the alveolar macrophage. In rabbits exposed to 2,3,7,8- tetrachlorodibenzo-pdioxin (TCDD), an inducer of CYP1A1, the immunopositive areas of CYP1A1
expression in the interalveolar septa were the capillary endothelium, with a minimum
labeling of type I and AT-II cells (Overby et al, 1992). On the contrary, rat CYP2B1
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isoform has been localized and concentrated mainly within alveolar type I cells because
the selective destruction of these cells by trialkylphosphothiolates resulted in a marked
loss of the enzyme (Dinsdale and Verschoyle, 2001).
Hyperplasia and hypertrophy of AT-II cells were evident in acute and chronic
exposures, compared to control as shown by the increase in the area of green
fluorescence for cytokeratins 8/18 per alveolar microscopic field in AT-II cells of the
alveolar septum (Figure 13) and by the histopathological examination. These findings are
in agreement with those of Miller et al (1990), who demonstrated approximately two fold
increase in the number of AT-II cells following silica exposure. The increased number
(hyperplasia) and size (hypertrophy) of alveolar AT-II cells were not associated with a
parallel increase of CYP1A1 expression in these cells. Indeed, per unit area of alveolar
AT-II cells, CYP1A1 expression (proportional CYP1A1 expression) was significantly
decreased in acute silicosis compared to control saline (Figure 9). This observation
suggests that many of the hyperplastic and hypertrophic alveolar AT-II cells appearing in
rabbit lungs following exposure to silica do not express detectable levels of CYP1A1.
This result is consistent with a previous rat study in our laboratory, which demonstrated
that intrapulmonary exposure to silica lead to appearance of new population of AT-II
cells without a detectable amount of CYP1A1 protein expression (Battelli et al, 1999).
The response of alveolar AT-II cells to silica exposure has been extensively studied
because these cells perform many vital functions in the lungs and increase in response to
dust exposure (Miles et al, 1993). AT-II cells play an important role in synthesis and
secretion of surfactant (Castranova, 1988) which increases surface tension (Pattle, 1955;
Clements, 1957) and protects lungs from potentially toxic respirable particles
(Castranova et al, 1988, Wallace et al, 1985) while contributory to the pathogenicity of
acute silicosis (Lesur et al, 1995). AT-II cells are also involved in repairing alveolar
epithelium by their differentiation into alveolar type I cells (Miller et al, 1990;
Castranova et al, 1988). The alveolar AT-II cell population of the lung has been found to
be very sensitive to the deposition of toxicants in the distal lung, and respond in two
major ways upon exposure. Damage to the type I alveolar epithelial cells stimulates ATII cell proliferation, which subsequently differentiate to repopulate the injured type I cells
and reconstitute the alveolar architecture (Miller and Hook, 1990; Melloni et al, 1995;
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Wang et al, 2002; Sutherland et al, 2001). The second portion of the AT-II cell
population may become enlarged in size (hypertrophic) (Miller and Hook, 1990).
Moreover, AT-II cells, being rich in endoplasmic reticulum (Baron and Kawabata, 1983)
and CYP monooxygenase system, are generally believed to be involved in metabolism of
foreign compounds (xenobiotics) (Devereux et al, 1979; Jones et al, 1983; Baron and
Kawabata, 1983; Rabovsky et al, 1986). However in our study, we found that the major
area of the alveolus containing induced CYP1A1 was not the AT-II cells. In our study,
we found that these hypertrophied and hyperplastic AT-II cells are frequently devoid of
detectable CYP1A1. In addition, in acute silicosis the proportional expression of
CYP1A1 in AT-II cells is reduced.
The mechanisms involved in the reduction of CYP1A1 expression in AT-II cells
following silica-induced proliferation are incompletely investigated. However, the
inverse relationship between AT-II cell hyperplasia and CYP expression that we have
observed in vivo is consistent with in vitro findings from previous studies. Lag et al
(1996) concluded that an inverse relationship could exist between CYP2B1 apoenzyme
expression and the proliferation level of AT-II cells. That conclusion was based upon the
observation that CYP2B1 apoenzyme was lowest in alveolar AT-II cell cultures during
the most active proliferative stage, which coincided with presence of largest proportions
of cells in S-phase and highest proliferating cell nuclear antigen (PCNA) expression.
Similarly, the CYP1A1-dependent enzymatic activity, EROD, was undetectable in
proliferating cultures of mouse lung epithelial cells, but the level became detectable once
cultures were confluent (Reiners et al, 1992). It was suggested that EROD expression
was regulated as a function of the proliferative process of the cell culture. An inverse
relationship between cellular proliferation and CYP expression was also suggested by the
observation that proliferative regeneration of hepatic cells following partial hepatectomy
was associated with lower P450s protein levels and activities than normal liver (Hino et
al, 1974; Presta et al, 1980; Klinger and Karge, 1987; and Ronis et al, 1992). It seems
that hepatic cells are allocated to replication, rather than transcription, as a main function
of DNA to proliferate and regenerate the cells after hepatectomy (Liddle et al, 1989,
Waxman, 1989; Morgan et al, 1985; Steer, T.C. (1995). Similarly, alveolar AT-II cells
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may repair the damaged alveolar epithelium by proliferating and regenerating the injured
alveolar wall instead of expressing CYP1A1.
A more detailed cell-specific localization and morphometric quantification
demonstrated that the area of alveolar NT-II cells expressing CYP1A1 was significantly
decreased in both acute and chronic silicosis compared to control and compared to the
internal control regions (RA regions) where few silica particles deposited (Figure 7,
Table 2). This finding suggested that silica exposure not only altered the induction of
CYP1A1 expression in AT-II cells, but also affected the alveolar NT-II cells. The overall
effect for the alveolus was significant reduction of the alveolar area expressing CYP1A1
in the whole alveolar septum in acute and chronic silicosis in PA regions compared to
control and to RA regions (Figure 12, Table 4).
Clara cells are considered the predominant nonciliated cell type at the terminal
bronchiolar epithelium (Widdicombe and Pack, 1982; Plopper, 1983). They serve as an
important site for xenobiotic metabolism in the distal lung (Boyd, 1977; Boyd et al, 1978;
Boyd et al, 1980). For this reason, we counted the number of CYP1A1 positive staining
cells and standardized that number per micrometer of the basement membrane. Rabbit
silicosis, either acute or chronic, in BNF-treated rabbits significantly reduced the number
of CYP1A1 immunoreactive Clara cells in the terminal bronchiolar regions compared to
BNF treatment alone (Figure 14 and 15). This may contribute to the reduction in EROD
activity in silicosis.
The inflammatory effects of silica on rabbit alveoli have been demonstrated by
assessing the histopathological changes. Both acute and chronic silicosis produced a
significant pulmonary inflammation and AT-II hyperplasia and hypertrophy as shown in
Figure 16. Previous studies on rat showed that the pulmonary reaction to the inhalation of
crystalline silica resulted in lung damage, inflammation, and hypertrophy and hyperplasia
of AT-II cells (Miller et al, 1986; Miller et al, 1990; Castranova et al, 2002). In our study,
the positive CYP1A1 immunoreactive cells completely disappeared in areas with
granulomatous inflammation associated with rabbit silicosis (Figure 11C). Although
these regions were not quantified morphometrically because of the absence of normal

119
alveolar cell populations, they may also contribute to the total reduction of the CYP1A1
activity measured by EROD assay by replacing normal parenchyma.
A number of investigators studying the effect of the inflammatory response on
hepatic CYP metabolic activity concluded that the acute inflammatory reaction caused by
subcutaneous injection of turpentine (Kobusch et al, 1986), bacterial lipopolysaccharide
(LPS) (Morgan, 1989) and viral and bacterial infection (El-Kadi and Du Souich, 1998)
depressed the constitutive hepatic CYP. It was also suggested that the inhibition in the
metabolism was attributed to the inflammation itself (or to its consequences) and not to
the inflammatory agents (Parent et al, 1992). Previous studies by Ke and co-investigators
(Ke et al, 2001) have demonstrated that the proinflammatory mediators, such as tumor
necrosis factor-α (TNF-α) that were released in response to lipopolysaccharide exposure
downregulated the CYP1A1 in vitro. Their results showed that TNF-α inhibited the
ligand-induced acetylation of histone H4 at the promoter region of CYP1A1 gene and
consequently prevented CYP1A1 induction in Hepa1c1c7 cells. In addition, they
demonstrated that nuclear factor kappa B (NF-κB) interacted with AhR and thus interfere
with AhR-mediated CYP1A1 induction. The effect of the mixed exposure to crystalline
silica and CYP1A1-inducers, such as BNF on CYP1A1 expression and activity has been
investigated only in our laboratory (Battelli et al, 1999). Our previous findings in rats
indicated that silica produced a significant reduction of the induced CYP1A1 enzymatic
activity (EROD). The current study indicated that such findings were not unique to the
rat. In rabbit with acute and chronic silicosis, the induction of CYP1A1 activity by BNF
was inhibited. Our study suggested that AT-II cells and Clara cells in silicotic rabbits
expressed CYP1A1 less frequently than did controls. Thus, one mechanism of modifying
CYP1A1 induction in silicosis, appeared to be decreased CYP1A1 expression in both
cells of the terminal bronchiolar and alveolar septum.
In conclusion, our data strongly suggests that rabbit silicosis is a modifying factor
for CYP1A1 induction in rabbits. Factors associated with downregulation of CYP1A1
induction in vivo include altering the cell specific localization of the apoprotein in the
alveolus and terminal bronchioles. Silicosis, both acute and chronic, inhibited the
induced-CYP1A1 enzymatic activity (EROD). This inhibitory effect on cytochrome P450
isoforms is not limited to CYP1A1 induction. PROD activity which is associated with
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CYP2B4, is also decreased with silica exposure. Suppression of CYP1A1 induction is
associated with reduction of protein expressed in Clara cells, AT-II cells, and other cells
of the alveolar septum, as assessed by quantitative immunofluorescence microscopy.
CYP1A1 was not the only CYP isoform modified by exposure to crystalline silica, but at
least one other CYP isoform, CYP2B4, also underwent suppression.
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CHAPTER 5
SUPPRESSION OF SHEEP PULMONARY CYP1A1 INDUCTION BY
INTRATRACHEAL EXPOSURE TO RESPIRABLE COAL DUST PARTICLES
ABSTRACT
A non-rodent model was used to investigate the effect of coal dust (CD) exposure
on CYP1A1 induction and localization in the lung. Since pulmonary effects of silica are
similar in sheep and humans (Larivee et al, 1990), lambs were used in this study.
Therefore, we investigated the hypothesis that CD exposure in sheep modifies CYP1A1
metabolic activity and localization in pulmonary cells. To investigate this hypothesis, the
right apical lobes of 9 Katahdin crossbred lambs were instilled with 500 mg coal dust (<5
microns) using a flexible fiberoptic bronchoscope. Lambs were sacrificed 8 weeks after
exposure. All lambs received 50mg/kg of the CYP1A1 inducer, BNF, suspended in corn
oil or corn oil by intraperitoneal injection, 2 and 3 days prior to sacrifice.
Bronchoalveolar lavage (BAL) fluid, microsomes and formalin-fixed lung tissue were
collected from the instilled right tracheal bronchial lobes and the uninstalled left apical
lobes. CYP1A1-dependent EROD activity and CYP2B-dependent PROD activity were
significantly reduced in the microsomes of CD-exposed tracheal bronchial lobes relative
to the uninstalled left lobes or the right tracheal bronchial lobes of sheep receiving BNF
alone. In addition, the cellular expression of CYP1A1 in alveolar type II cells, non-type
II cells, and whole alveolar septum was significantly reduced in sheep exposed to CD and
BNF compared to those receiving BNF alone. These results further support our
hypothesis that CD exposure modifies the induction and cellular localization of CYP1A1
protein.
INTRODUCTION
In the previous 2 chapters, we have demonstrated suppression of CYP1A1
induction and its dependent enzymatic activity (EROD) by pulmonary exposures to
respirable coal dust (in rats) and crystalline silica (in rabbits). In addition, coal dust and
silica particles respectively suppressed the enzymatic activity (PROD) of the CYP2B
isoforms in rat and rabbit lungs. However, there is a scientific debate concerning the
comparability of rat and human pulmonary responses to respirable particles of low
toxicity, such as coal dust (International Life Science Institute (ILSI) Risk Science
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Institute Workshop Participants, 2000). In this study, we used the lamb as a non-rodent
model to establish the relationship between pneumoconiosis, caused by coal dust
deposition in sheep lungs, and alteration in xenobiotic metabolism. Specifically, we have
examined the activity, quantity, and localization of CYP1A1, the CYP isoform which
activates some polycyclic aromatic hydrocarbons, such as those in cigarette smoke. In
addition, we have studied the activity of CYP2B. CYP2B is the major constitutively
expressed CYP member in sheep lung, which is analogous to CYP2B1 and CYP2B4 in
rats and rabbits, respectively (Williams et al, 1991). Sheep were selected as a model
because their pulmonary response to respirable crystalline silica, another cause of
pneumoconiosis, is similar to that observed in humans (Begin et al, 1989, Larivee et al,
1990). Sheep lungs are larger, which permits directed exposure and the use of internal
control lobes, an important advantages in an outbred species.
A literature search dealing with the effect of environmental toxicants, such as
PAHs, on sheep CYP1A1 did not reveal any studies. However, some studies have
investigated the effect of commonly used veterinary pharmaceuticals, such as ivermectin,
on CYP1A1, 1A2, 2B and 3A because of the role of these isoforms in drug metabolism in
farm and cloven-hoofed animals (Skalova et al, 2001). The sheep cDNA coding region of
CYP1A1 has an 85 % homology to human CYP1A1 (Hazinski et al, 1995). Therefore,
sheep appear to be an appropriate model to studying the effect of xenobiotics, such as
PAHs, on CYP1A1-associated carcinogenic pathways. Our results showed a reduction of
the CYP1A1-dependent (EROD) and CYP2B-dependent (PROD) enzymatic activities in
lung microsomes of sheep exposed to a CD particle suspension and BNF (CYP1A1
inducer). These results were further supported by Western blot analysis for CYP1A1
protein and immunofluorescence examination of tissue sections stained for CYP1A1 and
cytokeratins 8/18 (AT-II markers).
MATERIALS AND METHODS
Sheep
Eleven Katahdin crossbred castrated male lambs weighing 17-30 kg at the start of
the study were used. The lambs were housed in the Food Animal Research Facility
(FARF) of West Virginia University. Lambs were fed Alfagreen Supreme Dehydrated
alfalfa pellets (containing 17% crude protein, 1.5% crude fat and 30% crude fibers), with
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ad libitum supply of water. The lambs were kept in pens for 3 weeks prior to exposure for
acclimatization. During this period, they were examined physically for pulse and
respiratory rates. In addition, the body temperature and capillary refill time were
examined and all parameters were within normal range. To assure parasite-free lambs,
ivermectin was injected subcutaneously 3 weeks before instillation. Lungs were
examined by auscultation to assure normal lung sounds before coal dust instillations.
Complete blood counts were taken from each lamb and were within normal limits.
Experimental Design:
Lambs were randomized into a coal-dust exposed and a control group using a
randomizing program (www.randomized.com). The right apical lobe of each lung was
instilled with CD or saline and the left apical lobes served as internal controls. The lambs
were exposed in groups of two to three each day over an eight day period. The lambs
were sacrificed eight weeks after exposure based upon the results of a preliminary coal
dust instillation experiment. All lambs were subcutaneously injected with 10 mg/kg
Tilmicosin antibiotic (Mycotil, Eli Lilly, Indianapolis, IN) one day after instillation of the
final lamb as a prophylaxis against pulmonary infections. Three and two days before
sacrifice, lambs were intraperitoneally (IP) injected with 50 mg/kg beta-naphthoflavone
(BNF), to induce pulmonary CYP1A1.
Preparation of Particle Suspension
Coal dust particles (< 5 micrometer in diameter, 500 mg/lamb) were heat
sterilized for 2 h at 160 ºC. The particles used in this study contained 0.34 % total iron of
which 0.119 % was surface iron. The coal dust suspension was prepared by addition of
15 ml sterilized saline to 500 mg coal dust and vortexed. The suspension was drawn into
a sterile syringe attached to a 1 mm diameter polyethylene tube and inserted into an
endoscope (Jorgensen Laboratories Inc., Loveland, CO). The whole amount was instilled
in the right tracheal bronchial lobe. In the control group, only 15 ml of the sterile saline
was instilled into the same lobe under the guidance of the fiberoptic bronchoscope.
Intratracheal Instillation of Particles Using Flexible Fiberoptic Bronchoscope
Lambs were anesthetized by intramuscular injection of a combination of ketamine
hydrochloride (Keta-ject, Phoenix Laboratories Inc., St. Joseph, MO 64503) 11 - 15
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mg/kg and xylazine hydrochloride (Xyla-ject. Phoenix Laboratories Inc., St. Joseph, MO)
0.22 mg/kg. When the lambs were in surgical plane anesthesia (manifested by absence of
the palpebral reflex), they were placed in a dorsal recumbency with the head extended
down the surgical table to facilitate the passage of the bronchoscope tube into the trachea.
A mouth speculum (Ideal Instruments, Detroit, IL) was modified by cutting into 2 halves
and one half was inserted and fixed in situ by a piece of gauze to avoid damage to the
bronchoscope tube. Cetacaine spray (Cetylite Industries, Inc., Pennsauken, NJ) was
spayed in the pharynx to minimize pain and the swallowing reflex. An alcohol-sterilized
flexible fiberoptic bronchoscope (Jorgensen Laboratories Inc., Loveland, CO) with a 5mm external diameter was inserted though the speculum into the trachea by passage into
the laryngeal orifice. Positioning was confirmed by visualization of the tracheal rings and
a cough reflex. Once the bronchoscope was in the trachea, the lambs were turned into
sternal recumbency followed by further insertion of the endoscopic tube until the orifice
of the right tracheal bronchus appeared (just before the major bifurcation). At this point,
the distal tip of the endoscope was tilted toward the orifice, and a 1-mm diameter
polyethylene cannula (Becton Dickinson and Company, Sparks, MD) was inserted
through the working channel of the endoscope directly into the right tracheal bronchus
orifice through which the coal dust suspension was instilled into the lumen of the
mainstem bronchus of the right apical lobe. After the coal dust suspension instillation, 510 cc of air was instilled into the mainstem bronchus. Importantly, in sheep, the right
apical lobe is divided into 2 segments, the cranial segment and the caudal segment, each
one receives a separate bronchus from the mainstem right tracheal bronchus (Getty,
1975). In our instillation procedure, the CD was instilled in the mainstem tracheal
bronchus so that both segments were exposed. Post instillation, lambs were kept on the
right side to allow settling of particle suspension within the instilled lobe. To facilitate
anesthetic

recovery,

yohimbine

hydrochloride

(Yobine,

LLOYD

Laboratories,

Shenandoah, OH) was injected IV (0.2-0.4 mg/kg) after the lambs were placed in the
recovery stall.
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Figure 1: The flexible fiberoptic bronchoscope (JorVet 569) used in the study attached to
the light source (Jorgensen Laboratories Inc., Loveland, CO)
Lamb Necropsy
Lambs were euthanized by intravenous injection of Sodium pentobarbital
(Sleepaway®, Fort Dodge Animal Health, Fort Dodge, Iowa) 26 mg/lb. Under deep
surgical plane anesthesia, the abdomen was incised along the midline and the abdominal
aorta was transected to assure exsanguination. The entire lung was weighed and the right
tracheal bronchial lobe and the left apical lobe were separately weighed. Both lobes were
lavaged with PBS solution to collect the bronchoalveolar lavage fluid (BALF) as
described later. Following lavage, 10 % of each lobe, by weight was excised for
microsome preparation and the other 90 % was fixed by airway perfusion with a volume
of 3 ml/gm of 10 % neutral buffered formalin (NBF). The amount of NBF used was
calculated form the following formula:
Wt of lavaged lobe portion for histopathology x wt of the unlavaged lobe x 3 = mls of NBF
Wt of the total lavaged lobe

The formalin fixed tissues were trimmed later that day to prepare 4µm-thick
tissue sections for histopathology and immunofluorescence.
Certain criteria were set to include a lamb in the study. Any lamb that did not
meet any one of these criteria was excluded. These criteria were:
1- Absence of pulmonary infections.
2- Presence of coal dust particles in the instilled lobe.
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3- Absence of technical difficulties that may result in partial instillation of the
designated amount of CD
Two lambs were intended to be in the study but, due to failure to meet with the
previous inclusion criteria, they were excluded. One of the lambs instilled with saline
showed a bacterial pneumonia associated with translocation of bacteria and plant material
from the esophagus/pharynx to the right apical lobe. Another lamb (supposed to be
instilled with coal dust) was excluded because it showed no coal dust deposition by gross
examination of lung tissue, inspection of tissue sediments during microsomal preparation,
and microscopic examination of BAL and had minimal deposition noted histologically.
That lamb had coughed powerfully during instillation, dislodging the bronchoscope.
Therefore, that lamb was excluded. All the lambs were castrated males but a single
testicle was identified in one lamb that was determined histologically to be immature, as
it contained no spermatogonia. The lamb with the single immature testicle was included
in the experiment due to the internal control incorporated in the design.
Preparation of Sheep Lung Microsomes
The microsomal fraction of lung homogenate was obtained by differential
centrifugation method as previously described (Flowers and Miles, 1991; Ma et al, 2002).
These microsomes were used for measuring the CYP1A1 and CYP2B1-dependent
enzymatic activities (EROD and PROD, respectively). In addition, lung microsomes were
subjected to electrophoresis to determine the CYP1A1 protein by western blot analysis.
Determination of the Total Lung Proteins
The total amount of protein content of lungs was measured in the microsomal
suspension spectrophotometrically using the bicinchoninic acid (BCA) method as
previously described (Smith et al, 1985; Ma et al, 2002) according to the direction of the
BCA protein assay kit (Pierce, Rockford, IL) in a spectra Max 250 Spectrophotometer
(Molecular Devices Corporation, Sunnyvale, California). Bovine serum albumin was
used for the standard curve. Protein was measured as mg/ml.

127
Determination of CYP1A1- and CYP2B-Dependent Enzymatic Activities (EROD and
PROD)
Spectrophotometric assays for measuring EROD and PROD metabolic activities
were performed as previously described (Burke et al, 1985 and Ma et al, 2002) using a
luminescence spectrometer model LS-50 (Perkin-Elmer, Norwalk, CT) and 7ethoxyresorufin (7-ER) (Sigma, St. Louis, MO) as the standard. The 7-ER was used at a
concentration of 10 µM that was prepared by dissolving 2.35 µg 7-ER in 1 ml DMSO.
EROD and PROD activities were expressed as picomoles of the produced resorufin per
minute per milligram microsomal protein (pmol/min/mg protein) as previously described
(Ma et al, 2002).
Immunofluorescence Double Labeling
The tissue sections were stained to identify CYP1A1 and cytokeratins 8/18. The
technique was basically the same as in rats (chapter 2). However, the tissue sections were
incubated with the primary antibodies for 48 h instead of overnight in rat
immunofluorescence. The primary antibodies were a polyclonal rabbit anti-rat CYP1A1
(Xenotech) diluted 1:5 with PBS and a polyclonal Guinea pig anti-cytokeratins 8/18
(RDI) diluted 1:50 with PBS. Rabbit serum was applied as a negative control, and the
primary antibodies were omitted. After 48 h incubation at room temperature, the slides
were incubated for additional 2 h at 37 ºC. The slides were then thoroughly washed to
remove un-conjugated primary antibodies and then the secondary antibodies were
dropped onto the slides. The secondary antibodies were a mixture of a FITC-labeled,
donkey anti-Guinea pig IgG (Research Diagnostic Inc., Flanders, NJ) diluted 1:50 with
PBS and Alexa 594-conjugated goat anti-rabbit antibody (Molecular probes, Eugene,
Oregon) diluted 1:20 with PBS. The slides were incubated with the secondary antibodies
for two h in the dark at room temperature. The slides were visualized using a fluorescent
photomicroscope (OlympusAX70, Olympus American Inc., Lake Success, NY) and
images were captured using the 40x objective and a Quantix cooled digital camera
(Photometrics, Tucson, AZ) with QED camera plugin software (QED Imaging, Inc.,
Pittsburgh, PA). Five images were captured per slide from the proximal alveolar (PA)
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regions, where most of the CD particle tend to localize near the terminal bronchioles and
alveolar ducts.
Mophometry
Immunofluorescence

morphometric

analysis

using

Metamorph

software

(MetaMorph, Universal Imaging Corp., Downingtown, PA) was conducted on images
captured from the proximal alveolar (PA) regions where CD accumulation was observed
and from the same areas in control sheep. A representative slide from each lobe, where
most of CD was grossly observed, was stained for immunofluorescence. Five images
were captured per slide from completely perfused areas of the lung, where the alveoli
were fully distended. The digital images were captured using a 40x objective producing a
microscopic field with an area of 34466.1 µm2. The captured images were quantified as
previously described in chapters 3 and 4 to assess the localization of CYP1A1 in different
alveolar epithelial cells. Briefly, the area of CYP1A1 expression was quantified in AT-II
cells, NT-II cells, and the entire alveolar septum. The proportional CYP1A1 expression
in AT-II cells was calculated as previously described in chapter 3. AT-II cell hyperplasia
and hypertrophy were assessed by measuring the area of cytokeratins 8/18 expression.
Western Blot Analysis
The amount of CYP1A1 apoprotein in lung microsomes was determined by
Western blot as previously described (Ma et al, 2002) with minor adaptation. A Novex
Tris glycine gel with 15 small wells, (Invitrogen Corporation, Carlsbad, CA), and 30 µg
of microsomal proteins were subjected to SDS gel electrophoresis for 90 min at 120 volts
followed by transfer to a nitrocellulose membrane (blotting) for another 90 minutes at 25
volts. Liver microsomes of BNF-treated rat (Xenotech, Kansas city, KS) were used as a
positive control. The membranes containing protein bands were identified by using a
primary polyclonal rabbit anti- rat CYP1A1 antibody (Xenotech, Kansas city, KS) for
overnight incubation at 4 ºC. Then, the membranes were washed and blocked for 1 h at
room temperature with rocking with a 5% solution of dry milk in tris-buffered
saline/tween (TBS/tween). After blocking, the membranes were washed and incubated
for 1 h with a HRP (horse radish peroxidase)-conjugated goat anti-rabbit IgG (Santa Cruz
Biotech. Inc., Santa Cruz, CA) at room temperature. Super RX Fuji Medical X-ray film
was then exposed to the membranes at room temperature. Band intensity developed on
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the X ray film was measured by the Eagle Eye II scanner with Eagle Sight software
(Strategene, La Jolla, California). The density on the scanned images was measured
using ImageQuant software version 5.1 (Molecular Dynamics, Sunnyvale, CA). Each
image was quantified three times, the average of which was used for statistical analysis.
After quantification, the data were presented as a percentage of the CYP1A1 positive
control.
Bronchoalveolar Lavage Fluid (BALF) Analysis
Both the right apical (exposed) and left apical (internal control) lobes were
lavaged using ice-cold PBS (Ca++ and Mg++ free). Three consecutive lung lavages were
performed in which the first lavage was collected by using 2 ml/gm lung while the
subsequent 2 lavages were conducted by using 2.7 ml/gm lung weight. In the last 2
lavages, the PBS fluid was flushed in and out of the lobes through a cannula and a 60-ml
plastic syringe. The lobes were excised from the rest of lung and the incision site was
clamped off by digital pressure during BAL collection process. Nevertheless, some of the
lavage fluid was lost due to incision of the lung tissue which reduced the recovery of the
fluid. Therefore, the BAL differential is considered more accurate that the total BAL cell
yield.
The BALF analysis was conducted as previously described (Porter et al, 1999).
Briefly, the first BAL fluid was kept separate from the subsequent lavages and
centrifuged at 500 x g for 10 min at 4 ºC to collect the BAL cells. The acellular
supernatant was decanted and used for analysis as BAL fluid (BALF). Cells of the
subsequent BAL were collected by centrifugation and the acellular supernatant lavages
were decanted and discarded. BAL cells from the first and second lavages were
combined, re-suspended in HEPES buffer (145 mM KCL, 1.0 mM CaCl2, 5.5 mM Dglucose, 10 mM N-2-hydroxyethylepiperazine-N-2-ethanesulfonic acid:

pH 7.4),

centrifuged at 500 x g for 10 min at 4 ºC, and the supernatant was discarded. The cell
pellet was resuspended in HEPES buffer and kept in ice.
BAL Cell Count and Differential Count
To assess pulmonary inflammation associated with coal dust instillation, the
alveolar macrophages (AM) and the polymorphonuclear leucocytes (PMN) were counted
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by using a coulter multisizer II and AccuComp software (coulter Electronics, Hialeah, Fl)
as previously described (Castranova et al, 1990). Cytospin preparations of BAL cells of 1
x 105 total phagocytes (AM and PMN) suspended in 200 µl HEPES-buffered solution
were prepared by using a Shandon Elliot cytocentrifuge (800 rpm for 5 minutes). The
cytospin preparations were stained with modified Wright-Giemsa stain as previously
described, and cell differentials were determined by light microscopy (Porter et al,
2002a). To calculate the differential cell counts, the total cell count (PM-PMN) obtained
from Coulter Counter was multiplied by the cell percentage differentials from the
cytospin preparations. In addition, the percentage of alveolar macrophages containing
phagocytized coal dust particles was determined for each lamb.
BALF Albumin Concentration
The albumin concentrations in the BALF reflect the integrity of the bloodpulmonary epithelial cell barrier. The BALF albumin was measured as previously
described (Porter et al, 2002a) by using a Cobas Fara II analyzer (Roche Diagnostic
systems, Montclair, NJ). The albumin was determined colorimetrically, based upon its
binding to bromocresol green (Doumas et al, 1971), at 658 nm using a commercial assay
kit (albumin BCG diagnostic kit, Sigma Chemical Company, St Louis, MO).
BALF Lactate Dehyrogenase (LDH)
Lactate dehydrogenase activity was measured in the BALF as an indicator of
cytotoxicity, by detection of the reduction of NAD+ associated with LDH catalyzed
oxidation of lactate to pyruvate at 340 nm (Gay et al, 1969) using a commercial assay kit
(Roche Diagnostics Systems, Montclair, NJ) as previously described (Porter et al,
2002a).
Alveolar Macrophage (AM) Chemiluminescence (CL)
AM chemiluminescence (AM CL) is a marker of increased production of reactive
oxygen and nitrogen species by AM. In this assay, the use of unopsonized zymosan
permits the measurement of chemiluminescence emitted from stimulated AM only
(Castranova, 1987) and not PMN chemiluminescence (Hill, 1977; Allen, 1977). The
assay was conducted in a total volume of 0.25 ml of HEPES-buffered medium as
previously described (Porter et al, 2002a).
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Nitric Oxide Dependent AM CL
To determine the NO-dependent chemiluminesecence released from AM in
response to particle exposure, the zymosan-stimulated chemiluminescence from cells
preincubated with 1 mM nitro-L-arginine methyl ester (L-NAME, a nonselective NOS
inhibitor

(Vaughan

et

al,

2003))

was

subtracted

from

zymozan-stimulated

chemiluminescence from cells without nitro-L-arginine methyl ester as previously
described (Porter et al, 2002b).
Differential Blood Count
Blood samples were collected from all sheep to monitor the changes in blood
status before and after CD instillation until sacrifice. Blood collection was conducted
once after sheep arrival at the pens, 1 day before instillation, and 1, 3, 5, 7, 14, 28, 42,
and 56 days after instillation. Differential blood count was performed using a CellDYN® 3500 R (Abbot Diagnostics, Santa Clara, California). Hematocrit values were
measured by using microhematocrit tubes and microhematocrit centrifuge.
Statistical Analyses
All analyses were performed with SAS version 8.2 and using Proc Mixed. In the
comparison between CYP1A1 localization between AT-II cells and NT-II cells, in sheep
exposed to BNF only, the model was the two factor repeated measures analysis of
variance. In all other cases, where data of right exposed lobe were compared to the
control and to the left unexposed lobes, the model was single factor repeated measures
analysis of variance. All pairwise comparisons were performed using a pooled variance
estimate and Fisher’s LSD (Least Significant Difference). All results were considered
statistically significant at p<0.05.
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RESULTS
The coal dust deposition was observed in the right apical lobe as black spots
(Figure 2A) indicating a successful instillation.
A

B

Figure 2: Photographs of sheep lung showing (A) the deposition of coal dust particles in
the caudal segment of the right apical lobe and the cranial segment of the left apical lobe
as an internal control. In B, the orifice of the tracheal bronchus where the endoscope was
inserted is shown.
1- 7-Ethoxyyresorufin-O-Deethylase (EROD) Activity
The CYP1A1-dependent enzymatic activity (EROD), measured per mg
microsomal protein was significantly reduced (p=0.0166) in lambs exposed to CD and
BNF compared to those exposed to BNF alone. Moreover, EROD was significantly
reduced (p=0.0265) in microsomes prepared from the CD-instilled lobe (right lobe)
compared to the un-instilled lobe (left lobe) (Figure 3B).
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Figure 3. Effect of CD exposure on pulmonary EROD activity in lambs. In A, EROD is
significantly reduced in lambs exposed to CD and BNF compared to lambs with BNF
alone. In B, EROD activity is significantly reduced in CD-exposed lobes compared to the
control unexposed lobes. * Significantly different at p<0.05.
2- 7-Pentoxyresorufin-O-Deethylase (PROD) Activity
The CYP2B-dependent enzymatic activity (PROD) was significantly lowered
(p=0.042) in CD-exposed lambs with BNF compared to control (Figure 4A). Compared
to the non-instilled lobe, PROD activity was reduced to less than 50 % in the CD-exposed
lobe (Figure 4B) but did not reach a statistically significant difference.
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Figure 3. Effect of CD exposure on pulmonary PROD activity in lambs. In A, PROD is
significantly reduced in lambs exposed to CD and BNF compared to lambs with BNF
alone. In B, PROD activity is reduced 50 % in CD-exposed lobes compared to the control
unexposed lobes. * Significantly different at p<0.05.
3-Western Blot Analysis
CYP1A1 protein bands of right exposed lobes (Figure 5A) and left unexposed
lobes (Figure 5B) were quantified and expressed as percentage of positive CYP1A1
control. The CYP1A1 apoprotein measured in lung microsomes by Western blot was not
significantly reduced in lambs exposed to CD and BNF compared to control (p=0.2)
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(Figure 5C) and in the CD-exposed lobes compared to the control unexposed lobes
(p=0.5) (Figure 5D).
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Figure 5. Effect of CD exposure on CYP1A1 protein measured by Western blot. 30 µg
microsomal proteins were subjected to SDS-PAGE and electroblotted to a nitrocellulose
membrane. The membrane was primed by a polyclonal rabbit CYP1A1 as described in
the materials and methods. The results are expressed as a percentage of CYP1A1 positive
control. CYP1A1 protein is lower in lambs exposed to CD and BNF than control (C). The
CD-exposed lobes have a lower amount of CYP1A1 protein compared to the unexposed
lobes (D). In A, lanes 1-5 are for right lobes of control (exposed to saline) and lanes 6-10
are for right lobes of CD-exposed lambs. In B, lanes 1-5 are for left unexposed lobes of
the control and 6-10 are for the left unexposed lobes of the CD group. C is the positive
CYP1A1 control and MW is the molecular weight standard.
4-Immunofluorescence Double Labeling for CYP1A1 and Cytokeratins 8/18
A- Distribution of CYP1A1 in BNF-Induced Sheep.
Sheep CYP1A1 was visualized as red fluorescence in alveolar type II cells, nontype II cells, and endothelial cells of the alveolar septum (Figure 7). However, the area of
CYP1A1 quantified in alveolar non-type II (NT-II) cells is significantly greater than that
in alveolar type II (AT-II) cells of the left (p=0.009) (Figure 6A) and right (p<0.001)
(Figure 6B) apical lobes of the BNF-induced sheep.
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Figure 6. Morphometric analysis showing the distribution of CYP1A1 in sheep lung. In
A, the area of CYP1A1 expression in non-type II cells is significantly larger compared to
CYP1A1 area in type II cells of the alveolus of left lung lobes. In B, the area of CYP1A1
expression in non-type II cells is significantly larger, compared to CYP1A1 area in type
II cells of the alveolus of left lung lobes. * Significantly different at p<0.05. Data are
means ± SE, n=5 in the saline exposed group and 4 in the CD-exposed group.
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B- CYP1A1 Induction is Suppressed in the Alveolus of CD-Instilled Sheep
Morphometric quantification of the CYP1A1 area of expression in lamb alveolus
has been conducted in the CD-exposed and control sheep to assess the effect of CD
instillation on the CYP1A1 induction. CYP1A1 area was quantified in alveolar type II
cells, non-type II cells, and the entire alveolar septum.
a- In Alveolar Type II (AT-II) Cells
The proportional CYP1A1 expression in AT-II cells, which adjusted for the
increased area of AT-II cell, showed a highly significant reduction (p<0.001) in sheep
exposed to CD and BNF compared to those receiving BNF alone (Figure 8A). When
compared to the left unexposed (internal control) lobes, the right lobes exposed to CD
also showed a significant diminution (p=0.01) of proportional CYP1A1 expression in
AT-II cells (Figure 8B). In addition, the area of CYP1A1 co-localized (co-expressed)
with cytokeratins 8/18 marker in AT-II cells was smaller, albeit not significantly, in
sheep exposed to CD and BNF than BNF alone (Figure 8C). Furthermore, the area of
CYP1A1 that co-localized with cytokeratins 8/18 was also smaller in the CD-exposed
right lobes compared to the unexposed left lobes (Figure 8D), but these differences were
also not significantly different.
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Figure 8. Morphometric quantification of CYP1A1 expression in AT- II cells. In A, there
is a highly significant reduction of the proportional CYP1A1 expression in AT-II cells of
CD-exposed lambs with BNF compared BNF alone. In B, the proportional CYP1A1
expression in AT-II cells of the CD-exposed lobes is highly significantly decreased
compared to the left unexposed lobes. In C the proportional CYP1A1 expression is
reduced in CD-exposed sheep with BNF compared to BNF alone. In D, the proportional
CYP1A1 expression is reduced in CD-exposed lobes compared the left unexposed lobes.
** significantly different at p<0.001.
b- Alveolar Non-Type II (NT-II) Cells
Cells in the alveolar septum that do not express cytokeratins 8/18 (AT-II makers)
are not type II cells and are designated here as alveolar non-type II (NT-II) cells. These
cells are usually thin, elongated and often contain immunofluorescence CYP1A1. The
area of CYP1A1 expression in these cells is significantly diminished in alveolar septum
of sheep exposed to CD and BNF compared to BNF alone (p=0.0015) (Figure 9A). In
addition, the area of CYP1A1 expression in NT-II cells is significantly reduced in
alveolar septum right lobes exposed to CD compared to the left unexposed lobes of the
CD-exposed sheep (p<0.0299) (Figure 9B).
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Figure 9. Morphometric quantification of the area of CYP1A1 expression in NT-II cells.
In A, the area of CYP1A1 expression, measure in µm2 is significantly reduced in CDexposed sheep with BNF compared to BNF alone. In B, the area of CYP1A1 expression
in NT-II cells of the CD and BNF-exposed right lobes is significantly lower than the left
unexposed lobes exposed to BNF alone.* significantly different at p<0.05.
c- Total CYP1A1 Expression in the Whole Alveolar Septum of Sheep
The total area of CYP1A1 expression in alveolar septum includes expression in
AT-II cells and NT-II cells. This area showed significant reduction in sheep exposed to
CD and BNF compared to sheep that received BNF alone (p=0.006) (Figures 10A and
11). Moreover, in BNF-treated sheep, the area of CYP1A1 expression in the alveolar
septal cells of the right lobes exposed to CD is reduced by 65.3 % compared to the left
unexposed lobes of the CD-exposed sheep (Figure 10B).
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Figure 10. Morphometric quantification of the total CYP1A1 expression in alveolar
septum. In A, the total area of CYP1A1 expression in the alveolus, expressed as µm2 of
CD-exposed sheep with BNF is significantly lower than BNF alone. In B, the area of
CYP1A1 expression in the alveolus of right CD-exposed lobes is reduced by 65.3 %
compared to the left unexposed lobes of CD-exposed sheep. * significantly different at
p<0.05.
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C-Effect of CD Exposure on Alveolar Type II (AT-II) Cell Hyperplasia in Sheep
The area of AT-II cells, as indicated by lung area with green fluorescence due to
cytokeratins 8/18 expression, was quantified morphometrically. The area of AT-II cells
was increased in the alveolus of sheep exposed to CD and BNF compared to BNF alone,
albeit not significantly. The area of cytokeratins 8/18 expression in the alveolus of the
right CD-exposed lobe was also numerically, but not significantly, increased relative to
the left unexposed lobe (Figure 12). AT-II cell hyperplasia and hypertrophy were
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visualized in fluorescent-stained sections of CD exposed sheep (Figure 12).
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Figure 12. Morphometric quantification of the cytokeratins 8/18 expression in alveoli of
CD exposed and control sheep. In A, the area of cytokeratins 8/18 expression is
numerically higher in CD-exposed sheep with BNF compared to control. In B, the area of
cytokeratins 8/18 expression is numerically, but not significantly increased in CD
exposed right lobes compared to the left unexposed lobes. Results represent means ± SE,
n=5 in the saline exposed group and 4 in the CD-exposed group.
4-Results of BAL Fluid Analysis
A- BAL Cell Differentials
a- Alveolar Macrophages (AM)
The number of BAL AMs was not significantly increased in the CD-instilled right
lobe compared to the left lobes instilled with saline (Figure 13A) or the uninstalled left
lobes (Figure 13C).

Cell differentials of cytospin preparation showed a significant

increase in the percentage of AM in CD-exposed right lobes compared to the right lobes
instilled with saline (p= 0.0008) (Figure 13B) or the unexposed left lobes (p=0.0318)
(Figure 13D). While no CD-laden AM was observed in saline exposed groups or the left
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unexposed lobes, an average of 44.5% of the AM counted in the BAL of CD-exposed
sheep contained coal dust particles (range 23 to 73 %).
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Figure 13. Differential count of BAL cells. The AM yield is higher in CD-exposed right
apical lobe than saline-exposed lobe (A) or left uninstilled (unexposed lobes) (C). The
percentage of AM is significantly higher in CD-exposed right apical lobe than salineexposed lobe (B) or left uninstilled (unexposed lobes) (D). Results represent means ± SE,
n=5 in the saline exposed group and 4 in the CD-exposed group.
b- Polymorphonuclear Leucocytes (PMN)
The PMN yield in CD-exposed right lobes was not significantly higher than the
right lobes exposed to saline (Figure 14A) or the uninstilled left lobes (Figure 14C). Cell
differentials of cytospin preparation exhibited a significant increase in the percentage of
AM in CD-exposed right lobes compared to the right lobes instilled with saline (p=0.047)
(Figure 14B) or the uninstalled left lobes (p=0.04) (Figure 14D). These results suggest
that the CD-exposed lobes exhibit higher phagocytic cell percentage.
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Figure 14. Differential cell count of the BAL. The PMN yield is non-significantly higher
in CD-exposed tracheal bronchial lobe than saline-exposed lobe (A) and left uninstilled
(unexposed lobes) (C). The percentage of PMN is significantly higher in CD-exposed
tracheal bronchial lobe than saline-exposed lobe (B) or left uninstilled (unexposed lobes)
(D). Results represent means ± SE, n=5 in the saline exposed group and 4 in the CDexposed group.
B- BAL Fluid Albumin
The albumin measured in the BAL fluid was not significantly increased in CDexposed right lobes compared to the saline-exposed right lobes (Figure 15A) and to the
left uninstilled lobes (Figure 15B).
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Figure 15. Albumin levels in BAL of CD-exposed lobes are not significantly increased
compared to saline exposed (A) or left unexposed lobes (B). Results are means ± SE, n=
5 in the saline exposed group and 4 in the CD-exposed group.
C- LDH in BAL Fluid
The LDH concentration in BAL of CD-exposed tracheal bronchial lobes was not
significantly higher than saline-exposed lobes (Figure 16A) or left uninstilled lobes
(Figure 16B).
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Figure 16. BAL fluid LDH levels are not significantly increased in right tracheal
bronchial lobes exposed to CD compared to the right lobes exposed to saline (A) or left
unexposed lobes (B). Data shown are means ± SE, n= 5 in the saline exposed group and 4
in the CD-exposed group.
D-AM-Dependent (CL) and NO-Dependent AM (CL)
No change was seen in AM-dependent CL and NO-dependent AM CL in BAL
samples of CD-exposed lambs compared to the controls (data not shown).
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5- Differential Blood Count (Total Leucocytic Count)
The neutrophil, monocyte, and total leucocyte counts for both CD-exposed and
control sheep were temporarily increased the day after the instillation and then gradually
decreased the following days to reach almost the resting stage on the day of sacrifice
(Figure 17A, B, and C, respectively). In addition, the hematocrit values do not show
significant difference between CD-exposed sheep and controls (data not shown) at any
time period (data not shown).
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Figure 17. The total leucocyte count (A), neutrophil count (B), or monocyte count (C)
exhibits a brief increase one day after instillation then reduced gradually to resting levels
at the time of sacrifice for both CD-exposed and control group. Data shown are means ±
SE, n= 5 in the saline exposed group and 4 in the CD-exposed group.
6- Histopathological Changes
Histopathological changes of CD-exposed lung lobes included bronchointerstitial
pneumonia with accumulation of dust-laden alveolar macrophages, mainly in the
interstitial tissue with only occasional foci of alveolar histiocytosis, a finding expected in
a lavaged lung. These changes were irregularly distributed but consistently present in the
instilled right apical lobes. Thus, bronchointerstitial pneumonia with particle-laden
interstitial macrophages was observed in the right apical lobe of all instilled lambs but
was not present in all sections of this lobe in the instilled lambs. Bronchointerstitial
pneumonia was not seen in the control lambs (Figure 18 C and D). AT-II cell hyperplasia
and hypertrophy was also observed in CD-exposed lobes (Figure 18A and B).
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DISCUSSION
In this study, we investigated the modifying effect of respirable coal dust particles
on CYP1A1 induction in BNF-exposed sheep. The response of sheep lung to CD
particles, in regard to CYP1A1 expression, was similar to that of the other 2 species, rats
and rabbits that have been investigated in the previous chapters. The model of CWP in
sheep was based upon a previous model of sheep silicosis (Begin et al, 1989). However,
the CD suspension was instilled only one time and the sheep were kept for eight weeks
before sacrifice. The response of sheep lung to respirable particles, such as quartz, is
similar to the human response, particularly in cellular cytotoxicity (Larivee et al, 1990).
The results indicated that the intratracheal instillation of CD significantly
inhibited the CYP1A1-dependent metabolic activity (EROD) lung microsomes (Figure
1). This effect was localized only in the lobes that were instilled with CD (right lobes).
However, in the left lobes, which were not exposed to CD particle suspension, there was
no change in the activity, suggesting that the CD exposure inhibited the CYP1A1
metabolic activity locally and the effect did not extend to include the neighboring lung
lobes. Along with CYP1A1 activity, another CYP isoform, CYP2B, was measured.
CYP2B is the major constitutive isoform of CYP family in sheep lungs (Williams et al,
1991). The CYP2B-dependent enzymatic activity (PROD) showed a significant
diminution in lung microsomes prepared from lung of sheep exposed to CD and BNF
compared to BNF alone (Figure 2). This result suggested that, CD not only inhibited the
activity of BNF-induced CYP1A1 in sheep lung, but the inhibitory effect also included
another CYP isoform, constitutively expressed in sheep lungs.
To assess the effect of CD exposure on CYP1A1 induction, the CYP1A1 protein
was measured by Western blot. The amount of CYP1A1 protein measured by Western
blot was reduced, albeit not significantly, in the CD-exposed lobes compared to
unexposed lobes (Figure 3). Although the reduction was not significant, the general trend
seemed to be suppressive as shown in Figure B.
The suppressive effect of the CD on CYP1A1 induction in sheep lungs was
further demonstrated by immunofluorescence double labeling. By using this technique,
the CYP1A1 expression in different pulmonary epithelial cells was investigated. We used
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cytokeratins 8/18, which are cytoskeletal proteins highly expressed in primitive epithelial
cells, to recognize the AT-II cells (Kasper et al, 1993) in the lung alveolus. Accordingly,
the cellular components of the stained lung tissue section were divided into 2 distinct
populations using indirect immunofluorescence with a primary anti-cytokeratins 8/18
antibody and a green FITC-labeled secondary antibody. One population stained
distinctively green and those were AT-II cells (Figure 5A). The others did not stain green
and were designated as NT-II cells. The CYP1A1 has been visualized in alveolar type II
cells and NT-II cells. However, by morphometry, the area of CYP1A1 expression
measured in NT-II cells, where no green fluorescence was visualized, was significantly
higher than that area in AT-II cells. This result suggests that in the alveolus, AT-II cells
are not the major sites of CYP1A1 induction and NT- II cells are important sites of
CYP1A1 induction. In addition, there is a general deficit in the literature regarding the
localization of inducible CYP1A1 in ruminant lungs. The majority of literature in
ruminant CYPs concentrates on the inducibility of CYP1A1 in the liver of goat (van’t
Klooster et al, 1993), or cattle (Shull et al, 1986) and this study is the first, to our
knowledge to report the distribution pattern of CYP1A1 in sheep lungs.
The CD instillation in sheep significantly reduced the area of CYP1A1 expression
in AT-II cells (Figure 6), NT-II cells (Figure 7) and the entire alveolar septum (Figure 9).
Therefore, one mechanism of suppression of BNF-induced CYP1A1 by CD exposure
appears to be inhibition of CYP1A1 expression in different alveolar septal cells. These
results are not surprising and are comparable to those seen in rats exposed to coal dust
and rabbits exposed to silica. While increased size (hypertrophy) and number
(hyperplasia) of AT-II cells were not significant in this study, they were increased
numerically which is consistent with studies in other species. The area of CYP1A1
expression in AT-II cells, relative to the total area of AT-II cells showed a significant
reduction suggesting that the new hyperplastic AT-II cells do not express CYP1A1 in
proportion to their number and size. This result supports our findings in rats that CD
exposure leads to production of a new population of alveolar type II cells with decreased
CYP1A1 expression. The mechanism of downregulation of CYP1A1 associated with
cellular proliferation should be further investigated. However, in the rat liver with
hyperplastic nodules, induced by diethylnitrosamine and partial hepatectomy, the total
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amount of microsomal CYP enzymes was reduced 50% compared to the control (Degawa
et al, 1995). Moreover, the inducibility of CYP1A by inducers decreases slightly in the
rat liver bearing hyperplastic nodules (Degawa et al, 1995). Consistent with that, the
inducibility of CYP1A1 by BNF was markedly reduced in early lung hyperplastic foci
associated with urethane exposure and the lung carcinomas were devoid of expression of
CYP1A1 protein (Forkert et al, 1998). All of these previous studies suggest that CYP
protein is downregulated in proliferating cells - - a finding which is consistent with the
downregulation of CYP1A1 induction and CYP2B in our study of CD-exposed lambs.
To assess the local inflammatory reaction of sheep lung in response to the inhaled
CD particles, the AM and PMN were counted in BAL. The percentage of AM and PMN
showed a modest, but significant increase. This result suggests that an inflammatory
process accompanied the CD instillation in sheep. Interstitial pneumonia with
accumulation of dust-laden AM in the interstitial tissue were the hallmarks of
histopathological changes in lung sections of CD-exposed lobes in sheep. In spite of the
local inflammatory reaction, no systemic reaction was observed as there was no
significant change in the neutrophil count, monocyte count, or total leucocyte count
between CD-exposed and control sheep. This result suggests that CD instillation into a
localized region of the lung is not associated with a systemic reaction in lambs at the dose
instilled (500 mg/sheep). The local inflammatory process was also associated with nonsignificant enhancement of LDH (marker of cytotoxicity) and albumin levels (marker of
pulmonary-blood barrier in the lung) of the CD-exposed group compared to control. This
suggests that CD exposure in sheep is associated with an inflammatory response, which
involves the interstitium consistently.
In conclusion, the general response of sheep lung to the CD-mediated suppression
of BNF-induced CYP1A1 is similar to that observed in rats. The sheep results are also
comparable to the CYP1A1-downregulation observed in acute and chronic silicosis in
rabbits. Therefore, if the suppression of CYP1A1 by particle exposure occurs in 3 animal
species (rats, rabbits, and sheep), it is also likely to happen in any other species, such as
the human.
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CHAPTER 6
SOME MECHANISTIC INTERACTIONS ASSOCIATED WITH PARTICLEMEDIATED SUPPRESSION OF CYP1A1 INDUCTION IN RATS
ABSTRACT
CYP1A1 induction was suppressed by pulmonary exposure to coal dust and
crystalline silica. However, the mechanism of induction suppression was not completely
elucidated. Therefore, we investigated some of the alterations associated with suppression
of BNF- induced CYP1A1 in rat lungs. We hypothesize that the inflammatory response
and induction of apoptotic proteins are two potential mechanisms associated with
CYP1A1 downregulation. To investigate this hypothesis, male Sprague Dawley (SD) rats
were intratracheally (IT) exposed to 2.5, 10, 20, and 40 mg/rat coal dust (<5 µm) or
vehicle (saline). Three days prior to sacrifice, rats were intraperitoneally (IP) injected
with 50 mg/kg BNF (CYP1A1 inducer). At necropsy, bronchoalveolar lavage (BAL) was
collected to evaluate pulmonary inflammation by measuring BAL alveolar macrophage
(AM) and polymorphonuclear (PMN) cell counts, AM chemiluminescence (CL), and
nitric oxide (NO)-dependent AM CL. Pulmonary cytotoxicity was assessed by measuring
the BAL lactate dehydrogenase (LDH). In a parallel experiment, immunofluorescence
triple labeling was conducted to identify the interaction between CYP1A1, cytokeratins
8/18, and Bax expression. BAL analysis showed a dose-responsive enhancement of PMN
and LDH by CD exposure (r2=0.661, p<0.0001; r2=0.174, p= 0.0139 respectively), a
significant increase of AM count in all groups exposed to CD and BNF compared to
control BNF-treated rats, and a significant enhancement of NO-dependent AM CL in rats
exposed to the highest dose (40 mg/rat) of CD and BNF compared to rats treated with
BNF alone (p= 0.004). Immunofluorescence (IF) triple labeling showed an inverse
relationship between CYP1A1 expression and Bax expression in alveolar type II cells.
Because Bax is a pre-apoptotic protein, we investigated the role of Bax expression and
apoptosis on the CD-mediated suppression of CYP1A1 induction. To explore this
mechanism, male SD rats (50-70 gm) were IT instilled with 40 mg/kg coal dust or vehicle
(saline). At days 0, 5, 9, 10, 11, 12, 13 post instillation, rats were IP injected with the pancaspase inhibitor, Q-VD-OPH (20mg/kg), or vehicle (DMSO). Three days before
sacrifice, all rats were administered BNF IP (50 mg/kg). EROD and PROD activities
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were measured in microsomes of the right lobe. Histopathology, IF for CYP1A1,
cytokeratins 8/18, and Bax, as well as TUNEL assays were conducted on tissue sections
of the left lobes. EROD and PROD were significantly lower in CD-exposed rats
compared to control. CD-exposed rats with caspase inhibitor did not show statistical
difference in PROD and EROD activities compared to DMSO-injected rats. By IF, the
area of CYP1A1 expression within alveolar septum of CD and BNF exposed rats was
significantly lower than rats exposed to BNF without CD, but was unaffected by caspase
inhibition with Q-VD-OPH. In single label IF, Bax expression measured as area (µm2) or
number of cells/field was significantly lower in CD-exposed rats with Q-VD-OPH than
CD-exposed rats with DMSO, but significantly higher than saline-exposed rats with QVD-OPH. TUNEL assay showed a significant increase of percentage of apoptotic cells in
CD-exposed rats with BNF compared to rats receiving BNF alone. CD-exposed rats with
Q-VD-OPH had a significant reduction of percentage of apoptotic cells compared to the
CD-exposed rats with DMSO. Taken together, these results suggest that CD exposure
enhances the pulmonary inflammatory response in a dose-dependent manner, upregulates
the Bax expression in AT-II cell, and induces apoptosis in lung cells. CYP1A1 induction
and activity was not significantly affected by the Q-VD-OPH-mediated inhibition of
caspases but caspase inhibition decreased Bax expression and apoptosis. This suggests
that CD-associated suppression of CYP1A1 is associated with inflammation and
associated with, but not caused by, Bax expression.
INTRODUCTION
The pathogenesis and mechanisms of suppression of CYP1A1 induction by intrapulmonary deposition of respirable particles are important processes in understanding the
modification of the xenobiotic-associated lung cancer by downregulation of pulmonary
enzymatic systems. In the previous 3 chapters, we have demonstrated a downregulation
of CYP1A1 protein expression and its dependent activity, EROD by pulmonary exposure
to CD and silica. At the cellular level, the suppression of induction was demonstrated in
alveolar type II cells, non type II cells, and the entire alveolar septum in three animal
species, rats, rabbits and sheep. However, the mechanisms associated with this cellular
behavior in response to particle exposure were not entirely clear. Pulmonary
inflammation and lipoproteinosis were demonstrated by histopathological examination of
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particle-exposed lung tissue and were associated with reduced CYP1A1 induction. In this
study, we investigated the inflammatory response to CD exposure by examining
bronchoalveolar lavage (BAL) fluid collected from rats exposed to coal dust particles.
We examined the relationship between increasing levels of inflammation and increased
suppression of CYP1A1 induction. Since the sensitivity of tissue to apoptosis is increased
when expression of cell-death regulator proteins, such as Bax is upregulated (Guinee et
al, 1997), we also investigated the relationship between the upregulation of Bax
expression and apoptosis induction in alveolar cells and the CD-mediated suppression of
CYP1A1 induction.
Apoptosis is programmed cell death that is essential for homeostasis (Wang et al,
2002) and tissue remodeling (Stanley et al, 1992). Apoptosis helps eliminate cells that
have improperly developed, have been produced in excess, or have sustained genetic
damage (Thompson, 1995). Apoptosis is characterized by cell shrinkage, nuclear
condensation, DNA fragmentation, cytoplasmic blebbing and formation of apoptotic
bodies (Wyllie et al, 1980). Because the plasma membrane is intact during programmed
cell death, there is limited tissue injury and inflammation (Savill et al, 1993). Two
common mechanisms are associated with cellular apoptosis: receptor-dependent and
mitochondrial-dependent (Mayer and Oberbauer, 2003). The receptor-dependent
mechanism is mediated through specific receptors, such as tumor necrosis factor
receptors (TNFR). Stimulation of these receptors by extracellular stimuli, such as
cytokine release or an inflammatory process, results in recruitment and activation of
caspase 8. Activated caspase 8 can activate a cascade of downstream caspases that
eventually produce DNA fragmentation and apoptosis (Peter and Krammer, 1989). In the
mitochondrial pathway, intrinsic stimuli, such as ischemia and ionizing radiation (Mayer
and Oberbauer, 2003) enhance the release of apoptotic proteins, such as caspase 9, or
apoptosis inducing factor (AIF) from the mitochondrial outer membrane. These apoptotic
factors activate caspase 8 and caspase 3, resulting in apoptosis (Peter and Krammer,
1989). Some pre-apoptotic proteins, such as Bax, may be activated and translocated from
cytosol to mitochondria, enhancing the release of cytochrome c and stimulating the
mitochondrial-induced apoptotic mechanism (Aiba-Masago et al, 2002).
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In our coal dust response study, we demonstrated a dose-dependent increase of
Bax expression in alveolar cells by CD exposure. On the other hand, our previous
experiments showed a reduction of CYP1A1 expression in alveolar cells by CD
exposure. This suggests an association between increased Bax expression and reduced
CYP1A1 induction. In addition, the Bax gene has 2 AhR response elements that play a
role in PAH-mediated apoptosis of ovarian oocytes in mice (Matikainen et al, 2002).
Since agents triggering pulmonary inflammation, such as silica (Lim et al, 1999; Lyer et
al, 1996) and bleomycin (Kuwano et al, 2000), can also induce apoptosis of lung cells,
we investigated the effect of CD, which also triggers lung inflammation, on alveolar cell
apoptosis. Because apoptosis can be inhibited by specific caspase inhibitors, such as
zVAD-fmk (Kitamaka et al, 1997) and Q-VD-OPH (Rebbaa et al, 2003), we investigated
the effect of caspase inhibition on suppression of Bax-associated apoptosis and CYP1A1
induction. We demonstrated that CD increases the number of apoptotic lung cells, and the
caspase inhibitor, Q-VD-OPH inhibits both Bax expression and apoptosis. However, the
suppression of CYP1A1 by CD exposure was not reversed by injection of the caspase
inhibitor, suggesting that the suppression occurs by a mechanism other than Bax
expression or apoptosis of pulmonary cells.
MATERIAL AND METHODS
Experimental Design
In the coal dust dose response experiment, 40 male SD rats (220-270 gm body
weight at time of exposure) were randomized into 5 groups (8 rats/group) by a
randomizer program (www.randomizer.org). Rats were exposed to 2.5, 10, 20, or 40
mg/kg CD suspended in sterile saline or saline by intratracheal instillation (IT). Eleven
days later, BNF was administered IP as a suspension in sterile corn oil at a dose of 50
mg/kg for CYP1A1 induction. Three days after the BNF injection, rats were euthanized
and BAL was collected as described later.
In the caspase inhibitor (Q-VD-OPH) experiment, 24 male SD rats, (~67-93 gm
body weight at time of exposure) were randomized into 4 groups (Table 1) using a
randomizer program (www.randomizer.org). Rats were IT instilled with 40 mg/rat CD
suspended in 0.3 ml saline or saline. On the day of the exposure, rats were injected with
the caspase inhibitor, Q-VD-OPD dissolved in dimethylsulfoxide (DMSO) or the vehicle
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with a dose of 15 mg/kg. The initial dose of caspase inhibitor or the vehicle was then
followed by subsequent doses of 10 mg/kg injected at days 5, 9, 10, 11, 12, and 13 post
exposures. Eleven days post instillation, all rats received 50 mg/kg BNF suspended in
corn oil as a CYP1A1 inducer by IP administration. Rats were euthanized on day 14.
Group

Group size (n)

CD or saline

Q-VD-OPH or BNF

(IT)

DMSO (IP)

(IP)

Group 1

6

Saline

DMSO

BNF

Group 2

5

Saline

Q-VD-OPH

BNF

Group 3

7

CD

DMSO

BNF

Group 4

6

CD

Q-VD-OPH

BNF

Table 1. The treatment groups, group size and type of treatment in the caspase inhibitor
study. The number of rats per group was selected based upon a power analysis, utilizing
results of previous experiments.
Preparation of CD Suspension
The CD particulates used in the study are less than 5 microns in diameter with a
surface area of 7.4 m2/g. The particles contained 0.34 % total iron of which 0.119 % is
surface iron. The particles were heat sterilized in an oven at 160 ºC for 2 h. Coal dust
suspensions were made up daily from heat sterilized samples using pyrogen-free, sterile
0.9% saline (Abbott Laboratories, North Chicago). Suspensions were vortexed directly
after preparation and shaken well before instillation.
Intratracheal Instillation
The CD particles were suspended in sterile saline at a concentration of 8.3, 33.3,
66.6, and 133.3 mg/ml. Rats received either 0.3 ml of this suspension (~2.5, 10, 20, and
40 mg/rat) or 0.3 ml of saline (vehicle). The IT instillation was conducted as previously
described (Porter et al, 2002). Briefly, rats in the CD response experiment were
anesthetized by intraperitoneal (IP) injection of sodium methohexital (Brevital, Eli Lilly
Indianapolis, IN) and were intratracheally instilled using a 20-gauge, 4-inch ball-tipped
animal feeding needle. Rats in the caspase experiment were instilled using the same
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procedure except that an 18 gauge, 1.5 inch animal feeding needle was used for the
instillation
Preparation and Injection of Caspase Inhibitor, Q-VD-OPH
The Q-VD-OPH (Quinoline-Val-Asp (Ome)-VH2-OPH) (Enzyme Systems
Products, Inc., Livermore, CA), is a broad spectrum caspase inhibitor with potent
antiapoptotic properties (Caserta et al, 2003). The mechanism of action depends upon the
formation of an irreversible thioester bond between the active site cysteine of the caspase
and the aspartic acid residue in the inhibitor (Melnikov et al, 2003). The Q-VD-OPH was
injected in rats to block the caspase-dependent apoptosis in pulmonary cells. Solutions of
2 % of the pan-caspase inhibitor were prepared in endotoxin-free dimethyl sulphoxide
(DMSO) (Sigma Chemical Co., St. Louis, MO). Rats received 15 mg/kg in the first
injections (day 0) and 10 mg/kg in the following injections (days 5, 9, 10, 11, 12, and 13
post exposure) by IP administration.
Preparation of BNF
To prepare BNF suspension, the vehicle (corn oil) was sterilized by filtering with
non-pyrogenic Acrodisc 25 mm syringe filter (0.2 µm in diameter) (Pall Gelman
sciences, Ann Arbor, MI). Solutions of 5 % BNF (Sigma, St. Louis, MO) in sterilized
corn oil (50 mg/ml) were prepared 24 h before injection. The suspension was vortexed
and then sonicated 15 minutes in Ultronics sonicator (Mahwa, NJ). BNF solutions were
injected IP 72 h before sacrifice.
Necropsy of Rats
Rats were euthanized by IP injection of 0.5 ml 26% sodium pentobarbital
(Sleepaway®, Fort Dodge Animal Health, Fort Dodge, IA). The abdomen was opened by
incision in the midline and the lungs and attached organs, including tracheobronchial
lymph node, thymus, heart, aorta, and esophagus, were removed. The right mainstem
bronchus was ligated and the lung lobes were collected and immediately placed in ice for
isolation of microsomes. The left lung lobe was inflated with 3.0 mls of 10% neutral
buffered formalin (NBF). Tracheobronchial lymph nodes, liver, spleen, and right and left
kidneys were also fixed in 10 % NBF. Fixed tissues were trimmed the same day,
routinely processed in a tissue processor and embedded in paraffin the following
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morning. For histopathoological examination, tissue sections of left lungs were stained
with hematoxylin and eosin (H&E) for histopathology. Additional 5-micrometer sections
were used for immunofluorescence.
Microsome Preparation
Microsomes were prepared as previously described (Flowers and Miles, 1991; Ma
et al, 2002). Steps of microsomal preparation in rats are described in chapter 3.
Determination of the Total Lung Proteins
The protein content of lung microsomes was measured by the bicinchoninic acid
(BCA) method as previously described (Smith et al, 1985, Ma et al, 2002) using the BCA
protein assay kit (Pierce, Rockford, IL) in a spectra Max 250 Spectrophotometer
(Molecular Devices Corporation, Sunnyvale, California). Bovine serum albumin was
used as the standard.
Measurement of EROD and PROD Activities
EROD and PROD activities were measured as previously described (Burke et al,
1985 and Ma et al, 2002) using a luminescence spectrometer model LS-50 (PerkinElmer, Norwalk, CT). A 10 µM concentration of 7-ethoxyresorufin (Sigma, St. Louis,
MO) solution prepared from 2.35 µg 7-ethoxyresorufin in 1 ml DMSO was used for the
standard curve following each run. EROD and PROD activities were expressed as
picomoles of the resorufin produced during the reaction per minute per milligram
microsomal protein (pmol/min/mg protein).
Western Blot Analysis
Western Blot analysis of lung microsomes was conducted as previously described
(Ma et al, 2002). Using a 15-well Novex tris glycine gel (Invitrogen Life Technologies,
Carlsbad, CA), 30 micrograms of microsomal protein were loaded and subjected to a
SDS gel electrophoresis and blotted against nitrocellulose membrane (Invitrogen Life
Technologies, Carlsbad, CA). The nitrocellulose membrane was incubated with a
polyclonal rabbit anti-rat CYP1A1 antibody (Xenotech, Kansas city, KS) or a
monoclonal mouse anti-rat CYP2B1 antibody (Xenotech) at 4ºC overnight. The nonspecific binding was blocked by addition of 1% dry milk in tris-buffered saline/tween
(TBS/T) for 1 h at room temperature with rocking. The membranes were then incubated
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with a goat anti-rabbit antibody (Santa Cruz Biotech. Inc., Santa Cruz, CA) for CYP1A1
detection or goat anti-mouse antibody (Santa Cruz Biotech. Inc., Santa Cruz, CA) for
CYP2B1 detection for 1 h at room temperature with rocking. For the positive control,
liver microsomes of BNF-treated rats (Xenotech) were used for CYP1A1 or liver
microsomes of phenobarbital-treated rats (Amersham, Piscataway, NJ) for CYP2B1. The
CYP1A1 and CYP2B1 proteins were detected by an enhanced chemiluminescence (ECL)
reagent kit (Amersham).

The X-ray films (Fuji Film Corp., LTD., Tokyo, Japan)

containing protein bands were scanned by the Eagle Eye II scanner (Stratagene, La Jolla,
California) with Eagle Sight software. The scanned images were quantified by
ImageQuant software version 5.1 (Molecular Dynamics, Sunnyvale, CA). The values
were expressed as a percentage of the CYP1A1 or CYP2B1 positive controls.
Immunofluorescence Techniques
1- Single Label Immunofluorescence for Bax.
Single label immunofluorecence for Bax was conducted as described in previous
chapters with minor modification. Briefly, the slides were heated in the oven at 60 ºC for
15 minutes. The slides were deparaffinized and rehydrated in xylene in 3 sequential 6minute immersions, a 3 minute immersion in 100 % alcohol, 3 minutes in 90 % alcohol, 3
minutes in 80 % alcohol, and 5 minutes in distilled water. The antigen was retrieved by
0.01M disodium ethylenediamine tetraacetate (Fischer Scientific, Fair Lawn, New Jersey
07410), pH 8.0 in a microwave heating procedure. Non-specific binding was blocked by
5 % BSA in PBS (IgG free) (Sigma) for 10 minutes at room temperature (RT) followed
by 5% pig serum in PBS (Biomeda Corporation Foster City, CA) for 10 minutes at RT.
The slides were then rinsed with distilled water and a polyclonal affinity purified rabbit
anti-Bax antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA) was applied
overnight at a dilution of 1:20 with phosphate buffer saline (PBS) at room temperature.
For the negative control, one slide was incubated with non-immune rabbit serum
(BioGenex, San Ramon, CA). To maximize the antibody binding, slides were incubated
for 2 h at 37 ºC the following day after which slides were washed and Alexa 594conjugated goat anti-rabbit antibody (Molecular probes, Eugene, Oregon) was applied for
2 h at RT in the dark.
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2- Double Label Immunofluorescence for CYP1A1 and Cytokeratins 8/18
The double-label immunofluorescence was carried out by the same method
described in chapter one.
3- Triple Label Immunofluorescence for Bax, CYP1A1 and Cytokeratins 8/18
Triple label immunofluorescence for Bax, CYP1A1, and cytokeratins 8/18 was
conducted to localize the expression of Bax and CYP1A1 in AT-II cells (with
cytokeratins 8/18 marker) or NT-II cells. The technique was similar to the single label
and double label procedure. The only difference was the application of three polyclonal
antibodies for Bax, CYP1A1, and cytokeratins 8/18, which were added to the same slide
simultaneously. For Bax, a polyclonal affinity purified rabbit Bax antibody (Santa Cruz
Biotechnology Inc., Santa Cruz, CA) was applied at a dilution of 1: 20 with PBS. For
CYP1A1, a polyclonal affinity purified goat antibody (Santa Cruz Biotechnology Inc.,
Santa Cruz, CA) was applied at a dilution of 1:10 with the diluted Bax antibody. For
cytokeratins 8/18, a polyclonal Guinea pig anti-cytokeratins 8/18 (Research Diagnostic,
Inc., Flanders, NJ) was applied at a dilution of 1:5 with the diluted mixture of and Bax
CYP1A1 antibodies. The mixture of the polyclonal antibodies was applied by the aid of
capillarity between folded slides and kept in the humidity chamber overnight at RT. For
the negative control, one slide was incubated with rabbit serum (BioGenex, San Ramon,
CA). On the second day and after 2 h incubation of the slides at 37 ºC, a mixture of
appropriate secondary antibodies was applied on the slides for 2 h at RT in the dark. This
mixture contains an Alexa 594-conjugated donkey anti-rabbit (Eugene molecular probe),
Alexa 350-conjugated donkey anti-goat (Molecular Probes), and FITC-labeled donkey
anti-G pig (Research Diagnostic, Inc., Flanders, NJ) antibodies for detection of Bax,
CYP1A1, and cytokeratins 8/18, respectively.
Morphometry of Immunofluorescence
In all kinds of immunofluorescence, single, dual, or triple, five images were
captured from the proximal alveolar (PA) regions, where most of the instilled particles
were deposited. PA regions are areas of the lung that are located next to visible alveolar
ducts. PA regions are different from random alveolar (RA) regions, which are areas
without visible alveolar ducts. We concentrated on immunofluorescence in alveolus
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rather than airways because we have previously demonstrated that in CD-exposed rats,
changes in CYP1A1 expression principally occur in the alveolus. The threshold ranges
for red (Bax), blue (CYP1A1) and green (cytokeratins 8/18) fluorescence were held
constant throughout the morphometric analysis of all images. The slides were examined
under a fluorescent photomicroscope (Olympus AX70, Olympus American Inc., Lake
Success, NY) and images were captured using the 40x objective and a Quantix cooled
digital camera (Photometrics, Tucson, AZ) with QED camera plugin software (QED
Imaging, Inc., Pittsburgh, PA).
1- Morphometry for Immunofluorescence of Bax Alone (Single Label)
The area of Bax expression in the alveolar septum was measured by commercial
morphometry software (Metamorph Universal Image Corp., Downingtown, PA) and
expressed as µm2. In addition, the number of cells expressing Bax in the tissue sections
was counted and expressed as number per 40x field.
2- Morphometry for Double Label Immunofluorescence
Morphometry of images captured from slides stained for CYP1A1 and
cytokeratins 8/18 was conducted by the same method described in the previous chapters.
3- Morphometry for Triple Label Immunofluorescence
The morphometric analysis of immunofluorescence triple labeling for Bax,
CYP1A1, and cytokeratins 8/18 was mainly intended to investigate the sites of
localization of CYP1A1 and Bax expression and investigate the effect of caspase
inhibition on the expression of both proteins.

Quantification of triple-label

immunofluorescence includes the following:
A- Quantification of Bax Expression in the Entire alveolar Septum
The total red area (representing Bax) expressed in the whole alveolar septum
(including AT-II and NT-II cells) per 40x field was directly quantified by commercial
morphometry software (Metamorph Universal Image Corp.). The total Bax area was
expressed in µm2 and designated as Q.
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B- Quantification of CYP1A1 Expression in the Entire Alveolar Septum
The total blue area (representing CYP1A1) expressed in the whole alveolar
septum (including AT-II and NT-II cells) per 40x field was measured directly by the
commercial morphometry software (Metamorph Universal Image Corp.). The total
CYP1A1 area was expressed in µm2 and designated as T.
C- Quantification of Cytokeratins 8/18 Expression in the Entire Alveolar
Septum
The total green area (representing cytokeratins 8/18) per 40x field was measured
as an indicator of AT-II cell hypertrophy and hyperplasia. This area was also measured
by the commercial morphometry software (Metamorph Universal Image Corp.) and
expressed in µm2.
D- Quantification of Bax Expression in AT-II Cells
The area of Bax expression in AT-II cells was quantified and expressed as µm2 by
measuring the red area (representing Bax) colocalized to the green area (representing
cytokeratins 8/18 in AT-II cells) by the following mathematical formula:
A = P x Q where;
A is the area of Bax that co-expressed (colocalized) with cytokeratins 8/18 in
alveolar type II cells,
P is the percent of Bax expressed in type II cells measured by the Metamorph
software, and
Q is the total Bax area expressed in the whole alveolar septum (including alveolar
type II and non-type II cells) measured by Metamorph software as in A.
In addition to the area measured, the number of type II cells expressing Bax was
counted per field.
E-Calculating the Proportional Bax Expression Colocalized Within AT- II Cells
The proportional colocalization of Bax within type II cells was obtained by the
following calculation:
A (The area of Bax colocalized in type II cells as calculated in D, expressed as µm2)
Total green area of cytokeratins 8/18 expression, expressed as µm2
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This calculation helped to investigate the relationship of Bax expression in the
AT-II cells. Because AT-II cells increased in number and size in CD exposure, this
estimate was normalized Bax expression per area of AT-II cells.
F-Quantification of the area of CYP1A1 Colocalized with Bax
The area of blue color (representing CYP1A1) colocalized (co-expressed) with
red area (representing Bax) expressed as µm2 was calculated from the following formula:
M=G x Q where;
M is the area of CYP1A1 that co-expressed (colocalized) with Bax
G is the percentage of CYP1A1 expression colocalized with Bax when measured
by the Metamorph software, and
Q is the total Bax area expressed in the whole alveolar septum (including alveolar
type II and non-type II cells) measured by Metamorph software as in A.
G- Calculating the Proportional CYP1A1 Colocalized Within Bax Area
The proportional CYP1A1 expression within Bax area was calculated by the
following formula:
M (the area of CYP1A1 colocalized with Bax as calculated in E, expressed as µm2)
Q (the total area of Bax expression, expressed as µm2)
This measurement is very important as it reflects the changes in CYP1A1
expression relative to Bax expression in CD exposure.
H-Quantification of CYP1A1 Colocalized with Cytokeratins 8/18 (in AT-II
Cells).
The area of CYP1A1 colocalized with cytokeratins 8/18 in AT-II cells (expressed
2

as µm ) was obtained by the following formula:
C = R x T where;
C is the area of CYP1A1 that co-expressed (colocalized) with cytokeratins 8/18 in
alveolar type II cells,
R is the percent of CYP1A1 expressed in type II cells measured by the
Metamorph software, and
T is for the total CYP1A1 area expressed in the whole alveolar septum (including
alveolar type II and non-type II cells) measured by the Metamorph software.
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I- Proportional CYP1A1 Expression in AT-II Cells
The proportional CYP1A1 expression in AT-II cells was calculated as follows.
C (the area of CYP1A1 colocalized with cytokeratins 8/18, expressed as µm2)
Total green area of cytokeratins 8/18 expression, expressed as µm2
This measurement reflects the CYP1A1 expression in AT-II cells but adjusts for
area increases associated with the hypertrophy and hyperplasia of AT-II cells.
J- Counting AT-II cells with Colocalized CYP1A1 and Bax
Since CD exposure was associated with AT-II hyperplasia, the number of AT-II
cells that concomitantly express both CYP1A1 and Bax was counted per field of triplestained sections and the percentage of these cells from the total number of AT-II cells
was calculated as follows:
Number of AT-II cells with Bax and CYP1A1 X 100
Total number of AT-II cells
This percentage adjusts the number of cells expressing both Bax and CYP1A1 for
the increased number of AT-II cells associated with CD exposure.
TUNEL Assay
Apoptosis of pulmonary cells was determined by terminal deoxynucleotidyl
transferase-mediated dUTP nick end-labeling (TUNEL) assay using a TUNEL assay kit
(Promega, Madison, WI) as previously described (Wang et al, 2002). In this apoptotic
detection system, the fragmented DNA of apoptotic cells is measured by catalytically
incorporating fluorescein-12-dUTP at the 3/- OH end of the DNA using the enzyme
Terminal Deoxynucleotidyl Transferase (TdT) to form a polymeric tail in a TdTmediated dUTP Nick-End labeling process as previously described (Gavrieli et al, 1992).
Briefly, the formalin-fixed, paraffin embedded lung sections were deparaffinized by 3
sequential immersions in xylene, 3 minute each followed by rehydration with ethanol
(100%, 95%, and 80%), 3 minutes each. The slides were then incubated with protease
type 1 (Sigma) diluted with PBS at a concentration of 4%. For a positive control, a
positive control slide was prepared by incubating the slide with DNase 1 (Sigma Aldrich
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Co, St. Louis, MO) for 30 minutes at room temperature. All slides were then incubated
with the equilibration buffer for 10 minutes, during which the reaction mix per slide was
prepared by addition of 10 µl of the nucleotide mix to 90 µl equilibration buffer and 2µl
terminal deoxynucleotidyl transferase (TdT) enzyme, according to the manufacturer
instruction. For negative control, the 2 µl of TdT was replaced by 2 µl distilled water in
the fluorescein-12-dUTP reaction mix. The slides were then incubated for 1 h at 37 ºC in
the dark. Propidium iodide (100 µl/slide) (Sigma) was applied for 2 minutes as a counter
stain, after which slides were rinsed in distilled water and cover slipped using anti-fade
Gel/Mount (Biomeda, Foster City, CA) and kept at 4 ºC in the dark until examined. The
slides were examined under a fluorescent photomicroscope (Olympus AX70, Olympus
American Inc., Lake Success, NY) and images were captured using the 40x objective and
a Quantix cooled digital camera (Photometrics, Tucson, AZ) with QED camera plugin
software (QED Imaging, Inc., Pittsburgh, PA). Five images were randomly captured from
PA regions and another five images were randomly captured from the RA regions. The
number of positive and negative (normal) cells per field was counted. The results were
expressed as a percentage of the positive apoptotic cells.
Bronchoalveolar Lavage (BAL) and Cell Differentials
Lungs were lavaged and cells collected as previously described (Hubbs et al,
2001). To assess pulmonary inflammation, cell counts of alveolar macrophages (AM) and
polymophonuclear leukocytes (PMN) were obtained using a Coulter Multisizer II
(Coulter Electronics, Hialeah, FL) as previously described (Castranova et al, 1990)
BAL Fluid Albumin Concentration
BAL fluid albumin concentrations were determined as an indicator of the integrity
of the blood-pulmonary barrier.

BAL fluid albumin was measured colorimetrically at

628 nm based on albumin binding to bromcresol green (Doumas et al, 1971) using a
commercial assay kit (Albumin BCG diagnostic kit, Sigma Chemical Company, St.
Louis, MO) and a COBAS MIRA Analyzer (Roche Diagnostic Systems, Montclair, NJ).
BAL Fluid Lactate Dehydrogenase Activity
BAL fluid lactate dehydrogenase (LDH) activities were determined as a marker of
cytotoxicity, and were determined by monitoring the LDH catalyzed oxidation of lactate
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to pyruvate coupled with the reduction of AAD+ at 340 nm (Gay et al, 1968) using a
commercial assay kit (Roche Diagnostics Systems, Montclair, NJ) and a COBAS MIRA
Analyzer (Roche Diagnostic Systems, Montclair, NJ).
Zymosan-Stimulated AM Chemiluminescence
AM chemiluminescence was determined as an indicator of reactive oxygen and
nitrogen species production by AM.

The use of unopsonized zymosan in the

chemiluminescence assay allows only AM chemiluminescence to be measured, because
unopsonized zymosan stimulates AM chemiluminescence (Castranova et al, 1987) but
not PMN chemiluminescence (Hill, 1977; Allen, 1977). The assay was conducted in a
total volume of 0.50 ml HEPES buffer. Resting AM chemiluminescence was determined
by incubating 1.0 x 106 AM/ml at 37°C for 20 minutes, followed by the addition of 5amino-2,3-dihydro-1,4-phthalazinedione (luminol) to a final concentration of 0.08 µg/ml
followed by the measurement of chemiluminescence. To determine zymosan-stimulated
chemiluminescence, unopsonized zymosan was added to a final concentration of 2 mg/ml
immediately prior to the measurement of chemiluminescence.

All chemiluminescence

measurements were made with an automated luminometer (Berthold Autolumat LB 953,
Gaithersburg, MD) at 390-620 nm for 15 minutes. The integral of counts per minute
versus time was calculated.

Zymosan-stimulated (total) chemiluminescence was

calculated as the cpm in the zymosan-stimulated sample minus the cpm in the resting
sample.

1400W (N-(3-aminomethyl)benzyl)acetamidine•HCl), an inhibitor of nitric

oxide synthase, was used to determine the component of zymosan-stimulated (total)
chemiluminescence that is attributable to reactive nitrogen species. 1400W sensitive
chemiluminescence

was

determined

by

subtracting

the

zymosan-stimulated

chemiluminescence from cells pre-incubated with 1 mM 1400W from the zymosanstimulated (total) chemiluminescence from AM without 1400W.
Histopathology
Tissue sections from control and CD- exposed lungs were routinely stained with
hematoxylin and eosin (H&E) to assess histopathological changes. The changes were
evaluated by a board-certified veterinary pathologist while blinded to the exposure status.
The changes of interest that have been evaluated were: alveolitis (alveolar inflammation),
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and AT-II cell hyperplasia and hypertrophy. The histopathologic changes were scored on
a scale ranging from 0 to 5 for each of the severity and distribution scores to produce a
sum pathology score of 0 to 10 for each slide, as previously described (Hubbs et al,
1997).
Statistical Analyses
The dose responsive effects of coal dust instillation on quantity of AMs, PMNs,
levels of albumin, LDH, AM CL, NO-dependent CL for BAL fluid, Bax area and cells
with Bax/field, we used Proc Reg for the regression analysis.

All analyses were

performed with SAS version 8.2 and using Proc Mixed or using Proc Reg. In all other CD
response study comparisons, where we compared between groups, the model was single
factor repeated measures analysis of variance. In the case of comparison between PA
with RA, the model was three factors repeated measures analysis of variance. In all other
caspase inhibitor study comparisons, where we compared between groups, the model was
two factors repeated measures analysis of variance. All pairwise comparisons were
performed using a pooled variance estimate and Fisher’s LSD (Least Significant
Difference). All results were considered statistically significant at p<0.05.
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RESULTS
Effect of CD Exposure on Bronchoalveolar Lavage Fluid (BALF) Analysis
CD-exposed rats had a dose-dependent increase in polmorphonuclear leucocytes
(PMN) (r2=0.974, p= 0.002) (Figure 1A). The alveolar macrophage (AM) count was
significantly increased in the BALF of all rats exposed to CD and BNF compared to rats
treated with BNF alone (Figure 1B). AM CL and NO-dependent CL were significantly
increased in rats exposed to 40 mg CD and BNF compared to rats treated with BNF alone
(Figures 2A and B, respectively). The intrapulmonary deposition of CD particles
produced pulmonary cytotoxicity manifested by elevation of LDH activity in a dosedependent fashion (r2=0.963, p=0.003) (Figure 3A). The blood barrier in the lung was
also damaged in CD- exposed groups as shown by elevation of BALF albumin, which
was statistically significant following exposures to 20 and 40 mg/kg CD and BNF
compared to BNF alone (Figure 3B).
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Figure 1. CD exposure increased the BALF PMN count in a dose-dependent manner (A).
A significant PMN increase is shown in rats exposed to 10, 20, and 40 mg/rat CD and
BNF compared to control saline and BNF. Alveolar macrophages cell count was
significantly higher in all groups exposed to CD and BNF compared to the control saline
with BNF (B). The bars are values of means and SE for each treatment. *Significantly
different from control group at P < 0.05.
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Figure 2. In A, AM CL was significantly higher in rats exposed to 40 mg CD and BNF
compared to control saline and BNF. In B, the NO-dependent AM CL was also
significantly increased in rats exposed to CD 40 mg and BNF compared to control saline
and BNF. The bars are values of means and SE for each treatment. *Significantly
different from control group at P < 0.05.
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Figure 3. The effect of coal dust exposure on pulmonary cytotoxicity and vascular
leakage in BNF-exposed rats. In A, CD exposure causes a dose-dependent increase in
LDH that indicates pulmonary cytotoxicity (r2=0.963, p=0.003). In B, CD increased BAL
albumin in all CD-exposed rats that was statistically significant in rats exposed to 20mg
and 40 mg/rat CD compared to control indicating pulmonary vascular damage.
*Significantly different from control group at P < 0.05.
Effect of CD Exposure on Bax Expression in Lung Cells
By using single label immunofluorescence, Bax was mainly localized within cell
cytoplasm (Figure 5). The area of Bax expression quantified by morphometric analysis
was increased in a dose-dependent manner by CD exposure in rats (r2= 0.6541, p<0.001).
In addition, the average number of lung cells expressing Bax counted per field was
increased in a dose-dependent fashion by the CD exposure (r2= 0.903, p<0.001) (Figure
4).
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Figure 4. Bax expression is enhanced in a dose dependent manner by CD exposure in
rats. In A, the area of Bax expression in lung cells measured in µm2 is increasing in a
dose responsive fashion by exposure to 2.5, 10, 20, and 40 mg/rat CD. Similarly, the
number of positive cells for Bax is increased in a dose dependent manner by exposure to
2.5, 10, 20, and 40 mg/rat CD. * significantly different from saline/BNF at p<0.05.
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Relationship Between Bax Expression and CYP1A1 Induction
To investigate a relationship between Bax expression and the suppression of
CYP1A1 induction mediated by CD exposure, tissue sections were labeled for Bax,
CYP1A1 and cytokeratins 8/18 (AT-II markers) (immunofluorescence triple labeling). In
this procedure, cells containing CYP1A1 fluoresce blue, cells containing Bax fluoresce
red, and cells containing cytokeratins 8/18 fluoresce green (Figure 7). The proportional
CYP1A1 expression within Bax area was calculated with the aid of morphometric
analysis as described in the Materials and Methods. The proportional CYP1A1
expression within area of Bax expression was gradually reduced by increasing CD
exposure (Figure 6A) suggesting that the probability that cells concomitantly expressed
Bax and CYP1A1 decreased with CD exposure. In contrast, the proportional expression
of Bax colocalized with cytokeratins 8/18 (AT-II cell markers) gradually increased by
increasing the CD exposure (Figure 6B) suggesting that CD exposure increases Bax
expression in AT-II cells. In addition, the percentage of AT-II cells that concomitantly
expressed both Bax and CYP1A1 gradually decreased with increasing the CD exposure
(Figure 6C) suggesting an inverse relationship between CYP1A1 induction and Bax
expression in AT-II cells. In contrast, the percentage of AT-II cells expressing Bax only
gradually increased with the CD exposure (Figure 6D)
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Figure 6. Graphical representation of morphometric analysis of tissue sections stained for
CYP1A1, Bax, and cytokeratins 8/18 showing the relationship between CYP1A1
induction and Bax expression in AT-II cells. In A, the area of CYP1A1 colocalized with
Bax in AT-II cells is reduced with CD exposure. In B, the area of Bax expression in ATII cells is increased by the CD exposure. In C, the percentage of AT-II cells expressing
both CYP1A1 and Bax is gradually decreased by CD exposure. In D, the percentage of
AT-II cells expressing Bax alone is gradually increased by CD exposure.
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Effect of Caspase Inhibitor, Q-VD-OPH on EROD
BNF-induced EROD activity was significantly reduced in CD-exposed rats but
not affected by the caspase inhibitor, Q-VD-OPH (Figure 9).
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Figure 9. The pan-caspase inhibitor, Q-VD-OPH, did not alter the inhibition of EROD
activity by CD exposure. No significant change is observed between rats receiving the
inhibitor and those receiving the vehicle (DMSO). CD-exposed rats with DMSO have a
significant reduction (P=0.03) of EROD activity compared to saline-exposed rats with
DMSO. Also, CD-exposed rats with the Q-VD-OPH caspase inhibitor have a significant
reduction (p=0.001) of EROD activity compared to saline-exposed rats with the inhibitor.
* and □ mean significant difference at p<0.05 from rats unexposed to CD.
Effect of Caspase Inhibitor, Q-VD-OPH on PROD
CD significantly reduced PROD activity in BNF-treated rats and this effect
persisted when caspases were inhibited by Q-VD-OPH. PROD activity in CD-instilled
rats injected with Q-VD-OPH was not significantly different from CD-exposed rats
injected with the vehicle (DMSO) (Figure 10).
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Figure 10. Effect of the caspase inhibitor, Q-VD-OPH on PROD activity. CD-exposed
rats injected with the inhibitor are not significantly different from CD-exposed rats
injected with vehicle (DMSO). PROD activity in rats exposed to CD and injected with
DMSO is significantly (p=0.003) reduced compared to saline-exposed rats and injected
with DMSO. PROD activity in rats exposed to CD and injected with the caspase inhibitor
is significantly lower (p=0.001) than that in saline-exposed rats and injected with the
inhibitor. è and * significantly different from saline/BNF/DMSO and
saline/BNF/Inhibitor at p<0.05, respectively.
Effect of Caspase inhibitor on CYP1A1 Induction by Western Blot
The CYP1A1 apoprotein measured by western blot analysis was not significantly
changed in Q-VD-OPH-exposed rats. As observed in previous studies, CYP1A1 protein
was

significantly

reduced

in

CD-exposed

rats

compared

to

BNF

controls

(Saline/BNF/DMSO). In rats injected with Q-VD-OPH, CD exposure reduced induction
by BNF, albeit not significantly (Figure 11).
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Figure 11. Western blot showing the effect of the Q-VD-OPH on CYP1A1 protein. The
CYP1A1 protein is significantly reduced in CD-exposed rats with DMSO compared to
saline-exposed rats with DMSO. The CYP1A1 protein is reduced (not significantly) in
CD-exposed rats with Q-VD-OPH compared to saline-exposed rats with Q-VD-OPH. No
significant change in CYP1A1 protein in CD-exposed rats with Q-VD-OPH vs. CDexposed rats with DMSO. The designation of lanes is described above the blot. C is the
positive control. MW is the molecular weight marker. * significantly different from
saline/BNF/DMSO at p<0.05.
Effect of Caspase Inhibitor on CYP2B1 by Western Blot
The amount of CYP2B1 was not significantly affected by caspase inhibition with
Q-VD-OPH. (Figure 12).
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Figure 12. Western blot analysis of CYP2B1. In A, CD-exposed rats injected with DMSO
have non significant reduction of CYP2B1 protein compared to saline-exposed rats
injected with DMSO. In B, CD-exposed rats injected with caspase inhibitor have non
significant reduction of CYP2B1 protein compared to saline-exposed rats injected with
caspase inhibitor. No significant change is observed between CD-exposed rats injected
with caspase inhibitor and CD-exposed rats injected with DMSO. C. Quantification graph
of CYP2B1 protein in different treatment groups. The designation of lanes is described
above the blot. C is the positive control. MW is the molecular weight marker.
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Immunofluorescence Double Labeling
By using the morphometric analysis of immunofluorescent double stained tissue
sections for CYP1A1 and cytokeratins 8/18 (Figure 14), the areas of induced CYP1A1
expression were highly significantly reduced in NT-II cells (p<0.001), the entire alveolar
septum (p<0.001), but not significantly reduced in AT-II cells by CD in BNF-exposed
rats with DMSO compared with BNF exposed rats (Figure 13B, C, A). The proportional
CYP1A1 expression in AT-II cells was significantly reduced (0.0028) by CD in BNFexposed rats with DMSO relative to BNF-exposed rats (Figure 13D).

Similar results

were obtained when caspases were inhibited. In rats treated with both Q-VD-OPH and
BNF, CD exposure reduced the area of CYP1A1 expression in NT-II cells, the entire
alveolar septum as well as the proportional CYP1A1 expression in AT-II cells (p<0.001,
p<0.001, p<0.001, respectively) (Figure 13B, C, and D, respectively), but not
significantly reduced the area of CYP1A1 expression in AT-II cells (Figure 13A).
However, the areas of CYP1A1 expression in AT-II cells, NT-II cells, and the entire
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alveolar septum as well as the proportional CYP1A1 expression were not significantly
changed in CD-exposed rats with inhibitor compared with CD-exposed rats with DMSO
(Figure 13A, B, and C, respectively).
The injection of caspase inhibitor did not produce significant changes in AT-II
cell hyperplasia and hypertrophy in CD-exposed rats (data not shown).
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Figure 13. Morphometric analysis of dual immunofluorescence for BNF-induced
CYP1A1, and cytokeratins 8/18 in the PA regions of rats receiving either the caspase
inhibitor, Q-VD-OPH or the vehicle (DMSO) and IT CD or vehicle (saline). In A, the
area of CYP1A1 expression in AT-II cells is not significantly decreased in rats receiving
CD (CD/BNF/DMSO or CD/BNF/Inhibitor) and not significantly affected by caspase
inhibition (Saline/BNF/Inhibitor or CD/BNF/Inhibitor). In B, the area of CYP1A1
expression in NT-II cells is highly significantly decreased in rats receiving CD
(CD/BNF/DMSO or CD/BNF/Inhibitor) and not significantly affected by caspase
inhibition (Saline/BNF/Inhibitor or CD/BNF/Inhibitor). In C, the area of CYP1A1
expression in the entire alveolar septum is highly significantly decreased in rats receiving
CD (CD/BNF/DMSO or CD/BNF/Inhibitor) and not significantly affected by caspase
inhibition (Saline/BNF/Inhibitor or CD/BNF/Inhibitor). In D, the proportional CYP1A1
expression in AT-II cells is highly significantly or significantly decreased in rats receiving
CD (CD/BNF/DMSO or CD/BNF/Inhibitor, respectively) and not significantly affected
by caspase inhibition (Saline/BNF/Inhibitor or CD/BNF/Inhibitor). ** indicate highly
significant change at p<0.001. * indicates significant difference at p<0.001.
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Effect of the Caspase Inhibitor on Bax Expression in PA regions
Single label immunofluorescence for Bax (Figure 16) showed that the injection of
the caspase inhibitor, Q-VD-OPH in CD-exposed rats highly significantly reduced the
area of Bax expression (p<0.001) (Figure 15 A) and significantly decreased the number
of cells expressing Bax (p=0.001) (Figure 15B) compared to CD-exposed rats injected
with the vehicle (DMSO). However, the CD exposed rats injected with caspase inhibitor
had a significant increase in the Bax area and highly significant increase in number of
cells expressing Bax (p=0.005, p< 0.001, respectively) compared to saline-exposed rats
injected with the inhibitor, suggesting that caspase inhibitor reduced Bax expression but
not to the level of control values. These results were also confirmed by
immunofluorescence-triple labeling for Bax, CYP1A1, and cytokeratins 8/18 (data not
shown).
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Figure 15. Morphometric analysis of single-labeled immunofluorescence for Bax in the
PA region of BNF-treated rats after IT exposure to CD or saline with and without caspase
inhibition with Q-VD-OPH. In A, the letter a above the bar indicates highly significant
increase in the area of Bax expression in CD/BNF/DMSO group relative to
saline/BNF/DMSO group. Bax expressed as area (µm2) is highly significantly reduced by
the caspase inhibitor (letter b above the bar), but still significantly increased relative to
Saline/BNF/inhibitor group (letter c above the bar). In B, the letter d above the bar
indicates highly significant increase in the number of cells expressing Bax
CD/BNF/DMSO group compared to saline/BNF/DMSO group. The number of cells
expressing Bax is significantly lower in CD/BNF/inhibitor group relative to
CD/BNF/DMSO group (letter e above the bar), but highly significantly higher than
Saline/BNF/inhibitor group (letter f above the bar). Letters a, b, d, and f indicate highly
significant difference at P<0.001. Letters c and e indicate significant difference at
P<0.05.
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Effect of the Caspase Inhibitor on CD-Induced Apoptosis.
In the TUNEL assay, the apoptotic cells were identified by their green
fluorescence, while the non-apoptotic nuclei were identified by their red color (Figure
18). The percentage of apoptotic cells was highly significantly increased (P<0.001) in
CD-exposed rats in the absence of caspase inhibition with Q-VD-OPH. In addition, the
percentage of apoptotic cells was significantly increased (P<0.048) in CD-exposed rats
injected with caspase inhibitor compared to saline-exposed rats injected with caspase
inhibitor. In the CD-exposed rats, injection of caspase inhibitor significantly decreased
the percentage of apoptotic cells (p=0.013) (Figure 17).
Comparison of the percentage of apoptotic cells in PA regions vs. RA regions
revealed a significant increase in the PA regions compared to the RA regions in all
groups including Saline/BNF/DMSO, CD/BNF/DMSO, Saline/BNF/inhibitor, and

Percentage of positive apoptotic cells

CD/BNF/Inhibitor with p<0.013, <0.001, 0.025, and <0.001, respectively (Figure 17).
R A r e g io n s
P A r e g io n s

6

b ,c

5

4

e ,f ,g

3

a

2

d

1

0

Sal

BN
in e /

F /D

MSO

BN
CD/

F /D

M SO
S a li

ne

F/
/B N

In h i

b it o
CD

r
F/
/B N

In h i

b ito

r

Figure 17. TUNEL assay results showing the percentage of apoptotic cells in BNFtreated rats after IT exposure to CD or saline with and without Q-VD-OPH caspase
inhibitor. The percentage of apoptotic cells is highly significantly increased in rats with
CD/BNF/DMSO compared rats with saline/BNF/DMSO (letter b above the bar). Rats
with CD/BNF/inhibitor have a significant lower percentage of apoptotic cells than rats
with CD/BNF/DMSO (letter f above the bar). Caspase inhibition does not entirely
abrogate the CD-induced apoptosis and the apoptotic cell percentage in rats with
CD/BNF/inhibitor is significantly higher that in rats with saline/BNF/inhibitor (letter e
above the bar). The percentage of apoptotic cells in the PA region is significantly higher
than that in the RA regions of all groups (letters a, c, d, and g above the bars). Letters a, d
and e, and f indicate significant difference at p<0.05. Letters b, c, and g indicate highly
significant difference at p<0.001.
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Histopathological Changes
Histopathological alteration associated with CD exposure included histiocytic and
suppurative alveolitis with accumulation of dark brown particles within the cytoplasm of
many alveolar macrophages. No significant difference was observed in CD-exposed rats
injected with the caspase inhibitor compared to those injected with vehicle (Figure 19) by
scoring the severity and distribution of these changes. AT-II hyperplasia and hypertrophy
was demonstrated in CD-exposed rats (Figure 20). No histopathological changes were
observed in rats exposed to BNF or BNF and the caspase inhibitor, Q-VD-OPH
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Figure 19. Histopathological score of the severity and distribution of alveolitis and AT-II
hyperplasia in CD-exposed rats injected with caspase inhibitor or DMSO. No significant
change is noted between rats with CD/BNF/DMSO and rats with CD/BNF/Inhibitor.
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DISCUSSION
In this study, the pathogenesis of suppression of CYP1A1 induction in rat lung by
coal dust exposure was investigated. Because alteration of pulmonary xenobiotic
metabolism is an interplay with the inflammation (Ma and Ma, 2002), the inflammatory
reaction to CD exposure was assessed by examining the BALF. We demonstrated that
CD exposure enhanced the pulmonary inflammatory reaction in a dose-responsive
fashion. This inflammatory reaction was illustrated by a significant increase of the AM
and a dose-dependent recruitment of PMN in the BALF (Figure 1). The inflammatory
reaction to CD instillation was previously investigated by Blackford and coworkers
(Blackford et al, 1997) who demonstrated that CD had a less inflammatory effect than
silica but a more potent effect than carbonyl iron and titanium oxide in inducing
pulmonary inflammation. Activation of AM by CD exposure was also statistically
significant in the highest dose (40mg/rat) as shown by measuring the AM CL (Figure
2A).
BAL Fluid Analysis: AM
Alveolar macrophages are free lung cells located on the surface of the small
airways and the alveoli (Weibel, 1973). These cells act as the lung’s first line of defense
against the toxic effects of inhaled particles, as they play a major role in the protection of
lung against these particles. The reaction of alveolar macrophages to the inhaled particles
is complex. Upon contact with the particles, AM release superoxide anion (Sweeney et
al, 1981), which can be monitored by the measurement of chemiluminescence (Miles et
al, 1978; Castranova et al, 1980). Eventually, AM engulf these foreign particles and
attempt to digest them by releasing lysosomal enzymes into phagocytic vacuoles (Myrvik
and Evan, 1967). By histopathological examination of CD-exposed rats, dust-laden AM
were localized in the alveolar spaces and interstitial tissue as a dark brown pigment
(Figure 20).
BAL Fluid Analysis: LDH
LDH is an intracellular enzyme; therefore, its presence in the acellular BALF
indicates cytotoxicity (Porter et al, 2002). The elevation of LDH, in a dose-dependent
fashion, with CD exposure (Figure 3A) suggests that the reduction of CYP1A1
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expression in alveolar septa could partly be attributed to cellular injury and cytotoxicity
caused by CD exposure. Dinsdale and co-workers (Dinsdale and Verschoyle, 2001)
showed a reduction of CYP2B1 expression and protein activity in rat lung following
selective destruction of alveolar type I cells by pneumotoxic and nonpneumotoxic
trialkylphosphrothiolate. In addition, the significant release of albumin in CD-exposed
rats (Figure 3B) indicates damage of the blood-pulmonary barrier. Damage of the
endothelial cells of alveolar septum by CD exposure could contribute to the total
reduction of the CYP1A1 induction, since these cells are considered as NT-II cells that
express CYP1A1 (Pairon et al, 1994).
BAL Fluid Analysis: Nitric Oxide
Nitric oxide is a short lived inter- and intracellular messenger produced by a
family of enzymes known as nitric oxide synthases (NOSs) and brings about a number of
bioregulatory functions (Kim and Sheen, 2002). The inducible nitric oxide synthase
(iNOS) gene expression and NO production by BAL cells can be measured indirectly as
NO-dependent chemiluminescence (John et al., 1997). The NO-dependent AM CL was
significantly increased in rats exposed to 40 mg/rat CD with BNF compared to control,
which suggests that CD induces nitric oxide synthesis by alveolar macrophages. This
result is consistent with those reported by Blackford et al (1997) who concluded that coal
mine dust is among the various dusts that induce iNOS by the recruited PMN into the
alveolar spaces. In addition, Bingham et al, 1977, reported that in vivo exposure of rats to
coal dust results in an increase in mRNA for the inducible form of nitric oxide synthase
and elevated nitric oxide production by pulmonary phagocytes. The significant reduction
of EROD activity and CYP1A1 protein (as shown by western blot) in rats exposed to
40mg/kg CD with BNF with enhancement of the NO-dependent AM CL of the same
group suggests a possible relationship between nitric oxide and CYP1A1 expression and
activity. Since NO reacts with hemeproteins, CYP1A1, being a heme-containing protein
may represent a target of NO within the cells (Wink et al., 1993). Therefore, a number of
studies have investigated the effect of NO on CYP450s. Nitric oxide binds to the heme
moiety of the P450s forming an iron-nitrosyl complex in rat hepatic cells in a reversible
phase, subsequently preventing the binding of oxygen which normally occurs in the
course of catalytic sites and suppresses CYP1A1 functional activity (Wink et al, 1993).
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The same study also showed irreversible inhibition of CYP1A1 and CYP2B1 activity due
to destruction of the integrity of the primary structure of hemeprotein, resulting from the
action of nitrogen oxides produced from the oxidation of nitric oxide by oxygen. Not
only does nitric oxide inhibit CYP1A1 activity, but in vitro studies on Hepa I cells (Kim
and Sheen, 2002) suggest that nitric oxide also down-regulates the CYP1A1 expression
by inhibition of CYP1A1 promoter activity.
Bax Expression and CD exposure: Effect of the Caspase Inhibitor
Our results showed that Bax expression was increased in a dose dependent
manner by CD exposure (Figures 4 and 5). In single label immunofluorescence, the Bax
staining was mainly localized in the cytoplasm of cuboidal cells, suggestive to be AT-II
cells. In triple label immunofluorescence, the proportional Bax expression in AT-II cells
as well as the percentage of AT-II cells expressing Bax were gradually increased by
increasing the exposure to CD particles (Figure 6B and 6D, respectively), suggesting that
Bax was upregulated in the hyperplastic AT-II cells. These findings were consistent with
those of Guinee et al (1997) who demonstrated that Bax expression was increased in
diffused alveolar damage and was confined to hyperplastic AT-II cells. The proportional
CYP1A1 expression localized in the area of Bax as well as the percentage of cells
expressing both Bax and CYP1A1 were decreased by CD exposure (Figures 6A and 6C,
respectively). Thus, by increasing the dose of CD exposure, the Bax expression was
increased, but the CYP1A1 expression was reduced, suggesting an inverse relationship
between the expression of both proteins.
Bax is a pre-apoptotic protein related to BCL-2 family (Oltvai et al, 1993) that
predisposes cells to apoptosis (Narasimhan et al, 1998). We initially hypothesized that
the overexpression of Bax in lung cells increased the apoptosis of these cells and was
etiologically associated with the depression of CYP1A1 induction observed in CD. To
investigate this relationship, we used the newly developed pan caspase inhibitor, Q-VDOPD, which is known to inhibit caspases 1, 3, 8, and 9 to block the apoptotic pathway.
Apoptosis of lung cells, assessed by TUNEL assay, showed that CD significantly
increased the percentage of apoptotic cells (Figures 17 and 18) and rats injected with the
caspase inhibitor had a significantly lower percentage of apoptotic cells. This finding
indicated that Q-VD-OPH suppressed caspase-dependent apoptosis in pulmonary cells.
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This result coincided with that obtained by Caserta et al, (2003) who demonstrated the
effectiveness of

the Q-VD-OPH in blocking three different pathways of apoptosis;

caspase 9/3, caspase 8/10, and caspase 12. Although the caspase inhibitor significantly
reduced the apoptosis, the percentage of apoptotic cells remained significantly elevated
by IT CD exposure, suggesting that the caspase inhibitor did not completely inhibit the
apoptotic pathway. In addition, the caspase inhibitor significantly suppressed the Bax
expression in lung cells, but the area of Bax expression was significantly higher than the
control saline, suggesting that the caspase inhibitor down-regulated but did not prevent
all Bax expression in alveolar cells.
Although Bax expression and apoptosis in pulmonary cells were significantly
suppressed by Q-VD-OPH, the BNF-induced CYP1A1-dependent EROD activity,
CYP2B1-dependent PROD activity, the CYP1A1 and 2B1 proteins measured by Western
blot, and the CYP1A1 measured by immunofluorescence, were not significantly affected.
These findings suggested that the CD-associated suppression of CYP1A1 was not caused
by cellular apoptosis and Bax expression. Moreover, it seemed that Bax expression was a
feature of hyperplastic alveolar cells and the association of Bax with CYP1A1 expression
was a simple association.
Effect of Caspase inhibitor, Q-VD-OPH on Pulmonary Inflammation
Histopathological alterations, such as alveolitis and AT-II hyperplasia and
hypertrophy were not significantly different between CD-exposed rats injected with the
caspase inhibitor and the CD-exposed rats injected with DMSO. This result suggested
that the caspase inhibitor did not suppress the inflammatory process associated with CD
exposure. Other pan caspase inhibitors, such as N-benzyloxy-carbonyl-Val-Ala-Asp- (Omethyl)-fluoromethyl ketone (zVAD-fmk) and BOC-Asp-(O-methyl)-fluoromethyl
ketone (BOC-Asp-fmk) were reported to reduce the neutrophil accumulation in the lungs
of silicotic mice by 50 % (Borges et al, 2002). However in our study, the principally
histiocytic inflammatory reaction in the lungs of CD-exposed rats was not significantly
suppressed by the injection of Q-VD-OPH. While previous studies have used Q-VD-OPH
mostly in mice (Borges et al, 2002; Melnikov et al, 2002), our study clearly demonstrated
inhibition of both Bax and apoptosis, but not pulmonary morphologic changes induced by
CD. In addition, inhibition of Bax expression and apoptosis by caspase inhibition did not
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significantly affect downregulation of CYP1A1 induction associated with CD. This
suggested that neither caspase pathways, Bax, nor apoptosis was the cause of inhibition
of CYP1A1 induction in alveolar cells.
Studies from a number of laboratories, principally investigating the liver or using
in vitro systems, have noted an association between inflammation or inflammatory
mediators and decreased activity of CYP isoforms including CYP1A, CYP2A, CYP2B,
CYP2D9, CYP3A, CYP2E1 and CYP4A (Warren et al, 1999; Siewert et al, 2000; Jover
et al, 2002; Carcillo et al, 2003). Recent studies suggest that diesel exhaust particles and
carbon black downregulate CYP2B1 in the rat lung (Rengasamy et al, 2003). Consistent
with these findings, we have found that respirable coal dust exposure also downregulated
CYP2B1 in the rat lung. In addition, the induction of CYP1A1 was downregulated by
respirable coal dust exposure in the rat lung. In our studies, the downregulation of
CYP2B1 and induced CYP1A1 was positively associated with the severity of
inflammation.
Previous studies suggest that during inflammation, some mediators and
transcription factors, such as tumor necrosis factor alpha (TNF-α), interleukin 6, nitric
oxide and the nuclear factor kappa B (NF-κB) are upregulated and turned on (Ke et al,
2001; Baldwin, 1996; Hubbard et al, 2002; Jover et al, 2002) and suppress CYP1A1. A
physical association between the RelA subunit of the NF-κB and the AhR has been
demonstrated in vitro by immunoprecipitation (Tian et al, 1999) producing an inactive
complex that prevents the AhR from binding to the enhancer sequences of CYP1A1 (Ke
et al, 2001). Moreover, NF-κB has been demonstrated to inhibit the ligand-induced
acetylation of histone H4 at the CYP1A1 promoter area, especially around the TATA box
region, thus preventing the AhR/Arnt heterodimer from binding to the XRE at the DNA
resulting in downregulation of the CYP1A1 expression (Tian et al, 2002). TNF-α
suppresses the activity of RNA polymerase II, resulting in interference with the CYP1A1
elongation in Hepa1c1c7 cells (Tian et al, 2003). TNF-α also enhances the FasLmediated apoptosis in T lymphocytes (Bonetti et al, 2003), which occurs upstream of Bax
activation. Another inflammatory mediator released during pulmonary inflammation is
nitric oxide (Fubini and Hubbard, 2003). Nitric oxide demonstrated a high binding
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affinity to the heme moiety of the P450s forming an iron-nitrosyl complex in rat hepatic
cells suppressing the CYP1A1 metabolic activity (Wink et al, 1993). Nitric oxide is also
associated with induction of apoptosis in IC-21 macrophage cell line, which was
inhibited by the nitric oxide synthase inhibitor (Siewert et al, 2000). However, Sutherland
et al (2001) concluded that the macrophage-derived nitric oxide provides an antiapoptotic
mechanism that protects AT-II cells from undergoing apoptosis and enhancing the lung
injury. NF-κB seems to play an important role in protection against apoptosis (Ravi et al,
2001) because the RelA-/- mouse fibroblasts are highly sensitive to TRAIL [(Tumor
necrosis factor (TNF)-related apoptosis-inducing ligand)]-induced apoptosis. In addition,
TRAIL-induced apoptosis of human hepatoma cells by interferon alpha is associated with
NF-κB inactivation (Shigeno et al, 2003).

However, other studies showed that,

activation of NF-κB is correlated with the ability of p53 to induce apoptosis in tumor
cells (Ryan et al, 2000). Based upon these studies, Chen et al (2003) concluded that
opposite functions of NF-κB are dependent upon the expression of its subunits, where cRel and RelA function as proapoptotic and antiapoptotic proteins, respectively.
Consequently, the NF-κB may contribute to or inhibit the apoptotic response in different
conditions (Ryan et al, 2000). However, inflammation-associated suppression of hepatic
CYP1A activity in vivo appears to be TNF-α independent but IL-6 dependent. CYP1A
downregulation occurs in p55/p75 knockout mice that lack TNF-α receptors (Warren et
al, 1999) but does not occur in interleukin-6 knockout mice (Siewert et al, 2000).
Our studies extend these findings to associate the in vivo downregulation of
pulmonary CYP2B1 and induced CYP1A1 with inflammation that results from respirable
coal dust exposure. In addition, we have found that the downregulation of pulmonary
CYP2B1 and induced CYP1A1 appear inversely related to, but not caused by, Bax
expression in the cytosol. Because we found that caspase inhibition had no effect on
downregulation of CYP2B1 or induced CYP1A1 by respirable particle exposure, a
possible explanation for these findings would be an event or signaling cascade producing
both Bax activation and the CYP downregulation. These would include nitric oxide, NFκB and/or initiators of alveolar epithelial proliferation. It is also possible that Bax
expression and CYP downregulation are independent events which are both observed in
response to respirable particle exposures. Additional studies will be needed to fully
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elucidate how CYP2B1 activity and CYP1A1 induction are inhibited in the particleexposed lung.
In conclusion, CD exposure enhanced the inflammatory processes of rat lung in a
dose-dependent manner by increasing the recruitment of AM and PMN. In addition, CD
caused significant cytotoxicity of lung cells and damage of the blood-pulmonary barrier
as demonstrated by elevation of LDH and albumin levels, respectively. CD also enhanced
the Bax expression and induced apoptosis in lung cells, changes that were inversely
associated with suppression of CYP1A1 induction by CD exposure.
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CHAPTER 7
GENERAL DISCUSSION
Cytochrome P450s (CYPs) generate continued interest because these enzymes
play critical roles in the metabolism of drugs, carcinogens, dietary xenobiotics and steroid
hormones (James and Whitlock 1999). The CYP proteins are heme-containing proteins,
which are members of a gene super-family involving almost 1000 members in species
ranging from bacteria to plants and animals (Hasler et al, 1999). Cytochrome P4501A1
(CYP1A1) has garnered particular interest because of its association with cancer.
CYP1A1 is involved in the conversion of organic compounds, like polycyclic aromatic
hydrocarbons (PAH) in cigarette smoke, into carcinogenic intermediates (Crepsi et al,
1989; Shimada et al, 1989; Eaton et al, 1995) that can bind to DNA producing adducts
and initiate lung cancer.

Moreover, the expression of CYP1A1 can be induced at the

transcriptional level by its substrates. The transcriptional regulation of the CYP1A1 gene
by PAH is mediated through ligand-dependent activation of the aryl hydrocarbon
receptor (AhR). Upon activation by binding of specific substrates, AhR translocates to
the nucleus and dimerizes to the aryl hydrocarbon receptor nuclear translocator (Arnt)
protein. This heterodimer binds to the xenobiotic responsive element (XRE) in the
regulatory region of the CYP1A1 gene inducing expression (Ma and Whitlock 1997; Tian
et al, 1999). It has been demonstrated that high inducibility of CYP1A1 is considered to
be a risk factor for lung cancer in tobacco smokers (Anttila et al, 2001; Ishibe et al,
2001). Since smokers are exposed to carcinogenic PAH, their CYP1A1 expression is
induced (Willey et al, 1997). Therefore, modification of the induced CYP1A1 is of great
importance in smoking populations.
Coal is a fossil fuel mined all over the world. Coal mine dust generated during
underground coal mining results in significant respiratory exposure to coal miners.

In

addition to the carbon, which is the main component of coal, it also contains oxygen,
nitrogen, hydrogen, and trace elements, including non-coal minerals. The trace element
may include copper, nickel, cadmium, boron, antimony iron, lead, and zinc (Sorenson et
al 1974).

Some of these trace elements can be cytotoxic and carcinogenic in

experimental models (Castranova, 2000). Mineral contaminants include quartz, kaolin,
mica, pyrite and calcite (Parkes, 1994).

Coal dust inhalation is associated with

194
development of a respiratory disease in coal miners called coal workers’ pneumoconiosis
(CWP). CWP is categorized according to severity into simple and complicated CWP. In
the simple form, black dust macules appear and consist of dust-laden macrophages
concentrated near respiratory bronchioles.

In complicated CWP, also described as

progressive massive fibrosis (PMF), the nodules are larger (> 1 cm diameter) and more
numerous.

These nodules contain increased amounts of collagen, coal dust, and

inflammatory cells (Castranova, 2000). Silicosis is another occupational lung disease
resulting from exposure to the crystalline form of the mineral silicon dioxide or silica
(Driscoll and Guthrie, 1997). Silicosis is characterized by inflammation and fibrosis in
the lower respiratory tract.
Recently, crystalline silica, but not coal dust, has been classified as a class I
carcinogen by the International agency for Research on Cancer (IARC, 1997). However,
epidemiological data demonstrate that lung cancer in coal miners occurs less frequently
than in the general population after adjustment for age and smoking (Meijers et al, 1991
and Kuempel, 1995). In addition, lung cancer risk in coal miners exposed to silica and
PAH was absent or even less than those exposed to silica alone (Cocco et al, 2001).
Evaluating the lung cancer risk in coal miners is complex because these people are
usually exposed to a mixture of environmental contaminants, including the particulate
matter and the PAH in cigarette smoke. In this study, we investigated the hypothesis that
pulmonary CYP1A1 induction is inhibited by exposure to respirable particles. We also
investigated whether or not alterations in lung cell populations are associated with
suppression of CYP1A1 induction.
Using the rat model alone to investigate these hypotheses was not satisfactory
because of the existing debate concerning the species differences between rats and
humans regarding their response to inhaled particles (Mauderly, 1997). Moreover, the
pattern of particle retention as well as the lung tissue response to respirable particles in
rats may not be predictive of those of primates who are exposed to poorly soluble
particles, particularly at high occupational exposures (Nikula et al, 1997). For these
reasons, we used rabbit and sheep, in addition to rats, to investigate our hypotheses.
Generally, in any model, the respirable particulate suspension was intratracheally instilled
by the aid of feeding needle in rats, endotracheal tube and laryngoscope in rabbits, and
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flexible fiberoptic bronchoscope in sheep. In sheep, the right apical lobes were instilled
while the left apical lobes were collected as internal controls. Then the CYP1A1 was
induced in these animals by IP injection of the model PAH, beta-nephthoflavone.
In general, our results consistently showed that the CYP1A1-dependent EROD
activity, measured by spectrophotometric assay was significantly lower in BNF-induced
animals instilled with particles than control animals (receiving BNF alone). The
suppression of activity was associated with reduction of CYP1A1 protein measured by
Western blot. At the cellular level, the amount of CYP1A1 expression quantified by
immunofluorescence was reduced in AT-II cells, NT-II cells, and the entire alveolar
septum upon CD and silica exposure. Because particles tend to accumulate in different
areas of the lung (Nikula et al, 1997), the CYP1A1 expression was compared in areas
with maximal deposition to areas with minimal deposition. The area with maximum
deposition was localized in the proximal alveolar regions, near microscopically visible
alveolar ducts. For comparison, we also selected areas without visible alveolar ducts that
were designated as random alveolar (RA) regions as internal controls.

We found

significant reduction of CYP1A1 expression in AT-II cells, NT-II cells and whole
alveolar septum in the PA regions relative to RA region. This result suggests that the celltype specific suppression is localized to areas where the particles aggregate. In addition,
PROD activity, an indicator of the major constitutive pulmonary CYP which is not
inducible in lung (CYP2B1, CYB2B4, and CYP2B in rats, rabbits, and sheep,
respectively) was consistently lower in BNF-exposed animals instilled with particles than
the controls.
In our study, the exposure to particles, either CD or silica, produced AT-II
hyperplasia and hypertrophy. However, the expression of CYPA1 in the hyperplastic and
hypertrophied AT-II cells was markedly reduced. A number of studies showed that P450
activities and the level of P450 apoproteins decreased after partial hepatectomy and
regeneration of hepatic cells (Hino et al, 1974, Presta et al, 1980, Klinger and Karge,
1987, and Ronis et al, 1992). It was suggested that replication, but not transcription is the
prioritized activity of DNA to regenerate the cells (Liddle et al, 1989, Waxman, 1989,
Morgan et al, 1985, and Steer, 1995). In our studies, AT-II cells may behave similarly in
regenerating other damaged epithelial cells instead of transcripting genes. Consistent with
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that are the higher levels of CYP2B1 protein expression and mRNA in freshly isolated
alveolar type II cells, but this level is diminished in cell culture (Lag et al, 1996).
Moreover, the inducibility of CYP1A decreases slightly in the rat liver bearing
hyperplastic nodules (Degawa et al, 1995). Consistent with that, the inducibility of
CYP1A1 by BNF was markedly reduced in early lung hyperplastic foci associated with
urethane exposure and the lung carcinomas were devoid of CYP1A1 protein expression
(Forkert et al, 1998). All of these previous studies suggest that CYP protein is
downregulated in proliferating cells - - a finding which is consistent with the
downregulation of CYP1A1 induction and CYP2B in our study of CD-exposed rats and
lambs.
In rats, CD exposure enhanced the inflammatory reaction in a dose dependent
fashion by recruiting AM and PMN to the alveolar spaces as demonstrated by BAL fluid
examination. Cytotoxicity and damage of the pulmonary blood barrier were also
associated with CD exposure. Alveolitis and accumulation of dust-laden AM in the
alveolar spaces and interstitial tissue were major findings in histopathological
examination of CD-exposed sections. These findings were consistent with those
described by Nikula et al (1997). Kuempel et al (2003) also demonstrated dose-response
relationships between respirable crystalline silica in BAL collected from coal miners and
pulmonary inflammation. AMs become activated after phagocytosis of CD particles and
release a wide range of mediators including oxidants, cytokines, growth factors, and
proteases that result in cellular damage or hyperplasia of epithelial cells, such as AT-II
cells (Schins and Borm, 1999). In vitro exposure of AMs to CD particles elicited a
significant release of TNF-α and interleukin-6, compared to titanium dioxide that was
used as a biologically inert control dust (Vanhee et al, 1995). In addition, many other
mediators such as IL-1, IL-6, TGF-β1, and TGF-β2, and fibronectin are elevated in the
BALF of miners with radiographically defined CWP (Vallyathan et al, 2000). Our results
of BALF analysis of rat lung are consistent with the previous studies and support the
hypothesis that CD triggers inflammatory reactions and changes in cell populations in the
deep lung in rats.
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In sheep, the histopathological changes were comparable to those of rats, although
relatively modest. Changes were bronchointerstitial pneumonia with accumulation of
dust-laden alveolar macrophages, mainly in the interstitial tissue with only occasional
foci of alveolar histiocytosis- - a finding that is consistent with a lavaged lung.
In rabbit silicosis, pulmonary inflammation varied from histiocytic and
suppurative to necrogranulomatous bronchointerstitial pneumonia with thickening of the
alveolar walls. Alveolar lipoproteinosis was a common finding in silica-exposed rabbit
alveoli. In some rabbit lungs with silicosis, silicotic nodules were demonstrated.
Consistent with that, previous studies on rats showed that the pulmonary reaction to the
inhalation of crystalline silica resulted in lung damage, inflammation, and hypertrophy
and hyperplasia of AT-II cells (Miller et al, 1986; Miller et al, 1990; Castranova et al,
2002).
The association of inflammation with the suppression of cytochrome P450 has
previously been demonstrated in vitro and in vivo in several model systems. The acute
inflammatory reaction caused by subcutaneous injection of bacterial lipopolysaccharide
(LPS) (Morgan, 1989), turpentine (Kobusch et al, 1986), and viral and bacterial infection
(El-Kadi and Du Souich, 1998) depressed the constitutive hepatic P450 expression. In
addition, exposure of cultured hepatocytes to inflammatory stimuli decreases total
microsomal cytochrome P450, P450-catalyzed enzyme activities, and levels of P450
proteins and mRNAs (Morgan, 1997). A number of proinflammatory mediators may play
a role in CYP1A1 downregulation during inflammation. For example, TNF-α interferes
with CYP1A1 elongation during the transcription process by inactivating the RNA
polymerase II (Tian et al, 2003). In addition, nuclear factor kappa B (NF-κB) interacts
with AhR and thus interfered with AhR-mediated CYP1A1 induction (Ke et al, 2001).
NF-κB also inhibited the ligand-induced acetylation of histone H4 at the promoter region
of CYP1A1 gene and consequently prevented CYP1A1 induction in Hepa1c1c7 cells (Ke
et al, 2001). Interleukin-6 (IL-6) also depressed multiple hepatic P450 isoforms such as
CYP1A1, 1A2, 3A4, and 4A1, and IL-1β downregulates 1A2, 2C11, 2D6, 2E1, and 3A
(Fukuda et al, 1992; Trautwein et al, 1992, Donato et al, 1997, Parmentier et al, 1997).
In our study, using an in vivo rat model, we demonstrated that CD exposure elicited
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pulmonary inflammation in a dose-responsive manner and suppressed the CYP1A1dependent EROD activity in a dose dependent manner, suggesting an inverse relationship
between CYP1A1 induction and activity, and pulmonary inflammation.
Our data illustrated that CD exposure enhanced the expression of Bax in a dose
dependent manner suggesting that CYP1A1 suppression of induction was associated with
upregulation of Bax expression, particularly in hyperplastic AT-II cells. Since Bax is a
pre-apoptotic protein related to BCL-2 family (Oltvai et al, 1993) that predisposes cells to
apoptosis (Narasimhan et al, 1998), we investigated whether the suppression of Bax
expression and cellular apoptosis could ameliorate the suppression of CYP1A1 induction
by CD exposure. Therefore, the pan-caspase inhibitor, Q-VD-OPH was administered IP
to inhibit the Bax expression and the caspase-dependent apoptotic cascade. Our data
showed that although Bax expression and CD-induced apoptosis of pulmonary cells were
suppressed by the caspase inhibitor, the CD-mediated suppression of CYP2B1 expression
and CYP1A1 induction was not significantly affected. This suggested that the
suppression of these CYP isoforms appears to be inversely related to, but not caused by,
Bax upregulation and apoptosis induction. One possible explanation for this result is that
an event or signaling pathway initiated by one or more of the inflammatory mediators,
which such as nitric oxide or NF-κB, produced both Bax expression and CYP
downregulation. Alternatively, the Bax upregulation and CYP downregulation were
independent events observed in particle-exposed lung.

.
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CONCLUSIONS
The present study investigated the suppression of CYP1A1 induction by exposure
to particles and its association with morphological changes in cell populations in the
particle-exposed lung. To overcome the limitation of using rats alone as a model for
human, rabbits and sheep were also utilized to explore our hypothesis. Our results
demonstrated that:
1- CYP1A1 induction was suppressed by pulmonary exposure to CD and silica.
2- CYP1A1-dependent EROD activity was inhibited in a dose dependent-manner by CD
exposure in rats and was significantly suppressed by silica exposure in rabbits and CD
exposure in sheep.
3- PROD activity was suppressed in rabbit silicosis and rat and sheep CWP models,
respectively. PROD activity is dependent upon the major constitutive CYP isoform of the
lung which are CYP2B1 and its analogs, CYP2B4 and CYP2B in rats, rabbits, and sheep,
respectively.
4- CD or silica exposure reduced CYP1A1 expression at sites of alveolar damage with
reduced expression in alveolar epithelial cells, including AT-II cells and NT-II cells.
5- Silica and CD increased the size (hypertrophy) and number (hyperplasia) of AT-II
cells and reduced CYP1A1 expression in these cells.
6- CD particles induced dose-dependent pulmonary inflammation, manifested by
recruitment of alveolar macrophages and polymorphonuclear leucocytes.
7- CD particles upregulated the preapoptotic Bax protein expression in alveolar epithelial
cells and triggered apoptosis.
8- Inhibition of cellular apoptosis and Bax expression by the caspase inhibitor, Q-VDOPH, did not affect CYP1A1 induction and its suppression by CD exposure
These findings support the hypothesis that CYP1A1 induction and its metabolic
activity (EROD) are inhibited by particle exposure and associated with pulmonary
inflammation.
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FUTURE STUDIES
1-Investigating the effect of the nitric oxide produced during particle-associated
inflammatory processes on CYP1A1 induction by using nitric oxide synthase
knockout mice.
2-Investigating the effect of NF-κB and TNF-α on CYP1A1 induction by using
antisense olignucleotides techniques.
3- Localization of CYP1A1 expression in different alveolar non-type II cells by using
makers of alveolar type I cells, endothelial cells, and alveolar macrophages.
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